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SUMMARY
Laboratory tests can help to confirm or establish the 
diagnosis of a fungal infection. They can provide an 
assessment of the response to therapy and monitor the 
resolution of infection. Histopathological recognition of 
fungal elements in biopsy or post-mortem material provides 
the definitive diagnosis of fungal infection. To improve 
the performance and specificity of histopathological 
procedures, a peroxidase anti-peroxidase <PAP> staining 
method for the specific recogni tion of Aspergillus,
Candida and Rhizopus was developed. To verify the 
specificity of the primary fungal antisera employed in 
this method, they were tested for cross-reactivity by CIE, 
double diffusion and ELISA. The antisera were also tested 
for their cross-reactivity in PAP staining using sections 
cut from agar blocks inoculated with fungi. This novel 
technique was developed to simulate fungi growing in three 
dimensions through tissue. The sera could be tested 
against a wide range of fungi for which no control 
material was available. The agar block method conferred 
the additional advantage of having no background staining 
to complicate the results.
The PAP technique was shown to be extremely sensitive 
and able to detect fungi in tissue sections. It was able 
to distinguish fungi by genus and showed little cross- 
reactivity among the genera tested. However, none of the
xiii
antisera were completely specific and cross-reactivity was 
evident among species within the same genus.
The various manifestations of Candida infection present 
a range of diagnostic problems. One presentation of 
candidosis is Candida endophthalmitis. The epidemiology of 
this disease, in a cluster of heroin addicts from the 
Castlemilk area of Glasgow, was studied. Heroin samples, 
diluent, injection paraphernalia and clinical samples were 
cultured. Isolates of Candida albicans from these samples 
were further differentiated by a biotyping system. It was 
found that there was a preponderance of one biotype. The 
source of the Candida was unlikely to be the street drug 
as diamorphine hydrochloride was shown to have antifungal 
properties. The "Jif" lemon juice used by the addicts as a 
diluent proved to be the probable source of infection. The 
SO2  content of lemons purchased in the Castlemilk area or 
from new "Jif" lemons heated to drive off the 
preservative, was lower than the recommended standard. 
Juice from lemons with reduced levels of SO2  was shown to 
be able to support the growth of C. albicans.
An experimental murine model of haematogenous C. 
albicans endophthalmitis was investigated to study the 
pathology of the disease. The model demonstrated the 
presence of yeast in murine retinae five minutes after 
infection. Over several days the yeasts were seen to 
multiply and produce pseudomycelium. Local areas of 
inflammation developed around the yeasts and these
xiv
resulted in protrusions of the retinae. The presence of 
infection was confirmed by culture of the eyes and by 
tests for the detection of Candida antigenaemia.
'JLOK
21.1. Systemic Fungal Infection In the Uni-bed Kingdom
The systemic fungal diseases most often found in the 
United Kingdom are opportunistic infections caused by 
fungi which are common as commensals or saprophytes in the 
environment. This is unlike other areas of the world, 
notably the Americas and Africa where the true primary 
pathogenic fungi Histoplasma capsulation and H. duboisii, 
Coccidioides immltis, Blastomyces dermatitidis and 
Paracoccidioides brasiliensis are endemic.
Primary systemic fungal infections are restricted in 
their geographical distribution. They are mainly 
respiratory and cases of self limiting infection are only 
recognised by a positive skin test reaction, as a result 
of hypersensitivity. However, severe and fatal generalised 
infection can occur (Chandler, Kaplan and Ajello, 1980; 
Rippon, 1974; Emmons, et al. , 1977).
The majority of systemic fungal diseases found in 
Britain are secondary or opportunistic infections, that 
is, the fungi are able to invade a host which has a 
diminished ability to overcome the organism. The fungi 
which are implicated infiltrate following depression of 
the host's immune system and infection is rare in patients 
with intact immunological systems.
However, with the increasing number of passengers 
travelling internationally some patients with primary 
systemic mycoses are now being diagnosed in Britain. These
3are people who have contracted the diseases in the endemic 
areas before visiting or returning to the United Kingdom 
(Warren, 1985; Gentles, personal communication).
Although bacteria still account for the vast majority 
of infections in compromised patients, the number of 
fungal infections in these subjects is increasing. This is 
undoubtably due to the expanding number of such patients 
with underlying predisposing factors and the eventuality 
that, more of these patients survive episodes of bacterial 
infection as a result of improved antibacterial therapy. 
This means there are increasing numbers of potential hosts 
susceptible to fungal infection. Opportunistic fungal 
infections are now recognised more often and are being 
sought more actively.
The most common systemic fungal infections in Britain 
are Candidosis, Aspergillosis, Mucormycosis and 
Cryptococcosis.
1.2. Factors Predisposing to Fungal infection
The increase in the number and type of medical and 
surgical procedures presents a greater opportunity for 
fungi to cause infection. Often it is the susceptibility 
of the host rather than the pathogenicity of the fungus 
that allows an infection to become established. Factors 
contributing to the probable occurrence of systemic fungal 
disease include the degree of exposure to the fungus
4involved, the site implicated, the portal of entry into 
the body and the immunological competence of the patient.
The most common source of infection of systemic 
candidosis is believed to be the host's own gut flora, for 
example Candida can enter the blood stream by persorption 
of the gut wall (Stone et al., 1974). Administration of
oral antibiotics results in an increase in gut carriage of 
Candida and the incidence of perianal candidosis. 
Oesophageal candidosis occurs in 5% of cancer patients. It 
may interfere with their nutrition and lead to fatal 
dissemination. The oesophagus is a common site of 
candidosis in patients suffering from the aquired immuno 
deficency syndrome (A.I.D.S.) (Chandler, 1985). Other 
common paths of entry are contaminated infusion fluids and 
cannulaewhich are contaminated at the time of insertion. 
The latter can cause local inflammation and lead to the 
spread of infection. Prolonged parenteral nutrition using 
deep veins provides another potential seat of infection. 
The lines may remain in place for a long time and the 
concurrent use of broad spectrum antibiotics supresses 
competing flora. The yeast may have been present at the 
catheter entry site or may originate in the gut and adhere 
to the catheter during a bout of candidaemia. Removal of 
the catheter and therefore the focus of infection, may 
help to clear the condition but this is not always 
possible and is often done only after the fungus has 
become established.
5Aspergillus spores form a large part of the normal air 
spora (Gregory, 1973). The respiratory tract is the part 
of the body most regularly exposed to the greatest volume 
of air and Indeed Aspergillus infections most often 
originate in the lungs. The spores are expelled from 
healthy lungs or are destroyed by the host defences. 
However, when these mechanisms are not functioning 
correctly, or if the lungs are coated with mucus, for 
example in individuals with cystic fibrosis, the spores 
may settle and cause irritation and or infection. The 
immune defences are adept at protecting man from diseases 
caused by aspergill! and this is reflected in the relative 
rarity of infections caused by these organisms in contrast 
to their ubiquity in the environment.
The lung is the organ most commonly implicated in 
Aspergillus infections and is an ideal site from which to 
spread since the fungus is provided with a readily 
accessible transport system to every part of the body.
In the United Kingdom, mucormycosis is seen less often 
than either candidosis or aspergillosis but the 
zygomycetes are potent pathogens of debilitated patients. 
If a patient becomes infected, mucoraceous fungi can 
spread with alarming speed. Mucoraceous fungi refer to 
fungi belonging to the order Mucorales. The genera most 
commonly involved in human disease are Mucor, Rhlzopus and 
Absldia. At present antifungal therapy is only successful 
if administered in the early stages of illness and often
6extensive surgery is required as the fungus is associated 
with extensive necrosis. This group of fungi is most often 
implicated in rhinocerebral mucormycosis in diabetic 
patients. However, it has also been associated with 
colonization and infection of burn wounds (Dennis and 
Peterson, 1971).
Cryptococcus neoformans is a capsu1atedyeast which may 
be present in the atmosphere or can be found colonising 
the crop of pigeons and is found in their droppings 
(Evans, 1969). In the United Kingdom it causes problems 
only in immunocompromised patients, which suggests it is a
weak pathogen. However in the U.S.A. and Malaysia
Cryptococcus has been reported as causing infections in 
apparently healthy subjects. The yeast may cause sub- 
clinical infection of the lungs then, in a few cases,
spread to the central nervous system. As yet there is no
explanation for this difference in the yeast's pathogenic 
role in different parts of the world.
1.3. Imnunology of Systemic Fungal Infection
Mechanisms of defence against fungal infection in a non 
compromised subject rely on both immunological and non 
immunological factors. Mon immunological factors are non 
specific and include such protectors as the skin, surface 
secretions and the host's indigenous flora. The intact 
skin inhibits establishment of infection by allowing
7dessication and turnover of the epithelium sloughs off 
potential invaders. Sebum contains fatty acids with 
antifungal properties and the complement factor Ca in 
serum inhibits the adherance of Candida to corneocytes 
(Ray, Digre and Payne, 1984).
The flushing action of secretions on mucosal surfaces 
discourages invasion and the indigenous host flora 
competes with potential pathogens (Richardson and Warnock, 
1982)
In the host at risk, the defects are primarily in the 
immunological defence system especially neutrophil T and B 
cell defects. These can be due to an underlying disease or 
to treatment of the underlying condition.
The decrease in neutrophil numbers is an important 
factor in the successful outcome of treatment of some 
solid tumors. When medication inhibits cell proliferation, 
neutrophil production is also inhibited and this renders 
the patient more prone to infection (Warnock, 1982). 
Treatment of malignancies alters the immunological host 
response. The T cell mediated response can be eliminated, 
many agents administered to prevent graft or organ 
rejection abrogate the immunological response of the 
recipient. Intermittent therapeutic treatment of such 
people has a less damaging effect on their defence system.
81.4. Candidosis
Candida Is a heterogeneous genus and a member of the 
family Cryptococcacae of the fungi Imperfect!. Species of 
the genus Candida are predominantly dimorphic fungi often 
present in the yeast form but most possess the ability to 
form true mycelium and chains of elongated yeast cells 
termed pseudomycelium.
Candidosis is the most prevalent of the opportunistic 
fungal infections of man and it can also be the most 
difficult to diagnose. Candida species can cause 
superficial, subcutaneous and systemic disease. Unlike the 
other infections discussed, yeasts of the genus Candida 
form part of the normal microbial flora of man and usually 
live as commensals, in equilibrium with the host and other 
micro-organisms. The yeast is never present as a 
saprophyte in the blood or internal organs but it is a 
resident of the gastrointestinal tract of a substantial 
proportion of the population, especially people who are 
receiving medical attention. It is a facultative pathogen 
and can only produce disease if the host's defences are 
impaired otherwise it exists as a commensal with man.
There are no geographical limits to the disease as man is 
the most important reservoir of infection.
9Although eight species of Candida have been 
implicated in disease of man, by far the most frequently 
encountered species is C. albicans. It may be involved in 
superficial infection of the skin, nail folds and oral and 
vaginal thrush. The largest reservoir of Candida in man is 
the gastrointestinal tract and the principal source of 
systemic infection is the host's endogenous flora. Candida 
may enter the host's blood by persorption from the 
digestive tract but the site of invasion for systemic 
disease is difficult to confirm. Invasive forms of 
candidosis are rarely primary diseases. They are diseases 
of ill individuals with some defect of their immune 
system. The Candida adheres to the host tissue, may 
produce damaging toxins and if present in sufficient 
numbers, can overwhelm the patient's defence mechanisms.
There are several predisposing factors which contribute 
to an individual developing systemic or disseminated 
disease. These include neoplasia, leukaemia, 
immunosuppressive therapy, surgery especially 
gastrointestinal <Griffin et al., 1973), diabetes,
endocrine disorders, general serious Illness and narcotic 
drug addiction. Griffin et al., in 1973 published a study 
of 21 patients with candidaemia and ophthalmic lesions, of 
which 17 had gut and abdominal surgery. Often the
10
bacterial flora of the gut is suppressed before such 
procedures but the fungal commensals are not eradicated.
The presence of an indwelling catheter is an important 
factor in a patient's predisposition to systemic candidal 
disease and becomes a more important consideration the 
longer it remains in place, particularly if it is used for 
parenteral nutrition. There has been speculation that the 
catheter entry site is the initial site of infection but 
this is difficult to prove. An alternative hypothesis 
suggests the plastic surface of the catheter provides a 
site for adhesion of Candida circulating in the blood 
after persorbtion from the gut and offers a situation from 
which dissemination can occur. Hutritive solutions 
entering the blood through these catheters provide the 
organism with a rich growth medium as hyperalimentation 
fluids are high in glucose, amino acids and lipids. Their 
high osmolarity inhibits bacterial growth.
Antibacterial agents are often cited as an important 
consideration in the dissemination of candidal disease 
(Warnock, 1982). They may irritate the gut epithelium, 
disturb the ecosystem of the host's micro-organisms or 
suppress the host defences directly or indirectly.
The clinical manifestations of candidosis are numerous 
but several are well recognised.
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The superficial forms of Candida infection occur when 
there is damage to the skin, especially if the skin is 
very moist, or if the balance of micro-organisms on the 
mucous membranes is disturbed.
1.4.1. Oral
Oral candidosis occurs most frequently in infants who 
are thought to acquire the infection from their mother's 
birth canal. It is also a prevalent infection in people 
receiving radiotherapy for neck and head cancer. In adults 
it is linked to hormonal or immune problems. Stomatitis in 
denture wearers and angular cheilitis can be caused by 
Candida although in the latter situation it is usually a 
secondary i nvader.
1.4.2. Vaginal
Many otherwise apparently healthy women suffer from 
vaginal candidosis at some time or other. The incidence is 
increased during pregnancy when the pH of the vagina is 
low <Odds, 1979), when the woman is on antibacterial 
therapy and with the use of oral contraceptives. The 
symptoms are acute pruritis, discharge, irritation, 
itching and there may be white lesions on the vulva and 
vagina. The infection may spread to the perianal and pubic
12
area and inside thighs. Moreover, Candida may coexist with 
Chlamydia and Trichomonas.
1.4.3. Cutaneous
This infection occurs, most often, in intertriginous 
areas where there is local moisture, maceration or 
occlusion, for example submammary folds, axillae and nail 
folds. Cutaneous candidosis can be difficult to diagnose 
by clinical appearance. The skin is often erythematous, 
scaly and moist, there may be pustules and vesicles and 
development of pruritis may occur (Roberts, Hay and 
M-“=ken2 ie, 1984). The disease may resemble eczema, 
pemphigus, drug eruptions, psoriasis, seborrhoeic 
dermatitis or dermatophytosls. Candida paronychia is an 
occupational disease associated with longterm immersion of 
hands in hot water and has been well described by Gentles 
and La Touche <1969). Paronychia is a painful chronic 
infection of the nail folds and may be associated with 
bacterial co-infection. Superficial disease may also 
present as intertrigo in infants and incontinent patients 
and as onychia in previously damaged nails.
1.4.4. Chronic Mucocutaneous Candidosis
This malady first manifests itself in childhood, with 
candidosis often being detected before the immune
13
disorders which predispose the individual to this chronic 
candidal infection. C. albicans is the only species 
implicated. The underlying factor in this disease is a 
cellular immune defect associated with a genetic complaint 
involving the thymus. It is believed to be a T-cell 
defect, as antibodies to C. albicans are found in these 
patients. B-cell immunity is intact and the activity of 
the host's macrophages is unimpaired. The first indication 
of the disease is oral thrush in the white 
pseudomembraneous form, then angular cheilitis and lip 
fissures develop. There may be spread to the larynx and 
occasionally the oesophagus. Vaginal thrush is also seen 
in female patients. Candida onychia and paronchyia arise 
and there may be dry, mild erythematous skin lesions 
<Dwyer, 1981).
C. albicans is the species most frequently involved in 
systemic disease but several other species have also been 
implicated including C. guillermondii, C. krusei, C. 
parapsi losis, C. tropical is and C. glabra ta <Torulopsis 
glabrata). Recently C. tropical is and C. krusei have 
become noticeably more involved in infections of leukaemic 
patients.
There may be involvement of a number of deep sites or 
there may be a focal site of Infection. Candidaemia may be
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a danger sign as it might be a prelude to dissemination in 
immunocompromised hosts.
1.4.5. Gastrointestinal Tract
The most frequently infected site associated with this 
form of candidosis is the oesophagus (Blackwell, 1964). 
Oesophageal candidosis is often a precursor to 
disseminated candidal disease and this has become an 
important factor to look for in patients suffering from 
AIDS (Chandler, 1985).
1.4.6. Respiratory Tract
The lungs are an unusual site for primary infection 
although they may become involved in disseminated disease. 
It is a rare site for focal infection and it is difficult 
to diagnose this presentation unless a biopsy is obtained 
and the presence of fungal elements demonstrated in tissue 
sections.
1.4.7. Urinary Tract
The symptoms of urinary tract infection are frequency 
and dysuria. The infection usually follows catheterisation 
with obstruction of the bladder. The kidneys are the 
organs for which Candida has a predilection, although the 
reasons for this have not as yet been elucidated. This
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clinical picture is reflected in experimental animals as 
kidney metastases are frequently found in animals infected 
with. C. albicans. Symptoms of renal infection are typical 
of microbial kidney infection with candiduria, fever and 
not infrequently positive blood culture.
1.4.8. Endocarditis
Endocarditis is a relatively rare form of the disease 
but its grave prognosis and the difficulties experienced 
in its diagnosis have led to a considerable amount of 
investigation. It is generally encountered in the middle 
aged and twice as often in men as in women. The most 
common predisposing factors are prexisting heart disease, 
especially involving open heart surgery, or drug 
addiction. The most likely reason for this nidus of 
infection is the adherence of yeast, from the circulation, 
to the traumatised tissue of the heart or to a prosthetic 
implant. Joachim and Polayes <1940) were the first to 
describe the disease in a drug addict and identified the 
aetiologic agent as C. parapsilosis.
There is a confused clinical picture but the features 
are embolic phenomena, chills, fever vomiting, nausea, 
anorexia and heart failure. Endocarditis involves the 
aortic valve more often than the mitral valve but the 
tricuspid valves are infrequently implicated. This
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correlates with experimental findings that show the left 
side of the heart is more often involved than the right 
(Sande, Bowman and Calderone, 1977)
1.4.9. Central lervous System
The central nervous system <CNS> as the principal focus 
of the infection is very rare although the brain and 
meninges can be involved in disseminated infection. The 
main clinical symptoms are head and neck pain.
1.4.10. Bone and Joint
Infections of bones and joints due to Candida species 
are rarities. In adults they are usually associated with 
myelomas and are Infrequently cured. In neonates the 
common site is the knee and it occurs predominantly in 
infants with prolonged intravenous catheterisation. It is 
a manifestation of disseminated candidosis and often CNS 
involvement is a concomitant feature. This manifestation 
of candidosis has also been reported in heroin addicts 
<Collignon and Sorrell, 1983; Dupont and Drouhet, 1985)
1.4.11. Septicaemia
Candidal infections are often spread via the blood 
stream and although candidaemia is unusual it is by no 
means a rare complication in seriously ill patients. In
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adults the infection is often fatal and probably causes 
more deaths than are reported. In infants it is not often 
fatal if treated. In these patients there may be evidence 
of joint and CNS involvement. Odds <1979) reviewed the 
literature. The frequently encountered debilitating 
features of patients with Candida septicaemia are trauma 
of the thorax and abdomen, multiple antibiotic therapy or 
catheters. Any of these criteria indicate the severity of 
the illness of the host. Odds <1979) summaries the most 
susceptible case as "a seriously debilitated patient 
treated with a multiplicity of iatrogenic, medical and 
surgical procedures. M
Clinically the first signs may be general detioration 
and intermittant fever. There is pronounced leucocytosis 
in the early stages but leukopenia develops in terminal 
stages of the infection.
1.4.12. Endophthalmitis
Candida endophthalmitis presents in two forms. The 
rarer exogenous form, results from inoculation of the eye 
with an environmental source of the fungus or follows 
infection after an operative procedure (Rosen and 
Friedman, 1973; Gilbert and Novak, 1984; Edwards, 1985). 
An outbreak of Candida endophthalmitis caused by C. 
parapsilosis occurred in California, the source was
18
attributed to contaminated irrigating solution which had 
been used during intraocular surgery <0*Day, 1985; McCray 
et al., 1986).
Endogenous endophthalmitis infection arises from 
Candida being delivered to the eye via the blood stream. 
The endogenous form is becoming an increasingly important 
presentation of endophthalmitis. This is probably a 
reflection of the increase in patients with disorders 
rendering them susceptible to attack by opportunistic 
pathogens. Jones, Richards and Morgan, <1970) reviewed the 
literature of all cases of fungal endophthalmitis in the 
United Kingdom from 1880 — 1970 and could only find 30 
cases. C. albicans was the most commonly implicated 
organism and accounted for 12 of the cases. C. albicans is 
the species with the greatest propensity to cause 
infection although other species such as G. rugosa have 
been implicated CReinhardt et al., 1985). Septicaemia
caused by yeasts other than C. albicans is less likely to 
lead to eye infection <Edwards, 1985).
Endogenous Candida endophthalmitis was first described 
by Miale <1943) in a histopathological study. The disease 
is not common in healthy subjects but has been reported in 
isolated cases in women with vaginal candidosis in 
association with child birth <Michelson, Rupp and 
Efthimiadis, 1975; Cantrill et al., 1980).
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The majority of cases of Candida endophthalmitis 
reported in the literature have been described as 
complications of systemic candidosis (Fishman et al. ,
1972; Weinstein, Johnson and Moerllering, 1973; Griffin et 
al., 1973; Meyers, Lieberman and Ferry, 1973).
Endophthalmitis occurs mainly in post operative patients 
who, have undergone gastrointestinal surgery (Freeman, 
Davis and K*lcLean, 1974) and are being treated by multiple 
antibiotics and intravenous hyperalimentation subsequent 
to their surgery (DelIon, Stark and Chretein, 1975; Abel 
and Baxter, 1976; Montgomerie and Edwards, 1978; Nahata et 
al., 1981; Henderson et al., 1981). These patients develop
infection after febrile episodes and often yield Candida 
on blood culture (Abel and Baxter, 1978; Montgomerie and 
Edwards, 1978). Henderson et al. (1981) described the 
factors favouring development of Candida endophthalmitis 
in the group of patients they studied as: the alteration
of pulmonary clearing mechanisms by use of certain 
catheters, a high incidence of gastrointestinal 
haemorrhage, the propensity of C. albicans to cause 
endophthalmitis and the lack of immunosuppression. In non- 
immunosuppressed patients the eye lesions are easily seen 
compared to those found in neutropenic patients who may 
lack the ability to produce a sufficient immune response
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of polymorphonuclear leukocytes to develop visible lesions 
(Henderson et al. , 1981).
However, endophthalmitis has been reported in 
immunosuppressed people. Greene and Viernik <1972) 
described their success in treating Candida 
endophthalmitis in a patient with acute leukaemia and 
Yoshitomi, Inomata and Tanaka, <1983) reported on an 
autopsy of a case of malignant lymphoma which showed 
retinal lesions typical of candidosis.
Heroin addicts are emerging as a distinct group which 
is at risk from Candida endophthalmitis. (Section 1. 12.)
In such cases this manifestation of Candida infection may 
be present without systemic candidosis (Dally, Thomas and 
Mellenger, 1982; Collignon and Sorrell, 1983).
Although Candida endophthalmitis is a well recognised 
complication of candidosis, it occurs less frequently in 
children and babies despite newborn children having a 
deficient host defence system which probably makes them 
more at risk from infection by Candida species. The 
factors which predispose the infants to Candida 
endophthalmitis appear to be the same as for older 
patients. Palmer (1980) described a case of 
endophthalmitis after abdominal surgery and Speer, Hitter 
and Rudolph, (1980) reported a case associated with venous 
feeding and antibiotic therapy. Baley, Annable and
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Kliegman, <1981) looked at the incidence of the disease in 
premature infants. Four of eight premature infants with 
systemic candidosis had eye lesions. Candida sepsis was 
prevalent in low birth weight premature babies treated by 
antibiotics and the authors thought the course of the eye 
lesions reflected the prognosis for the patient. Baley, 
Kliegman and Fanaroff, <1984) stated that the clinical 
features of candidosis in these babies were poorly defined 
but that the underlying causes included total parenteral 
nutrition, the use of catheters and courses of broad 
spectrum antibiotics.
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1.5. Aspergillosis
The aspergilli are filamentous fungi responsible for a 
variety of diseases in man and animals. These range from 
toxicity caused by ingestion of contaminated foodstuffs, 
allergy and colonisation through to invasive disseminated 
disease.
Although there are 132 species in this genus, as 
described in the monograph by Raper and Fennel <1965), the 
species most frequently implicated as a cause of disease 
in man is A. fumigatus followed by A. flavus, A. niger and 
A. terreus. All of these aspergilli are thermotolerant.
The disease is seen in immunocompromised patients and the 
severity and clinical manifestations of the infection 
apparently depends on the debility of the host rather than 
the pathogenicity of the fungus.
The aspergilli are soil saprophytes which utilise 
decaying plant and animal debris for their nutrition. They 
produce massive numbers of airborne spores and so form 
part of the normal air spora in all areas of the world. 
They rarely invade tissue but can cause systemic infection 
in profoundly compromised individuals. Aspergillus 
infections are not communicable from one host to another. 
As these fungi are common laboratory contaminants a single 
isolation is not sufficient to establish it as the cause
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of disease. Contamination is a risk at every stage when 
handling specimens and appropriate steps must be taken to 
prevent contamination whenever possible; for example, 
consecutive early morning samples of sputum are less 
liable to be contaminated than those taken over a 24 hour 
period. The major clinical manifestations of aspergillosis 
are as follows.
1.5.1. Pulmonary
Aspergillus infection of the lungs is the most common 
manifestation of the disease in man and there are several 
different types; primary invasive, secondary invasive, 
secondary noninvasive and primary allergic 
bronchopulmonary <Al-Doory and Wagner, 1985).
Primary invasion of the lungs in a normal individual 
with an intact immune system is very rare and as a rule 
only occurs after repeated, prolonged exposure to massive 
numbers of Aspergillus spores which overwhelm the immune 
system.
Individuals with a low resistance to disease who have a 
severely debilitated immune system, for example patients 
with leukaemia or lymphomas, individuals with neutropenia 
and children with chronic granulomatous disease, are 
susceptible to secondary invasive aspergillosis. A. 
fumigatus is the species most often implicated. The
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severity of symptoms depends on the part of the lung 
infected and is sometimes overshadowed by the underlying 
condition. Patients may be acutely or chronically ill, 
they develop a non-productive cough, dyspinoea and fever. 
Dissemination to the brain, kidney and heart may occur. 
Radiological findings reveal a broad spectrum of 
radiological changes but typically there is a rounded area 
of consolidation with a radio-dense periphery around the 
flare that extends into the lung parenchyma.
The secondary noninvasive form of the disease entails 
colonisation of pre-existing cavities of the lungs caused 
by previous disease usually tuberculosis, sarcoidosis or 
ectatic bronchus. The British Tuberculosis Association in 
1970 reported that 12% of TB cases had radiological 
evidence of aspergillomas. The fungus grows as a compact 
ball either freely or it may be attached to the wall by 
fibrous exudate. The fungal ball is called an 
aspergilloma. The Aspergillus rarely invades but the 
vegetation may enlarge resulting in an i nflammatory 
reaction surrounding the cavity with fibrosis. Clinically 
it may be asymptomatic or there may be slight haemoptysis 
with a chronic productive cough with some weight loss or, 
in extreme examples, severe haemoptysis causing 
exsanguination and death. The principal distinctive 
feature is recurrent haemoptysis. In cases with increasing
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severity surgical resection is indicated. Within the 
aspergilloma there may be zonation of mycelial elements 
with pytnotic layers of host cells. This is indicative of 
dynamic evolution of the lesion. Furthermore, it has been 
postulated that endotoxins may play a role in the 
pathogenesis <Henrici, 1939; Bardana 1978).
The asthmatic and allergic bronchopulmonary forms of 
the disease occur in people previously sensitised by 
contact with the spores. The bronchopulmonary form of the 
disease is an exaggeration of the allergic condition seen 
in late onset asthma and atopic disease. Clinically, the 
signs are similar but in the bronchopulmonary state they 
are chronic and more severe. The symptoms are recurrent 
febrile episodes, severe cough, wheezing, production of 
purulent sputum with eosinophils and bronchial plugs 
harbouring fungal elements. Associated with this is 
pulmonary consolidation and peripheral blood eosinophilia. 
The mucous membranes of the bronchioles and bronchi are 
often red and congested but not invaded.
1.5.2. Paranasal
There are two forms of this disease. The first is 
noninvasive and mimics nonspecific sinusitis. It is 
unusual in the United Kingdom and is predominantly found 
in the tropics. The features that distinguish it from true
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invasion are that the patients are apparently healthy or 
may have a long history of sinusitus. It is slow to 
progress and develops over months or years. Histologically 
it is distinct as it forms a fibrosing granuloma and only 
small fragments of hyphae are found. The morphology of the 
organism in this manifestation of the disease may lead it 
to be mistaken for yeast. The most common species of 
Aspergillus causing this infection is A . flavus. The 
patient presents with unilateral facial pain and in the 
early stages surgical removal may be curative. 
Alternatively, lavage with or intravenous administration of 
amphotericin B may prove useful. It is fatal if it spreads 
to invade the CHS.
The second presentation of paranasal disease is the 
invasive form when the sinuses and the adjacent tissue are 
involved, this can simulate neoplastic disease. This form 
develops and spreads more rapidly.
Paranasal aspergillosis may be related to the 
inhalation of contaminated marijuana (Schwartz, 1985>. It 
has been cultured from samples of the drug and is 
considered a source of infection and allergy (Kagen,
1981).
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1.5.3. Otomycosi 6
A. niger is most frequently responsible for otomycosis. 
The fungus grows on epithelial scales, debris and cerumen 
in the external ear canal where it causes irritation, 
pruritis and can impair hearing. Although it is a benign 
condition it can be chronic and recurrent.
1.5.4. Onychomycosis
Invasion of nail tissues by Aspergillus species occurs 
in previously damaged finger and toe nails. Culture of 
aspergilli from these sites is not significant unless 
fungus has been seen on direct microscopical examination 
of the nail and no yeast or dermatophyte has been cultured 
(English, 1976).
1.5.5. Central lervous System
Aspergillus infections of the CHS can follow iatrogenic 
procedures or can be found in drug addicts possibly from 
contamination of the injected drug. It may also be a 
secondary problem to paranasal aspergillosis. Acute 
Aspergillus meningitis is rapidly fatal. The meningeal 
form of the disease may present with symptoms which may 
mimic a cerebral tumor with a slow onset of symptoms 
showing neurological dysfunction such as epilepsy.
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Granulomatous lesions may develop In the CNS of less 
debilitated patients such as diabetics who are able to 
mount some defence.
1.6. MUCORMYCOSIS
Mucormycosis is the most rapidly fulminating of all the 
fungal diseases. The classic description of the disease 
was written in 1943 by Gregory, Golden and Haymaker, when 
they delineated the syndrome. Pulmonary mucormycosis had 
been described previously by Furbringer in 1876 who 
attributed the infections to mucoraceous fungi. In 1885 
Paltauf described the first disseminated case and the 
rhinocerebral form.
When a person becomes infected with a fungus from the 
family mucoraceae an acute disease develops, which if left 
untreated will spread with alarming speed causing death in 
seven to ten days or less. The establishment of the 
disease may be due to a delay in phagocytic cell migration 
or a defect in phagocytic function. Amphotericin B is 
apparently the only antifungal drug able to halt the 
spread of the disease. Unfortunately drastic surgery is 
also required as the fungus causes extensive necrosis. 
<Meyer and Armstrong, 1973; Pillsbury and Fischer, 1977; 
Meyer et al. , 1979).
The mucoraceous fungi are thermotolerant and are very 
common in the environment. They are poor pathogens since, 
although they are ubiquitous and are not fastidious with 
respect to their nutrient requirements or growing 
conditions, relatively few cases of mucormycosis have been
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reported. In the United Kingdom there are on average four 
per annum (Roberts et al., 1984).
The fungus has a world wide distribution but 
environmental sources have not been linked to outbreaks 
although potted plants in hospital wards have been 
suspected sources on occasions.
It tends to be the hosts underlying susceptibility, not 
so much the organisms pathogenic potential, which leads to 
an infection being established. The fungi most frequently 
implicated in mucormycosis are Rhizopus oryzae and R. 
arrhlzus. Mucormycosis occurs most frequently in patients 
with acidosis due to uncontrolled diabetes. Other people 
at risk are malnourished children, patients suffering from 
burns, leukaemia or lymphomas (Meyer, Rosen and Armstrong, 
1972).
The fungus has a predilection for blood vessels^causing 
emboli which result in massive haemorrhagic infarction, 
with subsequent necrosis of the surrounding tissue. The 
fungus elicits a non-specific tissue response with a 
suppurative pyogenic reaction, granulomatous reactions are 
not generally found. Penetration through arterial walls 
and thrombus formation are characteristic features of this 
form of mycosis.
There are five major clinical forms of mucormycosis 
associated with different abnormalities in host defence 
mechanisms (Wong and Armstrong, 1982),
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1.6.1. Rhlnocerebral
This is the most frequently encountered form of 
mucormycosis and is most often seen in patients with 
diabetes mellitus and acidosis. It is characterised by 
unilateral facial pain and swelling, progressive invasion 
produces blindness and perforation of the palate. R. 
oryzae and R . arrhizus are the only agents to be 
implicated in this form of the infection (Rippon, 1974).
Spores settle on the mucosa of the nasopharynx, palate 
or paranasal sinuses where they germinate and invade. The 
likelihood of infection is related to the ability of the 
host's defence system to provide adequate protection. The 
diabetic, for example, may respond to treatment but the 
fungus may remain quiescent and then be reactivated during 
a subsequent episode of acidosis.
Clinical signs are a thick nasal discharge and necrotic 
areas in the septum and fistulas in the palate. This is 
accompanied by headache, tender sinuses, facial swelling, 
decreased vision and fever. Tissues show extensive 
ischaemic infarction and dry gangrene which facilitates 
the spread of the fungus across anatomical boundaries eg. 
into bone. With haemorrhagic necrosis and venous 
obstruction the extension of the disease often follows the 
routes of blood vessels and occasionally nerves or the 
lymphatic system. By these means the fungus progresses to 
the orbit and the frontal lobes of the brain. Orbital 
cellulitis is associated with a poor prognosis as it
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indicates that the organism has invaded the orbit and the 
central nervous system leading to loss of function of the 
fifth and seventh cranial nerves. Necrotic sequelae of the 
brain are irreversible and lead to coma and death.
The characteristics of this form of the disease are 
uncontrolled diabetes, orbital cellulitis and 
meningoencephalitis.
The mechanisms that reduce host resistance in diabetics 
are poorly understood but abnormal phagocyte function may 
play a role. Human serum contains a factor which inhibits 
the growth of Rhizopus but this factor does not operate in 
serum from diabetic patients <Gale and Welch, 1961>. In 
rabbits, microscopic examination of the infection reveals 
neutrophil exudates in normal animals and very few 
neutrophils in diabetic animals (Diamond et al., 1978). 
Rhizopus hyphae and spores have been shown to be damaged 
by neutrophils and ingested and killed by rabbit alveolar 
macrophages (Levitz et al. , 1986).
1.6.2. Pulmonary
Sporangiospores of causal fungi are inhaled and as they 
are small in size <2.5 - 8pm) they can reach the 
bronchioles and alveoli of the lower respiratory tract. 
After the fungus germinates, invading the mucosa and the 
blood vessels, it forms a tangled mass in the lumen which 
causes infarctions where the hyphae invade the surrounding 
tissue. The tissue necrosis leads to cavitation and death
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from pulmonary insufficiency, massive haemoptysis or 
occasionally from dissemination of the disease.
This form of mucormycosis is seen most usually as a 
complication of patients with leukaemia or lymphomas. 
Treatment with corticosteroids increases the likelihood of 
infection. The disease presents as a progressive 
nonspecific pneumonia with thrombosis and infarction.
1.6.3. Gastrointestinal
This is a rare manifestation of mucormycosis and is 
linked to malnutrition or gastrointestinal disease, the 
result of which is damage to the gut mucosa. Children 
appear to be most at risk. The infection usually 
progresses rapidly, ending in death.
1.6.4. Disseminated
Dissemination of the disease can occur in all forms 
unless treated but secondary lesions are most likely if 
the lungs are the metastatic site. On three occasions a 
predilection for the brain has been reported in heroin 
addicts who were apparently non immunocompromised (Adelman 
and Aronson, 1969; Hameroff, Eckholdt and Lindenberg,
1970; Chmel and Grieco, 1973).
1.6.5. Cutaneous
The largest group at risk from cutaneous mucormycosis 
is burn patients. Transient colonisation of the injured
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areas is not infrequent, spores invade through breaks in 
the skin. Swelling of the wound occurs and vascular 
penetration allows spread to the underlying tissues and 
the development of gangrene (Dennis and Peterson, 1971).
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1.7. CBYPTQCQCCQBIS
Fungi of the genus Cryptococcus have a worldwide 
distribution and infections attributable to these fungi 
have been reported in both immunocompetent and 
immunocompromised individuals. C. neoformans is the 
species most often involved in infection. C. neoformans is 
the imperfect state of Filobasidlella neoformans. There 
are two varieties of F. neof ormans, the mating strains of 
which are compatible with the four serotypes of C. 
neoformans. F. neoformans var neoformans is compatible 
with serotypes A and D while F. neoformans var gatti is 
compat i ble with serotypes B and C.
The disease is seen more frequently in the U.S.A. and 
Australia than in the United Kingdom and northern Europe. 
In Britain there are eight to 13 new cases every year, 85% 
of which are patients with underlying disorders <Hay et 
al., 1980). The infection generally occurs in young adults
and the middle aged, the most common debilitating 
conditions are sarcoidosis, Hodgkins lymphomas, 
malignancies and systemic lupus erythematosus and in the 
USA, also AIDS.
The disease is not contagious and is generally squired 
by inhalation of the infecting yeasts. The number of 
infections is low in relation to the yeast's wide
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distribution, this suggests that the fungus is not a 
virulent pathogen.
C. neoformans is a yeast that produces capsules in 
culture and in tissue. It is believed that the 
polysaccharide capsule confers an advantage since it 
impedes phagocytosis.
The saprophytic habitat of C. neoformans was 
established by Emmons in 1955 when he isolated the yeast 
from pigeon droppings, nests and lofts and the soil in 
their vicinity. Further work has shown that it can survive 
dessication and has a wide distribution <Staib, 1962). The 
fungus utilises low molecular weight nitrogen compounds 
such as uric acid, urea and creatine but the moisture in 
the environment, along with the pH and exposure to ultra 
violet light may influence its survival (Evans, 1969). C. 
neoformans is not good at surviving in competition with 
other micro-organisms which could be one reason for it not 
being isolated from the soil with greater frequency.
Cryptococcosis is primarily a disease of the lungs 
which is usually mild, transient and unrecognised. However; 
patients with the most commonly diagnosed form of the 
disease present with a slow progressive meningitis. The 
primary infection is always pulmonary but there may be 
dissemination with the CHS the prime target.
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1.7.1. Pulmonary
There are two forms of the pulmonary disease, a self- 
limiting, mild infection and a chronic form with lesions 
which appear as lesions of several cm in diameter on X— 
ray. The most common is a subclinical form in normal 
immunocompetent people which usually resolves rapidly, 
although if the host is exposed to a high concentration of 
C. neoformans, a chronic infection may develop. 
Sensitisation without clinical illness has been studied 
<Fink, Barboriak and Kaufman, 1968; Muchmore et al., 1968>
using intradermal skin tests with cryptococcal extracts.
In debilitated patients C. neoformans may disseminate 
from the lungs and the lungs may either become a focus of 
infection or the pulmonary lesions may heal after the 
spread of infection. There are no diagnostic symptoms but 
in most cases the signs are an asymptomatic cough with 
scanty sputum production, low grade fever, weight loss and 
pleural pain. The radiological picture is variable but 
infection tends to be in the lower lung fields, 
calcification is rare and most lesions heal as 
granulomatous foci without treatment. Massive infiltrates 
raise the possibility of dissemination especially in 
immunocompromised hosts.
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1.7.2. Central Nervous System
Infection of the CNS by C. neof ormans is the most 
frequently diagnosed form of the disease although as yet 
there is no explanation for the predilection of the fungus 
for this site. There is an incidence of underlying disease 
in 85% of cases in the United Kingdom but underlying 
disease is not as common in the U.S.A.. The drug 
amphotericin B has reduced the number of fatalities and 
flucytosine has been used successfully on occasions but 
there is recurrence in 25% of surviving cases. The 
patients present with pyrexia, frontal and temporal 
headaches, which become increasingly severe and frequent. 
There is often tenderness of the skull and neck. The 
patients experience nausea and vomiting with mental 
changes, then paralysis and coma develop. Ocular 
manifestations include papillodema, blurring of vision, 
vertigo and photophobia. The papillodema may necessitate a 
spinal tap to prevent optic damage. The cerebral spinal 
fluid <CSF> may show raised pressure, excess protein, low 
sugar concentration and a proliferation of lymphocytes 
with the occasional neutrophil. Encapsulated yeasts may be 
seen but if the lesion is restricted to the brain they 
will not be present.
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1.7.3. Cutaneous
Cutaneous lesions may accompany dissemination in 10-15% 
of cases (Roberts et al., 1984). The lesions are acneform 
pustules or papules which form ulcerated subcutaneous 
abcesses with time and often resemble those caused by 
other micro-organisms.
1.7.4. Osseous
Bone involvement occurs in 5-10% of cases and is 
accompanied by pain and swelling for several months. There 
is no characteristic radiological picture and the lesions 
are usually multiple, discrete and widely disseminated. 
This is a destructive, chronic form of the disease.
1.7.5. Visceral
In disseminated disease, any organ of the body may 
become infected and in such cases the clinical picture 
resembles tuberculosis. After the central nervous system 
the heart, testes, prostate and the eye are the most 
common sites invaded (Rippon, 1974). Infections of the 
kidney, adrenal glands, liver and spleen are less common. 
Eyes become involved by direct extension of the organism 
from the subarachnoid space or by haematogenous spread 
from other foci.
4 0
1.8. Diagnosis of Opportunistic Fungal Tnfpr.t.i i-itif;
The diagnosis of opportunistic systemic fungal 
infections often presents difficulties because the fungi 
causing the disease may form part of the normal endogenous 
flora of man or may be common laboratory contaminants. The 
mycologist must examine all the available evidence before 
deciding if the presence of an organism is of relevance. 
The patient's clinical history may help to decide the 
significance of a fungus seen on direct microscopical 
examination, on isolation in culture or from indication of 
its presence by serological techniques for detection of 
antigen or immunoglobulins associated with the fungus
1.8.1. Candidosis
Of all the opportunistic fungal infections this is 
perhaps the most difficult to diagnose, since yeasts of 
the genus Candida comprise part of the endogenous human 
flora. The presence of Candida in sputum, faeces or from 
superficial sites is therefore of little diagnostic 
significance unless isolated repeatedly in quantity and 
supported by other evidence. Serology must also be 
interpreted with care as many healthy people in the normal 
population have antibodies to C. albicans but do not have 
candidal infections.
41
The diagnosis of superficial candidal infections is 
relatively simple if fungus is seen on direct 
microscopical examination of the skin or nail sample and 
is grown in culture. The same procedures are required for 
vaginal smears and swabs.
The picture is less clear cut for patients with 
systemic infection. Clinically patients with invasive 
disease have pyrexia of unknown origin <PUO) which does 
not respond to antibiotics and is associated with night 
sweats and weight loss. Blood cultures may give a useful 
indication that the potential for dissemination exists but 
these are often negative in cases of systemic infection 
and transient candidaemla may occur without an established 
infection. Urine cultures may indicate the extent of 
spread of the fungus and are an important sample to 
examine as kidneys are a major target organ for Candida.
In lmmunosuppressed patients at risk from 
opportunistic infections, the isolation of Candida from 
skin, sputum or oral mucosa, although not diagnostic for 
candidosls, should alert the physician to the possibility 
of future infection. If culture results are indicative of 
heavy colonisation, there is obviously a large reservoir 
of potentially pathogenic organisms. Biopsy specimens are 
useful for the diagnosis of disseminating disease, 
although since this procedure is Invasive it is not
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advisable for seriously ill patients. Examination of 
bronchial secretions or washings, collected by a 
bronchoscope, to avoid invasive procedures and to 
eliminate contamination by mouth flora, is helpful.
Candida species grow readily over a wide range of pH 
values and on most solid media. The yeast can be isolated 
selectively from clinical specimens contaminated with 
bacteria by the addition of antibiotics such as 
chloramphenicol to the medium. Some yeasts are suscepti ble 
to this compound at levels of 6.25 /ig/ml or greater 
<McGinnis, 1980). After purifying the culture the yeast is 
identified using biochemical tests for assimilation and 
fermentation <Lodder, 1970).
As C. albicans is the yeast most frequently isolated 
from man, procedures have been developed for its rapid 
identification. These include the formation of germ tubes 
when incubated in serum at 37°C and the production of 
chlamydospores on a dalmau plate or Czapek Dox agar 
(Dawson, 1962).
Serology may be useful in many instances, especially 
when the results are examined in conjunction with other 
information such as cultural investigations and the 
patient's clinical condition. Antibodies and antigens 
associated with Candida may be detected in a number of 
ways: double diffusion, counterimmunoe1ectrophoresis,
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indirect immunofluoresence and latex particle 
agglutination.
The detection of candidal antigens is a method which 
is being investigated with interest but these tests are in 
the developmental stage. The latex agglutination test 
appears to be the most promising (Richardson and Warnock, 
1982; Hopwood, Evans and Carney, 1985; Fung, Donata and 
Tilton, 1986). However, experience is required to 
interpret the results as there may be false positive 
results, problems with the sensitivity of the antibody 
coated latex with storage and cross-reaction of this 
reagent with rheumatoid factor.
A single positive antibody test result is not 
indicative of infection since, for example, patients who 
have undergone cardiac surgery have high titres in the 
absence of overt systemic infection (Evans and Forster 
1976). The number of yeasts present in these patients is 
high and increases post-operatively (Evans, 1975). 
Seroconversion and rising titres may be helpful in 
diagnosis <de Repentigny and Reiss, 1984).
The presence of Candida endophthalmitis may indicate 
that the patient has systemic candidosis. Patients present 
with ocular pain, blurred vision, photophobia and may be 
conscious of floaters in their visual field. The eyes 
often appear blood—shot with circumlimbal injection and
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episcleral vessel dilation. On ophthalmic examination off- 
white cotton wool-like masses may be seen. These lesions 
may resemble "a string of pearls" <Aguilar et al. , 1979)
extending into the occasionally hazy vitreous. If there 
has been circumfrential haemorrage then the lesions may 
resemble Roth spots. Clinical appearance is often used to 
make the diagnosis but three procedures employed to obtain 
a definitive diagnosis are: anterior chamber aspiration, 
although this is rarely helpful in cases of
haematogenously spread Candida endophthalmitis; a vitreous 
tap and a diagnostic vitrectomy through the pars plana.
The last method is the most effective <Edwards 1985). 
Microscopical examination of smears or culture from such 
samples provide good evidence of infection. A negative 
result may be due to the relatively small number of yeasts 
present, the difficulty in aspirating a lesion through a 
fine needle or the vitrectomy not being lesion directed.
1.8.2. Aspergillosis
A single isolation of an Aspergillus species from a 
clinical specimen is not sufficient evidence that it is 
causing disease as the aspergilli are commom laboratory 
contaminants. The fungus must be demonstrated in body 
tissues or fluids by direct microscopical examination of a 
potassium hydroxide mount of the sample or histological
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examination of biopsy material. Moreover, it must be 
isolated from repeated specimens and identified by 
morphological characteristics.
Examination of the sample may also help to elucidate 
the form of aspergillosis, for example the peripheral 
blood and sputum of allergic cases may exhibit 
eosi nophi1i a .
Contamination is possible at every stage of specimen 
collection, transportation and processing as the 
aspergilli are ubiquitous in the environment. The 
traditional 24 hour sputum collection gives rise to 
contamination while the sample is being collected. The 
time interval allows any yeast contamination from the 
mouth flora to multiply thus obscuring filamentous fungi 
which are usually slower growing and present in smaller 
numbers.
Isolation of aspergilli is relatively simple on most 
mycological laboratory agars as they possess few special 
nutritional requirements. Identification is most 
frequently performed on 2% malt or Czapek Dox agar at 28° 
C, there are several texbooks that detail the 
identification of the aspergilli but the definitive text 
is Raper and Fennel's "The genus Aspergillus" <1965).
With non sporing varieties of the fungus, exoantigen tests 
may prove helpful in identification (Kaufman, 1981).
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The fungus is not susceptible to chloramphenicol, 
which, if included in the media reduces bacterial 
contamination. However, there may be problems with 
overgrowth of the sample with yeasts. The pathogenic 
Aspergillus species are thermotolerant and will generally 
grow at 28, 37 or 45 °C. A. fumlgatus> the most frequently 
encountered species causing disease in man, will grow at 
45° C while yeasts will not.
Biopsy specimens are invaluable in the diagnosis of 
aspergillosis particularly if invasive disease is 
suspected. Both transthoracic and open lung biopsy have 
been used.
Serological tests can prove useful in diagnosis. 
Longbottom and Pepys <1964) correlated clinical types of 
infection with skin tests and double diffusion for the 
detection of precipitins. Double diffusion and countei—  
immunoelectrophoresis are the most widely used but enzyme 
linked immunosorbent assay (ELISA) for antibody levels may 
also be used. However, in patients with invasive 
aspergillosis only a small proportion of cases produce 
detectable antibodies as the patients tend to be 
immunosuppressed and if antibodies are present they 
usually have a low titre. In allergic aspergillosis 
elevated levels of specific IgB are frequently found.
ELISA methods are being developed for antigen detection
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<Sabetta, Minter and Andriole, 1985). In cases of 
aspergillama, skin tests are of little use, although the 
immediate and late skin tests might be positive in some 
cases. However, these tests are often positive in cases of 
allergic bronchopulmonary disease, showing a type 3 Arthus 
reaction.
Radiological techniques can be helpful in the diagnosis 
of aspergillosis particularly the pulmonary presentations. 
On radiography the picture of an aspergilloma is that of a 
round opaque mass clearly delineated within a cavity. When 
the patient is tilted the mass is seen to move. A crescent 
shaped radiolucent area called Monad's sign may be present 
over the upper part of the mass <Rippon, 1974). In the 
allergic form of the disease there may be only transient 
lung shadows, segmental shadowing or extensive fibrosis 
and some cavitation. Whereas with invasive pulmonary 
aspergillosis the picture is one of focal consolidation 
with a broad spectrum of radiological changes. Round the 
flare at the area of consolidation there is a radiodense 
periphery extending into the lung parenchyma <Roberts et 
aJ., 1984).
1.8.3. Mucormycosis
The rapid diagnosis of this disease is imperative since 
of all the fungal infections occurring in the United
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Kingdom it is the most rapidly fatal and to prevent spread 
immediate excision of the infected tissue and the earliest 
possible treatment with the antifungal amphotericin B is 
required.
Clinical signs depend on the underlying condition of 
the host. Its most common manifestation is as 
rhinocerebral mucormycosis in diabetic patients. Diagnosis 
at an advanced stage is relatively easy but for a good 
prognosis early diagnosis is vital. The most useful clue 
may be a dark necrotic discharge which resembles dried 
blood eminating from the patient's nasal pharynx or 
palate. Swabs of the area may be negative and may be of 
little value. Multiple biopsies are the ideal as they 
provide enough material to allow for both culture and 
histological examination. Care should be taken when 
obtaining biopsies since the causal fungi have a 
predilection for invading blood vessels and the subsequent 
necrosis which occurs means the organism is unlikely to 
be found in the centre of a lesion. It is often more 
fruitful, therefore, to look for the fungus at the edge 
"upstream" from the centre. In patients with the cutaneous 
form of the disease biopsies should be taken from the 
growing edge of the lesion.
Often direct examination, after clearing in potassium 
hydroxide, provides enough evidence to initiate treatment
49
without having to wait for culture results, which 
unfortunately are positive in a relatively low proportion 
of cases. Although failure to see fungi in a potassium 
hydroxide mount does not mean it is not present (Greer and 
Rodgers, 1985). Cryostat sections can accelerate the 
diagnosis of mucormycosis and the time they save could be 
critical.
Biopsies should be processed immediately, whenever 
possible but if storage is necessary, this should be at 
room temperature as mucoraceous fungi do not survive for 
longer than a few hours on refrigeration.
The mucorales will grow on most media wich does not 
contain cycloheximide, however other antibiotics are 
required in the media to prevent bacterial overgrowth, 
especially when purulent exudates are cultured. The 
numbers of viable organisms present in tissue is small, so 
a heavy inoculum is required and minicing the tissue is 
preferable to homogenisation as it kills fewer hyphae.
When cultures are obtained, R. oryzae is most often the 
fungus isolated.
Other aids that have been used in the diagnosis of 
mucormycosis include radiology, which delineates the 
extent of infection but does not identify the etiologic 
agent and angiography, which has been used to define the 
extent of vascular destruction. Serological studies for
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antibodies have shown that precipitins are not always 
present in patients with proven mucormycosis. However, 
this could be related to the small numbers of reports, as 
the work is only in the preliminary stages <Jones and 
Kaufman, 1978). Skin tests have not proved to be specific 
enough for diagnostic purposes.
Examination of faeces and gastric aspirates have 
sometimes proved useful in the diagnosis of the 
gastrointestinal form of the disease.
As fungal elements are not always present or are small 
in number in discharges and in tissue, diagnosis is often 
based on clinical evidence. As these fungi are ubiquitous 
in the environment a positive culture result, in addition 
to being difficult to obtain, cannot be taken as 
irrefutable evidence of infection but, in any patient at 
risk, an isolation of a mucoraceous fungus cannot be 
dismissed as transient flora or contamination.
1.8.4. Cryptococcosis
Cryptococcal meningitis is the usual presentation of 
this disease and it is the form with the poorest prognosis 
especially in a debilitated individual. The outcome will 
be fatal unless the condition is diagnosed and treated. 
Unfortunately there are no symptoms that will give an 
accurate differential diagnosis. Chronic disease of any
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organ is marked by recurrence and exacerbation of the 
infection which renders the assessment of treatment 
difficult.
In the pulmonary disease the x-ray picture is variable, 
although the organism is generally seen in the lower lung 
fields. The picture may be that of a solitary dense 
infiltrate or of a broader more diffuse infiltrate that 
may show fibrosis following healing. The disease may 
appear as extensive peribronchial infiltrates or, as often 
occurs in patients with leukaemia and lymphomas, there may 
be lesions in all areas of the lungs. Vailed off lesions 
may require surgery to exclude carcinoma. Active lesions 
are granulomatous masses containing yeasts which can 
displace the host tissue mechanically. If the lesion 
penetrates the wall of the bronchus, masses of yeast cells 
may be present in the sputum but in general the scanty 
sputum which is produced does not contain yeast cells.
As there are no clinical features which are pathognomic 
for cryptococcosis the identification of the aetiologic 
agent starts with the microscopical examination of a 
specimen. Direct microscopical examination might not 
permit identification to species but will provide useful 
early clues, for example the presence of a capsule, the 
size and shape of the yeast, whether pseudomycelium is 
found and the presence or absence of buds and how they are
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attached. A minimum of five ml of cerebral spinal fluid is 
required for adequate microscopy and culture. The sample 
should be centrifuged or membrane filtered to concentrate 
the solids. A wet mount made in India ink can show up the 
capsule but experience is needed to differentiate yeasts 
from blood cells and lipid granules. Alcian blue and 
mucicarmine stains are useful in the detection of 
cryptococci. Fluorescent antibody techniques have also 
proved useful as have calcofluor white stains (Hollander 
et al. , 1984).
C. neoformans is not a fastidious organism but it is 
sensitive to cycloheximide. The yeast will grow on many 
routine laboratory media and can develop in culture after 
24-48 hours although it is best to retain the culture 
plates for six weeks. Birdseed agar is a differential 
medium for Cryptococcus on primary isolation. It is made 
with an extract of the Indian thistle plant and C. 
neoformans develops as brown colonies within a week. The 
colour is caused by a phenol oxidase mediated reaction 
which leads to the formation of a melanin pigment in the 
yeast cell walls.
In a urine sample catheterised from the lower 
urogenitary tract more than 10‘* colony forming units of 
yeast per ml are required for convincing diagnosis of
53
urinary tract infection. However a single colony of C. 
neoformans from CSF is suggestive of infection.
Samples of sputum rarely yield C. neoformans on 
culture, Tynes et al. <1968) have reported asymptomatic
carriage, indicating that a positive culture may not be 
indicative of an infection but must be regarded with 
suspicion in patients who are at risk of infection.
Examination and culture of biopsy specimens can be 
helpful in the diagnosis.
In osseous infections the diagnosis is indicated by the 
relatively stationary appearance of the lesions and lack 
of periosteal proliferation.
Skin tests are of little value in the diagnosis of 
cryptococcosis, as the capsular antigen does not elicit a 
response in a significant number of patients. A positive 
skin test is not indicative of an active infection.
Serology is very useful in detecting cryptococcosis.
The most valuable test has proved to be the latex 
agglutination test to detect the polysaccharide capsule 
antigen. The titre of this test can be employed to monitor 
the progression or cure of the disease in response to 
treatment.
For noncompromised patients the guidelines recommended 
to ensure that there is an active infection and not merely 
colonisation, include: pyrexia, the absence of any other
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chronic pulmonary disease and the detection of 
cryptococcus antigen in serum or CSF. Other investigations 
which maybe helpful are full physical examination, 
including examination of the skin for rashes, a blood 
screen including biochemistry for liver function tests and 
electrolytes, culture of blood and CSF, protein and sugar 
levels in the CSF.
Another test for C. neof ormans is pathogenicity for 
mice, in which infection of the brain leads to death in 
four to five days if injected intracranially and in one 
week if injected in the tail vein with a suspension of 10^ 
C. neof ormans.
As C. neoformans elicits minimal inflammatory 
reactions, the gross pathology of an infected organ 
especially the CITS is often normal. Tissue reaction is 
sparse but in an active infection a focus may evolve into 
a tuberculoid granuloma. Early lesions are gelatinous and 
contain aggregates of encapsulated yeasts while older 
lesions are granulomatous with the degree of granuloma 
formation being related to the resistance of the host to 
infection. Necrosis and cavitation are rarely seen in a 
cryptococcal infection. An enlarging brain lesion has the 
appearance of a growing neoplasm and often patients may 
have to undergo neurosurgical procedures before the 
correct diagnosis is made.
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1.9. Histology of Fungal Infections
The fungi capable of causing opportunistic infections 
in man can usually be isolated from tissues, exudates and 
body fluids but often diagnosis is based on a combination 
of clinical history, serological investigations, cultural 
studies and histopathological evidence. Isolation of a 
fungal pathogen may take several days and on occasions may 
take a few weeks, which may be too long to wait before 
initiating treatment, if the patient is to survive the 
fungal challenge. The rapid diagnosis of a fungal 
infection is particularly important if the patient is 
seriously ill with an underlying disease or is 
immunocompromised, as is often the case with individuals 
susceptible to opportunistic infections.
When a fungal infection has not been suspected, the 
entire available biopsy or autopsy material may be fixed 
for histological examination and therefore culture cannot 
be attempted. In such instances, the recognition and 
accurate identification of fungal elements in frozen or 
paraffin embedded sections is important. Histological 
recognition of opportunistic infections also provides 
proof of invasion by the fungus which may have been 
mistaken for a laboratory contaminant or part of the 
commensal flora.
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Histopathology will reveal tissue reactions, detect the 
presence of fungi and disclose morphological 
characteristics which enable the fungus to be identified. 
The size, chemical composition and morphology of fungi can 
be studied by light microscopy and, when the classical 
form of the fungus is seen, the mycosis can be named. The 
appearance of fungal lesions in tissues depends on many 
variables such as the organ involved, the underlying 
disease, the resistance of the host and the duration of 
the infection. In the prevailing conditions, inflammatory 
reactions to fungal invasions are similar regardless of 
which agent is involved but an inflammatory reaction does 
alert the pathologist to the fact that there is an 
infection present. However, in immunosuppressed patients 
the host response may be minimal.
1.9.1. Stains
<i) Haematoxylin and Eosin <H & E)
This stain is used to show the tissue response to the 
aetiologic agent and will also allow distinction between 
hyaline and dematiaceous fungi. As the special fungal 
stains do not visualise tissue reactions a H & E 
counterstain with the Gomori method is recomended by some 
experts (Chandler et al. , 1980; Roberts et al., 1984). H
and E is the stain of choice for demonstrating Splendore-
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Hoeppli material. However, although aspergilli and 
zygomycetes da stain with this method other fungi stain 
poorly. Small numbers of fungi may be overlooked and some 
difficulty is encountered in distinguishing fungal 
elements from tissue components.
(ii> Grocott's/Gomori's <GMS>
This stain shows the fungi as brown or black. In the 
presence of chromic acid, the hydroxyl groups of the 
polysaccharides in the hyphal walls are oxidised to 
aldehydes which reduce the methenamine silver nitrate 
complex, resulting in the deposition of reduced silver at 
these foci. Light green is a frequently utilised 
counterstain as it gives a uniform background, however, 
light green does not demonstrate the presence of any 
tissue reactions. If sections are overstained then 
erythrocytes and naked nuclei may resemble yeast cells and 
blood vessels, especially if branched, are easily confused 
with zycomycetes
<iii> Periodic Acid Schiff's (PAS)
With this stain the polysaccharides of the fungal cell 
walls are oxidised to aldehydes in the presence of 
periodic acid. The aldehydes react with Schiff's reagent 
to give a reddish purple colour. To eliminate some of the
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nonspecific staining seen with PAS the sections can be 
pretreated by diastase digestion to remove glycogen, this 
results in a better contrast with the background. The PAS 
technique stains calcific bodies which can resemble 
yeasts.
(iv) Gridley
This stain utilises chromic acid to oxidise the fungal 
polysaccharides which are then reacted with Schiff's 
reagent. The mycelium stains a deep blue and any conidia, 
on the rare occasions when they are present, stain rose to 
purple.
<v> Fluorescent Techniques
Fluorescent agents have been used to enhance the 
visibility of fungal elements in specimens. Fluorescent 
brighteners such as calcofluor white and Blankophor, 
possess a diaminostilbene backbone structure and have high 
affinities for cellulose and chitin, as they bind to j31-3 
and J31-4 glycosidic linkages of polysaccharides. Moheit, 
Cowan and Moore, <1984) demonstrated C. albicans, A. 
fumigatus, R. oryzae and C. neoformans in paraffin 
embedded and frozen sections of tissue from humans and 
animals using the nonspecific fluorescent stain calcofluor 
white. Monheit et al. <1985; 1986) used the brightener in
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conjunction with papanicolaou stain to detect fungi in 
cytology specimens.
Hollander et al. <1984) employed Blankophor BA to
examine samples of skin and nail. Frozen and paraffin 
tissue sections were also examined. C. albicans, C. 
neoformans, Kucor sp. and several dermatophytes were 
readily detected with this agent.
Although calcoflour white is the brightener most often 
used, other whiteners with different backbone structures 
have been tested. Three compounds with a
diaminostilbenedisulfonic acid-cyanuric chloride backbone 
structure have been reported as having superior 
fluorescence on fungal wet mounts (Green and Moore, 1985).
Fluorescent agents are technically simpler to employ 
than other histological methods, however a fluorescence 
microscope is required and the preparations are not 
permanent. There may be false positive reactions due to 
contamination of the slides with cotton wool, paper 
fibres, pollen and spores.
1.9.2. Candldosis
The diagnosis of candidosis may rely on demonstrating 
invasion of the tissues by the fungus, since culture 
results do not differentiate between invasion and 
colonisation. Therefore, candidosis is sometimes not
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diagnosed until autopsy when the predominance of Candida 
species in a lesion assumes a pathogenic significance and 
the large number of yeasts may result in inflammatory 
reactions due to cellular components. Once invasion of 
tissue occurs, although there are both yeasts and mycelial 
forms present, the proportion of hyphal elements increases 
with the age of the lesion (Okudaira, 1985>.
Terminal infection is frequently acute with lesions 
characterised by suppuration and necrosis. The multifocal 
microabscesses have an abundance of degenerating 
neutrophils associated with pseudomycelium, hyphae and 
blastospores. The abscesses are associated with acute 
pyogenic reaction and radiating colonies of Candida may 
also be present <Chandler et al., 1980), Fibrin and
erythrocytes are other components of these lesions. Small 
masses of yeast cells surrounded by tissue macrophages are 
seen throughout the tissue especially in the brain. The 
characteristic abscesses may not have time to develop in 
early stages of infection or they may not be formed in 
immunocompromised patients, due to suppression of the 
host's cellular response. In such cases haemorrhagic 
necrosis associated with hyphae may be seen. Aspergilli 
and Zygomycetes have a great predilection for invading 
blood vessels but this also is seen on occasions with 
Candida.
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In the rare cases of chronic candidal infection 
multiple abscesses are ringed by epitheliod cells, giant 
cells and fibroblasts. Candida may also be seen in solid 
granulomas which simulate tuberculosis but the candidal 
lesions are not so well organised.
The kidneys are the organs most frequently involved in 
systemic candidal infection and may become so invaded that 
they cease to function. Infection may be restricted to the 
cortex, sometimes the medulla may also be invaded. Gut 
lesions lead to ulcer formation and necrosis. In lung 
sections C. glabrata can resemble Histoplasma and specific 
immunohistological stains may be required to differentiate 
the two fungi.
In superficial infections Candida is restricted to the 
stratum corneum but hyperkeratosis and acanthosis of the 
epidermis with chronic inflammatory reaction in the dermis 
is often seen.
The picture in chronic mucocutaneous candidosis is 
different from other forms of candidosis. There are masses 
of hyphae and budding yeast cells with blastospores more 
numerous in the epithelium and hyphal forms more prevalent 
in the deeper epidermis. Inflammatory cells are present in 
the underlying tissues. The epidermis may exhibit varying 
degrees of hyperkeratosis, acanthosis and 
pseudoepitheliomatous hyperplasia. Dense collections of
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lymphocytes, plasma cells, macrophages and foreign body 
giant cells are present in the dermis.
Candida stains poorly with H & E and may be easily 
overlooked. The fungal stains PAS, GMS and Gridley*s 
demonstrate the organism well, although, since they are 
non specific stains, they do not differentiate Candida 
from other fungi.
1.9.3. Aspergillosis
The demonstration of Aspergillus in biopsy or autopsy 
tissue is irrefutable evidence of infection by the 
organism. If there is an airspace adjacent to the fungus 
then conidial heads may be seen but these are not formed 
if the fungus is invading tissue.
The aspergilli stain with H & E if the tissue is 
properly fixed and not necrotic but they can be difficult 
to see (Chandler, et al., 1980). PAS may be disappointing
(Rippon, 1974).
The aspergilli in tissue are characterised by repeated
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dicjptomous branching at a 45° angle. The hyphae are 
septate but the septae may not be readily evident and the 
mycelium may resemble a mucoraceous fungus. The hyphal 
walls are parallel and smooth and the tip is refractile. 
Conidia are generally not seen but transverse sections of 
hyphae often resemble yeasts. The centre of a radial
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lesion may contain swollen cells and yeast-like hyphae 
which can measure up to 8pmin diameter.
The histological picture in aspergilloma is a tangled 
mass of hyphae which may show zonation of mycelial 
elements with pyknotic layers of host cells, this 
presentation indicates the dynamic evolution of the 
lesion. There may be little tissue destruction as these 
fungal balls tend to form in pre-existing lung cavities. 
The ball of fungus is surrounded by a thin fibrotic 
capsule with a few inflammatory cells.
Invasive aspergillosis is an acute disease displaying 
necrotising, pyrogenic lesions and infarcts. The 
appearance of the disease is similar to mucormycosis as 
the fungus readily invades blood vessels causing 
thrombosis. Hyphae appear to penetrate the vessel walls 
allowing direct haematogenous spread from a primary 
pulmonary lesion. The classic appearance of invasive 
aspergillosis is of hyphae radiating from a central focus. 
This starburst appearance is the actinomycetoid form of 
the fungus. Necrosis of the surrounding tissue is due to 
endotoxin production in addition to vascular obstruction 
<Rippon, 1974; Chandler et al., 1980). The host response
in cases of invasive aspergillosis may be absent due to 
the depression of the immune system but there is usually a 
dense infiltrate of neutrophils.
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Early lesions develop as aggregates of mycelium with 
radiating hyphae. The peripheral fungus is surrounded by 
neutrophils. A zonation pattern may be farmed by slow and 
rapid phases of growth and variation in the density of the 
fungus.
Chronic lesions contain scattered giant cells, 
neutrophils and eosinophils. The fungal elements may be 
short, globose and distorted. Fibrosis is progressive and 
may be severe. Isolated foci are walled off by 
granulomatous reactions and contain giant cells similar to 
those seen in tuberculosis.
Sinus granulomas do not show the regular branching 
pattern of acute invasion but these hard fibrosised bodies 
are composed of aggregates of foreign body giant cells and 
fibrous tissue associated with the fungus. Splendore- 
Hoeppli material may coat the hyphal fragments. The 
histology is distinctive, only small fragments of mycelium 
are found and as a result of this morphology the infection 
may easily be attributed to a yeast. Occasionally, 
extensive local deposits of calcium oxalate crystals may 
be seen. These are birefringent when viewed under 
polarised light. The crystals are formed from oxalic acid 
produced by the fungus and they are seen only when the 
organism is associated with necrotic tissue.
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1.9.4. Mucormycosis
The mucoraceous fungi are readily seen using the H & E 
stain and GMS but their detection rate when stained with 
the conventional specialised fungal stains of Gridleys and 
PAS is uneven and barely adequate.
The pathology does not vary with the site of infection. 
Gangrene involvement is common, surfaces show massive 
haemorrhage with recent emboli and in older lesions the 
appearance is putty-like. The tissue reaction is not 
consistent. In some cases no cellular response is seen but 
usually there are varying degrees of oedema and necrosis 
with neutrophil accumulations, plasma cells and some giant 
cells. The acute reaction shows the diffuse infiltration 
of polymorphonuclear leukocytes. Eosinophils are not often 
seen. Tissues often exhibit suppurative reactions but may 
show granulomatous changes. The characteristic feature is 
the involvement of the blood vessels with mucoraceous 
fungi invading the walls of arteries, causing thrombosis 
and necrosis of the adjacent tissue.
The hyphae are irregularly and haphazardly branched and 
lateral mycelium often grow at nearly 90°; lateral 
vesicles may be seen. The hyphae are sparsely septate and 
although the mycelium is broad, its width may vary greatly 
and the hyphal walls also vary in thickness. The 
mucoraceous fungi can be mistaken for sclerosed
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capillaries, nematodes and they may also be confused with 
empty spherules of C. immitis in endemic regions. The 
small amount of fungus present in tissue sections and the 
oblique angles at which they are often cut, makes their 
identification by histological morphology alone difficult.
1.9.5. Cryptococcosis
In tissues cryptococci are present as unicellular, 
yeasts, producing buds and if surrounded by a capsule can 
be detected fairly readily. The size of the capsule varies 
from 4-15pmand may be five times the size of the cell.
There are two forms of lesions, granulomatous with a 
few organisms or thick walled cysts with large numbers of 
yeasts. In active lesions there are multiple budding 
yeasts.
Tissue reactions vary a good deal from little 
inflammatory response to granulomatous reaction. Although 
reactions vary from case to case and with different 
organs, the tissue reactions tend to be mild, with few 
macrophages appearing in active infection; suppuration and 
necrosis are infrequent.
If there is no tissue response then the yeast growth 
develops rapidly. In the lungs they are attacked by 
alveolar macrophages and giant cells. Poorly encapsulated 
forms elicit granulomatous inflammatory reactions,
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neutrophils are not numerous and the tissue response is 
usually non-suppurative.
In the gelatinous histological pattern there are masses 
of organisms and mucoid degeneration of the tissue. There 
is no walling-off, the infected tissue and the yeast lie 
free. In these active lesions there is multiple budding.
In the granulomatous type of reaction there are smaller 
numbers of yeasts, almost all of which are surrounded by 
macrophages and giant cells. The fungi are intracellular 
with fragmented cell walls and poorly stained cryptococci 
can be seen in phagocytes. The yeasts in these lesions are 
"dry" variants, very small and poorly encapsulated.
When tissues are stained by H & E, cells of C. 
neoformans stain pale blue to pink and are 2-20 pmin 
diameter. H & E does not stain the capsular material so 
the yeast cells are seen surrounded by a clear zone. They 
have thin walls, are of varying shape and the internal 
contents cannot be seen in detail. A presumptive diagnosis 
of C. neof ormans infection can be made on
histopathological examination if the sections are stained 
with mucicarmine or alcian blue since other pathogenic 
yeasts do not absorb these stains. When stained by Mayers 
mucicarmine, the capsule stains bright red and the 
background is blue or yellow depending on the counterstain 
used.
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1.10. TmnniTinhigtochemical Staining
Immunohistochemical techniques help to alleviate some 
of the problems encountered when attempting to identify 
fungi in tissue sections by their morphology and tissue 
reactions they elicit.
Van Noorden and Polak <1979) defined 
immunocytochemistry as "the identification of a tissue 
constituent in situ by means of a specific antigen- 
antibody reaction tagged by a visible label." If it can be 
proved the antigen-antibody reaction is specific, it is 
possible to identify the tissue constituent.
1.10.1. Immunofluorescence
The original method described was a direct 
immunofluorescent technique developed by Coons and Kaplan 
<1950). A fluorescent dye, fluorescein isothiocyanate, 
attached to an antibody, was used to identify the 
corresponding antigen in tissue sections. The sections 
were incubated with the dye in phosphate buffered saline 
and then examined using a microscope fitted with an 
ultraviolet light source. Coons and his co-workers refined 
the technique with the result it became widely employed by 
the 1960's <Coons and Kaplan, 1950; Coons, Leduc and 
Conolly, 1955).
The direct method requires the application of the 
fluorescent antibody to deparaffinised sections. With the
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indirect method, the unconjugated initial antibody is 
washed off, then a conjugated antibody, raised against the 
primary animal species, is applied enabling the reaction 
to be seen. The indirect method produces a brighter 
fluorescence although the direct method is preferred by 
some workers (Chandler et al., 1980).
Hotchi (1967) was the first to use immunofluorescence 
to demonstrate Aspergillus in lung sections. The 
aspergilli can be differentiated from the zygomycetes and 
Candida but as yet the identification of Aspergillus 
species is not possible (Warnock, 1979; Kaplan, 1985). 
Candida has been studied using immunofluorescence but the 
fluorescent conjugated antisera crossreact with the other 
members of the genus and other fungi eg. H. capsulatum 
(Warnock, 1979: Kaplan, 1985). Some Candida species may be 
identified by a compilation of fluorescent antibody 
regimes (Gordon, Elliott and Hawkins, 1967).
In contrast to the mycelial fungi, reagents have been 
developed for Cryptococcus, Blastomyces, Coccidioides and 
Sporothrix (Chandler et al., 1980). Fluorescent antibody
techniques are used routinely for the detection of C. 
neoformans in tissue and in CSF. Marshall et al. (1961)
were the first to stain histological tissue sections from 
cases of cryptococcosis using direct immunofluorescence.
The indirect method has been used to demonstrate 
Trichophyton rubrum in frozen sections of biopsy material 
from chronic dermatophyte infections (Hay and Saeed,
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1981). However cross-reaction with T. mentagrophytes var 
Interdigitale and T. mentagrophytes var mentagrophytes 
occurs.
The antigenic properties of the fungi in tissue 
sections are not altered by prolonged storage CKaplan, 
1985). As a result retrospective immunohistochemical 
staining can be performed to test new antibodies and 
examine old case histories. It is possible to restain H &
E stained sections by an immunohistochemical method, if no 
other material is available. PAS and GMS stained sections 
cannot be restained as the oxidation of the wall 
polysaccarides alters their antigenicity, therefore there 
is no reaction with the antibody.
Ideally, the sections to be examined are most 
satisfactory if they are thin, 4-6pcn, the tissue is not 
dense and the fungal elements are numerous. If the 
material is not satisfactory, the sections may need to be 
treated with trypsin to expose more antigenic sites. If 
there is calcification of the tissue the sections will 
have to be decalcified before staining CKaplan, 1985; 
Chandler et al., 1980). Other disadvantages of this
technique are: a fluorescent microscope is essential, the
background details may be difficult to discern and the 
slides are not permanent as the stains cannot withstand 
dehydrat i on.
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1.10.2. Peroxidase Staining Methods
Nakae and Pierce (1966) introduced the use of enzyme 
labels to immunohistochemistry employing the enzyme 
peroxidase conjugated to an antibody. Histochemical 
development of the antigen-antibody reaction results in a 
coloured end product which can be seen using a light 
microscope. The reaction is made visible with 
diaminobenzidine <DAB) using the reaction described by 
Graham and Karnovsky <1966). Development of enzyme 
reactions can be monitored and stopped when the "signal to 
noise” ratio is at its optimum. That is when there is 
sufficient strength of specific staining with as little 
background staining as possible. There is no requirement 
for specialised equipment and the preparations can be 
stored indefinitely. Disadvantages of the technique are, 
the danger that sections may become detached during the 
procedure, the endogenous peroxidase activity must be 
blocked and DAB may be carcinogenic on prolonged exposure 
at high concentrations.
<i) Direct Method
The direct method employs a labelled primary antibody 
which is applied directly to the section, it then attaches 
to antigenic sites.
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<ii) Indirect Method
The indirect method is more sensitive, the primary 
antibody is not conjugated and it is the secondary 
antibody which is tagged with the enzyme. The first 
antibody is applied to the section, washed off, then the 
second antibody raised in another species against the IgG 
of the primary species is applied to the section. A 
substrate is used to visualise the reaction, and the 
primary antigen site is thus revealed. The indirect 
method, apart from being more sensitive, may be more 
economical as the primary antibody is used at lower 
strength and, provided the antisera are all raised in the 
same species, one labelled antibody can be utilised with 
many antigens. The disadvantages of this method are the 
additional washing steps and incubation stages required. 
They make the test more time consuming and there is a 
greater danger that the sections may float off during the 
staining proceedure.
<iii> Peroxidase Anti-peroxidase Method
One of the more sensitive of the immunoperoxidase 
methods is the peroxidase anti—peroxidase (PAP) technique 
(Sternberger, 1979). This involves the use of a bridging 
antibody between the primary antiserum and the final 
conjugated antibody. The final layer, a peroxidase anti­
peroxidase combination, is a cyclic complex with three 
peroxidase molecules to two antibody molecules. As this
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enables more peroxidase to attach at the reaction site 
than in the indirect technique, the method is extremely 
sensitive. The technique allows for higher dilution of the 
primary antibody as a result of the magnification by the 
third antibody and this reduces the background staining. 
The second layer antibody must be in excess of the primary 
antibody to achieve competition for the binding sites.
This means that only one site of the second antibody is 
occupied by the primary antibody, leaving one site free to 
combine with the PAP complex.
As the peroxidase is attached to the complex by 
immunological and not chemical bonds, it loses none of its 
enzymatic activity. This reduces nonspecific staining as 
the higher dilutions employed eliminate unwanted 
antibodies present at low titres.
Civ) Immunoperoxidase Stains in Diagnosis of Fungal 
Infections
Immunoperoxidase staining methods have not been 
employed routinely in diagnostic medical mycology.
However, the indirect method of immunoperoxidase staining 
has been used to recognise Sporothrix schenckii, C. 
neoformans CRussell, Beckett and Jacobs, 1979) and A. 
fumigatus CSaeed and Hay 1981) in tissue sections.
The reports so far described for fungi have used dried 
fungal smears as the positive control material. The 
negative control material for comparison was provided by
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air dried smears from fungal suspensions (Russell et al., 
1979) or sections from cases of mucormycosis or candidosis 
(Saeed and Hay, 1981).
Controls have an important role in histochemical 
staining to ensure that the staining components are 
working and that the technique has been carried out 
correctly. Control material is also valuable in the 
determination of the specificity of the method to stain 
the organisms involved. The lack of availability of 
optimal control material, especially for fungal 
infections, can be a problem. Jung (1985) developed a 
fairly complicated system to produce control material by 
culturing micro-organisms in clotted plasma. Moreover he 
noted staining differences when other types of positive in 
vitro controls such as lyophilized fungi were used.
With all immunohistochemical techniques the specificity 
of the antibody determines the specificity of the test.
The antigen injected into the rabbits, to raise the 
antiserum, ideally should be as pure as possible to raise 
as specific an antigen as possible. Despite this, the 
antiserum will not be active solely against the challenge 
antigen. The serum will contain natural antibodies which 
may cross-react with tissue components. Therefore an 
antiserum cannot be deemed specific unless stringent 
controls are applied.
Tests for the presence of antibodies in the serum 
include counterimmunoelectrophoresis (CIE) <de Repentigny
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and Reiss, 1984), ELISA and, most importantly, the 
staining of known positive tissue. The serum must be 
evaluated against staining of the background and tissue 
constituents other than the ones intended to be stained.
Characteristics of a good antibody include good 
affinity to the antigen, it must have strong avidity in 
order not to be washed away during the washing procedure. 
The antiserum should have a high titre to allow dilution 
of unwanted antibodies to below a significant level and to 
allow for less "background to noise" ratio.
The antigen in the tissue must be insoluble yet 
available to the antibody. The architecture of the tissue 
should remain recognisable after processing to help with 
orientation of the sections. Fixation may cause problems 
as cross-linkages of tissue proteins are formed with 
aldehyde fixatives. Pretreatment with a protease such as 
trypsin prior to staining breaks cross-linkages to reveal 
more antigenic sites. However it is possible that some 
large protein molecules are cleaved to liberate sites not 
available before the pretreatment and so resulting in 
false positive results.
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1.11. Cross-reactivity Among Fungal Antigens And Antibodies
Fungi have a wide range of antigenic determinants, 
which may allow their differentiation if antigenic factors 
peculiar to a genus or species can be isolated. However 
the complexity and variability of fungal antigens still 
leads to controversy about the relative value of the 
majority of the antigens.
Fungal antigens may be proteins associated with the 
cytoplasmic contents, or if derived from the cell wall, 
they may be polysaccharides or glycoproteins. It is not 
yet possible to distinguish those antigens implicated in 
the disease process from pathologically irrelevant 
antigens. Studies on the nature and substrate specificity 
of fungal antigens may lead to a greater understanding of 
the pathogenicity of fungi and help to identify those 
antigens produced when a particular fungus is involved in 
a disease process.
1.11.1. Mucoraceous fungi
Only a few investigations into the antigenic 
relationships of the mucoraceous fungi have been made.
Jones and Kaufman <1978) analysed filtrate and homogenate 
antigens from Absidia, Nucor and Rhizopus spp. . They 
demonstrated common antigens and also antigens which would 
permit differentiation of the fungi. Immunodiffusion tests 
with serum from proven systemic cases reacted with
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antigens from each species. Immune serum showed 
considerable cross-reactivity if a filtrate antigen was 
used, whereas more genera-specific antigens were seen with 
homogenate antigens.
Unique and common antigens were found when 10 species 
of mucoraceous fungi were compared by crossed 
Immunoelectrophoresis (Hessian and Smith, 1982). The 
investigators found little cross-reactivity of mucoraceous 
sera with A . fumigatus and no cross-reactivity with C. 
albicans . R. oryzae and R. arrhizus exhibited a great 
deal of antigenic similarity, but the Rhizopus spp. had 
only slight cross-reactivity with Nucor, Nortierella and 
Absidia. Moreover Absidia and Nucor exhibited relatively 
high antigenic sharing.
1.11.2. Candida
Candida expresses protein, carbohydrate and mannan 
antigens. The mannan antigens are responsible for the 
majority of the false positive reactions but they may be 
the only antigen to react with sera from some invasive 
cases (Kaufman, 1981). Mannan—free antigen is more 
specific but its sensitivity is poor in immunodiffusion 
tests.
Different serotypes of C. albicans appear to possess 
differing antigens. Serotype A and C. tropicalis and 
serotype B and C. stellatoidea have close antigenic 
similarities (Hansenclever and Mitchell, 1961).
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In later studies, when tested by ELISA, patients with C. 
tropical is infections gave positive results for 
C. albicans. C. albicans also cross-reacted with 
Cryptococcus. Spinal fluid and serum from patients with 
cryptococcal infections gave a wide range of titres when 
tested for antibody to Candida but there was no evidence 
of mannan antigeifemia <Meckstroth et al. , 1981).
Reaction of human serum against antigens from H. 
capsulatum, C. albicans and S. cerevisiae occurred most 
frequently against the antigens shared by the three fungi, 
although the intensity of the reactions varied. Reactivity 
to antigens specific for individual fungi was uncommon. 
Antibodies in immunized rabbits also cross-reacted with 
antigens of the other two fungi (Kumar et al., 1985).
Magaldi and MOKCkenzie <1984) noted a strong cross-reaction 
between a rabbit antiserum raised against C. albicans and 
Aspergillus antigens.
Monoclonal antibodies have been employed to clarify the 
specificity of antigenic determinants. Polonelli and 
Morace <1986) demonstrated a 12 Kda antigen common to all 
the C. albicans strains tested that was not produced by 
the other yeasts tested. Miyakawa et al. <1986) produced 
monoclonal antibodies against a C. albicans mannan antigen 
but cross—reactivity patterns were shown with C. 
tropical is and C. glabrata.
Recent work has suggested that there may be some cross­
reactivity of C. albicans and mammalian antigens <Manning-
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Zweerink et al., 1986). Numerous C. albicans antigens
were detected, by immunoblot analysis, in serum samples 
from patients with systemic candidosis but the same 
antigens were also detected in normal subjects.
Hyperimmune rabbit serum was used to detect several 
antigens of C. albicans in human sera from patients with 
systemic candidosis, the same antigens were detected from 
normal sera. Pre-immune rabbit serum did not react with 
any antigens suggesting that human serum may contain 
shared antigenic components with C. albicans.
1.11.3. Aspergillus
There is a remarkably wide range of antibodies against 
antigens of aspergilli. Aspergillus species have been 
shown to posses 16-26 antigenic components for each 
species analysed electrophoretically. The immunological 
similarities within groups of these fungi reflect the 
botanical classification of Raper and Fennel <1965), 
(Vernes and Biguet, 1980). A. fumigatus is the species 
most commonly associated with infection in man and its 
antigenic determinants have been studied in some detail. 
Differences in individual patients and the variety of 
different antigens from different strains of the fungus 
make it desirable to use a battery of antigens for 
serological testing of clinical specimens.
Longbottom and Pepys <1964) studied the significance of 
antigens of A. fumigatus. Sera giving a positive
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precipitin response to A. fumigatus also demonstrated some 
cross-reactions with, antigens from A. terreus, A. flavus, 
A. nidulans and A. niger in immunodiffusion tests.
Patients with evidence of an A. nidulans infection not 
only had a precipitin response to A. nidulans but also had 
a positive response with A. fumigatus.
Reed <1978> found that sera positive against A. 
fumigatus antigens were often also positive with A. 
clavatus antigens. Different strains and varieties of A. 
fumigatus have high antigenc similarities. A. flavus 
immune serum reacts with A . fumigatus . It would appear 
that A. fumigatus is more closely related to A. flavus 
than A . niger based on fused rocket electrophoresis and 
skin tests <Kim and Chaparas, 1979).
Cross-reaction of patient sera is common between A. 
fumigatus and A. flavus also between A. fumigatus and A. 
nidulans (Vernes and Biguet, 1980).
Fractionation of antigens from Aspergillus species 
into, water soluble antigen, triton detergent extracted 
fractions and a triton/water soluble component has been 
attempted. The water soluble/triton extracted fractions 
were the most specific when tested by double diffusion 
against antiserum raised in animals. However, when the 
sera from patients were tested against the same antigens 
there was cross-reactivity amongst the different species 
indicating shared antigens in these extracts.
Magaldi and M",ckenzie <1984) noted marked cross­
reactivity between species of Aspergill us when examined by 
ELISA and immunofluorescence. Antiserum raised against A. 
terreus was the most specific as it only reacted with its 
homologous antigen. However, the A. terreus antigen did 
cross-react with the sera raised against other species of 
Aspergillus. Antigens of A. flavus cross-reacted only with 
antiserum raised to A. fumigatus showing lines of identity. 
A. fumigatus antigens cross-reacted with the other three 
sera producing several lines of identity when examined by 
line immunoelectrophoresis (Magaldi and Mu,ckenzie, 1984). 
In general, there were only weak reactions of heterologous 
fungal sera against antigens of Aspergillus species with 
the exception of C. albicans antiserum which gave a strong 
response to A. fumigatus, A. flavus, A. terreus and A. 
niger antigens.
The complexity of immunological relationships of fungi 
necessitates the use of carefully monitored and controlled 
experiments when employing immune serum or fungal antigens 
as markers or bridges in systems for identification of 
fungal disease. The use of immune serum to detect fungi in 
tissue sections by means of immunoperoxidase staining 
techniques is one such system.
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1.12. Fungal Infections In Drug Addicts
Drug addicts have been reported as being susceptible to 
mycosis caused by various fungi at different body sites. 
Candida, is the most commonly reported fungus associated with 
infections of these individuals. Pulmonary candidosis has 
been reported in a heroin addict, on one occasion (Lazzarin 
et al., 1985). Other fungal infections include cryptococcal
meningitis in an intravenous cocaine abuser (Schuster, 
Valentine and Holzman, 1985). Penicillium sp. was the cause 
of endophthalmitis following parenteral drug abuse on one 
occasion but no attempt was made to establish the source of 
infection (Swan et al. % 1985).
Candidal endocarditis is a recognised complication of 
heroin abuse and was first described in a heroin addict by 
Joachim and Polayes (1940). However, of the 11 cases of 
endocarditis described by Luttgens (1949) only one involved 
Candida and that was in a mixed infection. Of the 28 cases 
of heroin associated endocarditis reported by Dreyer and 
Fields (1973) only one was attributed to Candida. These 
authors suspected that earlier reports overemphasised the 
fungal infections.
Heroin associated candidal endocarditis causes 
predominantly left sided valvular infection with the aortic 
and mitral valves most frequently involved (Sande et al., 
1977).
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1. 12. 1. Endophthalmitis In Drug Addicts
Fungal endophthalmitis is not a common disease. Jones et 
al. <1970) reviewed all the cases of fungal endophthalmitis
reported in the United Kingdom between 1880 and 1970 and 
could find only 30. C. albicans was the most commonly 
implicated fungus, accounting for 12 of the cases. Recently 
Candida endophthalmitis has been seen more frequently and 
many of the patients have been heroin addicts (Salmon, 
Partridge and Spalton, 1983; Servant et al., 1985). Fungal
endophthalmitis in heroin addicts, particularly if Candida 
is the aetiologic agent, appears to present with a different 
picture to that found in other patients. In addicts it is 
frequently unilateral with little other evidence of candidal 
infection and no evidence of life threatening deep seated 
disease.
Candida endophthalmitis was first described in 1943 by 
Miale and was a histological study. The first diagnosis 
based on clinical evidence was made by Van Buren (1958). 
However, the disease was not described in association with 
drug abuse until much later. Fungal endophthalmitis 
associated with intravenous drug abuse was first attributed 
to an Aspergillus sp. and no yeast forms were evident 
(Sugar, Mandell and Shalev, 1971). The diagnosis of the 
first case of endophthalmitis attributed to C. albicans in a 
drug abuser was based on an agglutination test for Candida 
in the serum and recognition of yeast elements in a sample 
of vitreous. Although no yeast was cultured and fluorescent
84
antibody tests could not confirm the identity of the yeast 
<Getnick and Rodrigues, 1974). Vastine et al. <1976) 
reported a cluster of four addicts with presumed candidal 
endophtha1mi t i s .
The histopathology of candidal endophthalmitis was 
examined in a drug abuser who died as a result of a car 
accident seven weeks after commencement of antifungal 
treatment. A presumptive clinical diagnosis had been made 
and was confirmed by culture of a pars plana vitrectomy 
sample. No fungus was visible in the histological material 
but there were lymphocytes, neutrophils and macrophages, 
infiltrating the vitreous. Granulation material was seen at 
the optic cup extending into the vitreous, forming a 
fibrovascular nodule of chronic inflammatory cells and 
multinuclear giant cells (Stern, Fetkenhour and O'Grady, 
1977).
It was Aguilar and co-workers <1979) who first suggested 
that the presentation of endophthalmitis in drug addicts may 
be different from that seen in other patients. The anterior 
chamber reaction seen in the three cases they described was 
not typically seen in other forms of the disease. These 
authors also emphasised the benefits of concentrating the 
vitreous sample before attempting culture. They suggested 
that Candida endophthalmitis might often be missed in drug 
addicts as there may be a long latent period between 
inoculation and manifestation of the clinical disease. The 
patients may not admit to being drug addicts and the
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diagnosis may not be considered as the patients may respond 
initially to steroids administered for uveitis (Aguilar et 
al., 1979).
The first report of related cases of mycotic 
endophthalmitis in drug abusers described a man and wife 
(Elliott et al., 1979). The vitreous from the man grew C.
albicans. His wife also presented with endophthalmitis 
associated with glaucoma, she had a history of candidal 
infection of the scalp, nails and mucous membranes. The wife 
had a positive skin test reaction to C albicans extract. 
However vitrectomy samples yielded Aspergillus flavus, 
Torulopsis glabrata and a Helminthosporium sp. .
Salmon et al. <1983) described a British addict with 
candidal endophthalmitis. Ho speculation was made as to the 
source of the yeast but it was thought to follow intravenous 
infection. Tarr (1980) also reported a case and he described 
the addict as being healthy apart from slight backache, The 
cause of this back pain was not investigated but it may have 
indicated another site of candidal infection. Localised 
candidal infection, not associated with the generalised 
systemic disease in heroin addicts was first alluded to by 
Dally et al.,(1982) when he reported not only 
endophthalmitis but hair loss and skin rashes. This theme 
was expanded by Collignon and Sorrell (1983) who thought 
that this may be a distinctive syndrome in heroin abusers. 
They saw seven addicts who developed eye, skin and costal 
cartilage lesions. The eye was involved in every instance.
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Cultures from skin and costal cartilage grew C. albicans.
The authors regarded lesions on the scalp associated with 
regional lymphadenopathy as being a feature of candidosis in 
heroin adicts. Dally, Thomas and Danan, <1983) agreed with 
Collignon and Sorrell's observations.
1.12.2. Clusters of Candida Endophthalmitis in Drug Addicts
The first evidence that Candida endophthalmitis and other 
manifestations of candidosis could occur as epidemics in 
communities of heroin abusers was provided by Mellenger et 
al. <1982) who described 35 cases in the Paris region. There
were cutaneous lesions in 88% of cases, eye involvement was 
seen in 65% of the patients and there were instances of 
osteoarticular and pleuropulmonary infection. The skin 
lesions manifest themselves as papulo-nodular sores often 
located in the hairy regions of the body. If present in the 
scalp they are likely to cause pain. Eight patients were 
involved in one outbreak in Australia <Hoy and Speed, 1983) 
and four in a small cluster in New Zealand <M",c:Kay, 1983) .
It was speculated in both these reports that the source of 
the yeast may have been the fresh lemon juice used to 
dissolve the heroin. Other outbreaks were recorded in 15 
American heroin addicts (Cuandra et al., 1984), in 17 in
Australia (Sorrell et al. , 1984 : Gallo et al., 1985) and 11
cases were reported in Spain (Podzamczer et al., 1985). Two
heroin addicts with extensive folliculitis were described 
from Switzerland (Calandra et al., 1985) and 38 Parisian
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addicts were described as having candidosis by Dupont and 
Drouhet, <1985). Clusters of cases have been reported in
several areas of the world; in ten addicts from two groups 
in the Netherlands (Hogeweg and De Jong, 1983; Malecaze et 
al., 1985) and in Glasgow in 8 addicts (Servant et al.,
1985). These reports predominantly involved skin papules and 
nodules although the eyes were infected in some instances.
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1.13. Epidemiolngy nf fungal Infections In Drug Addicts
The transmission of infection amongst heroin addicts 
has been ascribed to several sources but the most commonly 
cited hypothesis is the sharing of needles and syringes, 
although the prevalence of this practice is difficult to 
ascertain.
Bacterial infection of a married couple who shared 
needles was reported by Hussey et al. in 1944, and a 
malaria outbreak in heroin addicts was attributed to the 
communal use of injection equipment by Most <1940). The 
high proportion <70%) of addicts with evidence of current 
or past hepatitis B virus infection <Follett et al. , 1986)
is related not only to the addicts' disregard of hygienic 
injection technique but the repeated and communal use of 
the syringes and needles. In one recent study, it was 
found that 68% of intravenous drug abusers engaged in 
needle sharing <Black et al., 1986). The recent advent of
AIDS and its spread through the heroin addict community, 
in all parts of the world, has highlighted the problems 
associated with sharing blood contaminated injection 
paraphernalia <Paine, Tonuma and Monheit, 1985; Friedland 
et a1., 1985; Follett et al., 1986). Currently, 17% of all
AIDS patients in the United States are intravenous drug 
users <Mulleady and Green, 1985).
The sharing of syringes and needles has also been 
implicated in the epidemiology of Candida endophthalmitis
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in heroin addicts. This manifestation of candidosis has 
been reported in isolated incidents and in clusters and 
outbreaks, with as yet no proven common link, in the 
heroin communities throughout the world.
Although syringes, needles and other paraphernalia have 
been proposed as being the source of Candida 
endophthalmitis, on circumstantial evidence,(Vastine et 
al., 1976; Hogeweg and De Jong, 1983; Sugar et al. , 1971)
little effort has been made to verify this hypothesis. 
Sorrell et al. (1984) described Candida endophthalmitis in
seven young men and reported that they had shared two 
syringes. Unfortunately they did not culture the needles 
or syringes.
In a further study, 100 random sets of injection 
paraphernalia, not necessarily taken from addicts with 
infections, confiscated from the street were cultured to 
identify any microbial contamination. Only 11% yielded no 
organism, 9% grew fungi, the rest yielded bacteria. The 
most frequently isolated fungus was Saccharomyces spp. 
which was isolated five times. Aspergillus spp. was 
isolated three times and Rhodotorula sp. once. C. 
albicans was not recovered (Tuazon, Hill and Sheagren,
1974).
The attempts that have been made at culturing syringes 
and needles from patients with evidence of candidosis have 
had varying degrees of success. Calandra et .al. <1985)
found the culture of a syringe shared by two heroin
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addicts with candidosis was positive for C. albicans. 
Podzamczer and Gudiol <1986) also isolated C. albicans 
from syringes, whereas Elliot et al., <1979) cultured some
injection paraphernalia and recovered Cryptococcus 
laurentii and a Rhodotorula species. Dupont and Drouhet 
<1985) believe these findings are exceptional and do not 
account for the epidemic nature of Candida endophthalmitis 
in heroin abusers.
Another likely source of Candida is contaminated street 
heroin and this might account for the sporadic outbreaks 
of the disease. In all published reports of candidosis in 
addicts, in which the type of heroin has been described, 
it has been brown heroin, regardless of where in the world 
the cases have presented. <Vastine et al., 1976 (Chicago);
Mellinger et al., 1982 <Paris); Dally et al., 1982; 1983
(Paris); Lopez et al., 1983 (Rome); Calandra et al., 1985
Switzerland); Dupont and Drouhet, 1985 <Paris); Malecaze 
et al., 1985 (Toulouse); Podzamczer and Gudiol, 1986
(Barcelona)). This form of the drug has appeared on the 
market only in the last few years during which time a 
syndrome of candidosis has become more frequently 
recognised in drug abusers.
Three patients, from seven cases described in the 
Netherlands, obtained their heroin, independently of each 
other but via the same dealer and developed Candida 
endophthalmitis about the same time, suggesting that the 
heroin might be the source of the infection (Hogeweg and
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De Jong, 1983). Heroin obtained from a single dealer was 
implicated in ocular candidosis in two Australian addicts. 
In neither of these two instances was an attempt made to 
culture the drug (Sorrell et a1., 1984).
Culture of heroin has been attempted on several 
occasions without success. Halecaze et al. (1985) reported
that all the samples they procured were sterile. Dally et 
al. (1982) cultured four samples with a negative result.
Podzamczer et al. <1985;1986) were also unsuccessful when
they cultured the drug. There is little detail as to how 
these investigations were performed and the size and 
number of samples and their relationship to the infected 
addicts are seldom indicated. Mellinger et al. (1982)
reasoned that the negative findings in their study were 
due to the small sample size and inadequate methodology. 
However, Lopez et al. (1983) cultured 50 samples and
although they found bacterial contamination in 37 no fungi 
were recovered. In Barcelona 210 samples of street heroin 
were cultured without isolation of C. albicans (Miro et 
aJ., 1986).
To try to find a correlation between infection and 
street heroin, all heroin confiscated by the Chicago 
police department during a two week period was cultured 
and although no Candida was recovered, four unidentified 
fungi were isolated (Vastine et al., 1976). One hundred
heroin samples seized by the Bureau of Narcotics and 
Dangerous Drugs in the USA were cultured at random, no
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Candida species, nor any other yeasts, were isolated but 
Aspergillus fumigatus was the second most common organism 
recovered (Tuazon, Miller and Shamsuddin, 1974).
In another study, 31 samples of street drug that were 
examined for chemical adulterants and microbiological 
contamination. 61% were positive for microbial growth, No 
yeasts were recovered but Aspergillus spp. were recovered 
on three occasions and Penicillium once. On three 
occasions unidentified saprophytic fungi were cultured 
(Moustoukas et al., 1983).
Heroin has been shown to have some antimicrobial 
activity, although it is limited and variable (Tuazon et 
al., 1980). The survival of C. albicans in heroin was
studied by mixing a suspension of 120-150 colony forming 
units (CFU) of the yeast in 100 mg of the drug and 
culturing the inoculated paste one week later. C. albicans 
was not recovered (Dupont and Drouhet, 1985).
Another possible source of the Candida causing 
outbreaks of endophthalmitis, is the diluent addicts use 
to dissolve their drug. The brown heroin now commonly used 
by the addicts is not as soluble in water as the white 
heroin previously available. As a result many addicts use 
a slightly acidic solvent, such as vinegar or lemon juice 
(Mellenger et al. t 1982; Malecaze et al., 1985). Sorrell
et al., (1984) reported two addicts who bought their drug
from the same dealer also used the Juice from the same 
lemon and similar situations have been noted elsewhere.
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Three Australian patients who developed endophthalmitis 
had shared a lemon (Hoy and Speed, 1983) and four drug 
addicts from New Zealand who had used the same lemons, 
presented with Candida endophthalmitis <M"'cKay, 1983) . 
Dally et al., (1982) find this phenomenon is unlikely to
explain the contamination and are supported by Dupont and 
Drouhet <1985) who suggest that gentle heating of the 
mixture could have a sterilising effect . Other 
investigators have found fresh lemons to be an excellent 
culture medium for C. albicans (Hoy and Speed, 1983; 
Podzamczer and Gudiol, 1986). Fresh lemons experimentally 
inoculated with C. albicans promoted the rapid growth of 
the organism with even a very small inoculum resulting in 
a heavily contaminated lemon after one week (Newton—John, 
Wise and Looke, 1984). However, Miro et al.(1986) cultured 
25 samples of lemon juice used by heroin addicts and 
failed to isolate C. albicans.
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1.14. Biotyping of Candida a 7 hi r^ ns Isolates
Biotyping divides species of fungi into groups which 
may not be phylogenetically accurate. It is a procedure 
whereby isolates of a species may be grouped or divided 
according to morphological, biochemical or physiological 
criteria which cannot be directly attributed to genetic 
varieties. A strain is a physiological race but a biotype 
has no formal taxomonic status.
Biotyping medically important fungi has practical and 
epidemiological applications and a number of attempts have 
been made to differentiate strains of C. albicans <Odds, 
1985>. These range from serotyping into groups A and B by 
their antigenic composition (Hasenclever and Mitchell, 
1961) to elaborate techniques distinguishing hundreds of 
groups. Ideally these systems will determine enough groups 
of C. albicans to enable the isolate to be
"fingerprinted". The system must be sufficiently sensitive 
to recognise as many characteristics as required to select 
several groups which highlight the differences of the 
isolates. Unfortunately the larger the number of 
characteristics tested the more unwieldy the test becomes 
and the fewer the number of isolates which can be handled.
Colony morphology was the basis of Brown—Thomsen's 
<1968) biotyping system but his 18 morphological forms 
reverted to the form from which the majority of the 
Isolates originated.
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Varnock et al., <1979) devised a method of
differentiating C. albicans based on differences of 
resistance to six chemicals at concentrations which gave a 
differential effect. If a chemical inhibited growth then a 
letter code assigned to that chemical was included in the 
isolate*s resistotype description. This biotyping method 
allowed for the ten control and 15 unknown strains to be 
tested on one plate. The system had the potential to 
distinguish 1092 strains but in practice it revealed a 
restricted number. A further disadvantage of the method 
was the requirement for biological titration, as there was 
batch to batch variation in the critical concentrations of 
the chemicals. In addition it proved impossible to obtain 
a precise pattern of inhibition for the reference strains.
This resistogram method was employed to differentiate 
strains of C. albicans in patients with vulvovaginitis. It 
was found that 16 of the 30 patients harboured a single 
type while 14 carried more than one strain <Warnock et 
al,, 1979). McCreight and Varnock <1982) modified the 
resistogram method and replaced four of the original 
chemicals to enhance the differentiation of isolates. The 
improved method was used to investigate cases of denture 
induced stomatitis and discovered one resistotype to be 
most prevalent <McCreight, Varnock and Vatkinson, 1984).
An alternative system for the presumptive 
identification and strain differentiation of C. albicans 
was devised by Odds and Abbott <1980). The test was
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designed for routine screening, as it can be applied to 
large numbers of clinical isolates. Ten biotyping agars 
were used, one allowed the identification of C. albicans 
and the other nine differentiated the strain types. The 
agar media constituents and the inoculum size were very 
precisely controlled in this method. Depending on the 
growth or non-growth or pigment production of the yeasts 
on the media the fungi were given a number which reads out 
as a digital sequence which is unique for that combination 
of test results. The group of numbers constitutes the 
biotype. This system has been modified slightly to enhance 
the test and to permit the identification of other 
medically important Candida spp. . Four other 
differentiation test plates containing inhibitory 
chemicals have been introduced. The glycerine assimilation 
test has been replaced by a test for resistance to boric 
acid COdds and Abbott, 1983).
It has been shown that most people carrying C. albicans 
have the same biotype at different body sites and often 
for long periods of time (Varnock et al. , 1979; Odds,
1982; McCreight et al., 1984). Biotypes have not yet been
linked to pathogenicity of C. albicans strains but they 
have been shown to be informative in studying the 
epidemiology of infections. The results indicated that 
some biotypes which are isolated more frequently than 
others may have a greater pathogenic potential. (Burnie et 
al.t 1985).
97
In this study the biotyping system of Odds and Abbott 
<1980; 1983) was used to assist the discovery of the 
source of an outbreak of Candida endophthalmitis in 
Glasgow.
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1.15. Animal Models Por Candida Bndoph-fchal tbH-.I «
Investigations of the eye are performed with animal 
models to correlate normal and abnormal structure and 
function. Although there are numerous similarities amongst 
the visual systems of vertebrate animals, there are 
significant differences which must be taken into 
consideration when selecting a research model and when 
extrapolating results from one species to another. A 
subhuman primate provides the ideal laboratory model for 
eye research <Peiffer, Armstrong and Johnson, 1981) but in 
practice this is not possible for financial and logistic 
reasons.
Duke-Elder <1958) wrote a description of the comparative 
anatomy and physiology of animals in which he included the 
classification of placentals according to their retinal 
vascularization.
The retina of both man and the mouse is holangiotic and 
the entire retina receives a direct blood supply. In 
rabbits and hares the blood vessels are limited to the 
horizontal expanses and such retinae are termed 
merangiotic. In animals with paurangiotic retinae only 
small vessels are present and these extend just a short 
distance from the optic disc. This group includes the 
guinea pig. Anangiotic retinas have no retinal vessels and 
this is seen in some primitive mammals.
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There are numerous animal models for the study of 
candidosis (Guentzel, Cole and Pope, 1985) and for various 
ophthalmic conditions (Peiffer et al., 1981) but models
for fungal eye diseases have been infrequently described. 
Studies of keratitis have been made in rabbits with both 
Fusarium solani (Forster and Rebel1, 1975) and C. albicans
and in the latter fungus corticosteroids were used to 
induce keratitis. (Stern, Okumamoto and Smolin, 1979).
Anterior uveitis due to F. solani <0'Day et al. , 1979)
was initiated by direct transcorneal chamber inoculation. 
The intravitreal route has also been used for posterior 
segment infection by introducing the organism via a needle 
through the pars plana. This technique requires the animal 
to be heavily sedated or anaesthetised.
Histoplasmosis has been studied in several animals 
<Smith et al., 1978) and ocular cryptococcosis has been
induced in rabbits, primates and cats, Blouin and Cello 
<1980) successfuly reproduced lesions similar to those 
occuring in man. Metastatic Candida endophthalmitis has 
been produced in both rabbits and mice (Hoffman and 
Vaubke, 1961; Hoffman, 1966). In experimental animal 
models designed to compare the ocular pathogenicity of 
Cryptococcus neoformans, Candida glabra ta and Aspergillus 
fumigatus in relation to C. albicans, only C. albicans and 
C. neoformans could be recovered from eye cultures, and no 
lesions were seen on ophthalmic examination of any of the
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animals infected with fungi other than C. albicans (Fujita 
et al., 1982).
Candida endophthalmitis has become of increasing 
interest in view of its association with candidaemia, 
heroin addiction and its use as a diagnostic aid in 
disseminated candidosis. The rabbit, despite its retinal 
vasculature, has proved to be the most popular animal 
model for candidal endophthalmitis. Endophthalmitis has 
been induced by direct inoculation of C. albicans into the 
eye and this method has been used to assess treatment of 
the infection with amphotericin B and flucytosine (Peyman, 
Vatine and Meisels, 1975). However, this method of 
establishing the disease is not analogous to the route of 
inoculation in drug addicts or patients receiving 
hyperalimentation, when the organism is spread via the 
bloodstream to the eye.
Intravenous inoculation of Candida into the rabbit has 
proved useful in establishing a model for experimental 
haematogenous candidal endophthalmitis. In one study 88% 
of rabbits had ocular lesions two weeks post infection 
(Edwards et al., 1975) and it was consistently found by
culture that the numbers of organisms isolated from both 
the eyes and kidneys in each animal were approximately 
symmetrical. There was some discrepancy between the 
numbers of organisms seen on histological examination of 
tissue sections from the lesions and the number of 
organisms isolated on culture. This was attributed to the
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sampling error caused by examining a single central 
section of the lesions. Demant and Easterbrook <1977) 
employed a rabbit model similar to that of Edwards et al. 
<1975) in an attempt to correlate quantitative culture 
results with the number, size and severity of the animals' 
clinical lesions. They did not obtain consistent results 
although the eyes with the worst clinical appearance did 
yield the highest colony count on culture.
Animal models have been designed to investigate the 
reliability of diagnostic vitrectomy in experimental 
Candida endophthalmitis. Henderson et al., <1979) found
vitreous aspiration to be a most useful procedure, since 
culture results correlated well with the clinical picture 
in experimental disease.
Although ophthalmic assessment is of diagnostic value 
in many patients it may not prove to be so reliable in 
severely immunocompromised or neutropenic patients. 
Henderson et al. <1980) reported that immunosuppression 
alters the development of ocular lesions in experimental 
haematogenous endophthalmitis and any lesions seen are 
small and atypical.
Species of Candida other than C. albicans have been 
implicated in endophthalmitis (O'Day, 1985; McCray et al.,
1986) but the relative ocular pathogenicity of other 
species of Candida was shown to be poor when examined 
using a model for haematogenous endophthalmitis. C. 
parapsilosis, C. krusei and C. guillermondii failed to
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produce any ocular lesions in this model. C. tropicalis 
and C. stellatoidea caused extensive renal infection but 
not significant eye infection, they did have a low level 
of ocular pathogenicity but the vitreous was not infected 
<Edwards et al., 1977).
A model of endogenous Candida endophthalmitis in 
rabbits has been used to look at the possibility of 
treating the disease by laser photocoagulation. Regression 
and healing were seen when the laser was applied to early 
lesions and although larger lesions did not heal they were 
less inflammed than those in the control animals. No 
damaging effects were reported <Santos, Buen and Juarez, 
1967).
Hany animal models have been established for the 
purpose of examining the penetration of drugs to the eye. 
Ocular structures are easily accessible and as a result a 
number of routes of administration are available that are 
not possible with other organs. However, the hydrophobic 
corneal epithelial layer and the hydrophilic corneal 
stroma over external surfaces act as barriers to topical 
drugs. Systemically administered drugs are hindered by the 
blood—ocular barrier similar to that of the blood—brain 
barrier CRapoport, 1976). Contributing to the blood ocular 
barrier are the endothelial cells of the iris and the 
retinal vessels and the pigment epithelium. Inflammation 
may also affect ocular penetration of drugs (Peiffer et 
al., 1981).
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Toxicity of antifungal drugs has been evaluated by 
means of animal models of exogenous endophthalmitis. 
Axelrod et al., <1973) found doses of 5 and 10 pg could be
injected into normal rabbit eyes without change but if the 
dose was increased to 25 pg it was etremely toxic. In a 
further study Axelrod and Peyman, <1973) reversed the 
course of an exogenous Candida endophthalmitis infection 
in rabbits by a single intravitreal administration of 5 - 
10 pg of amphotericin B. Intravitreal amphotericin B was 
tested in uninfected and infected vitrectomised eyes and 
was found to be nontoxic at the highest dose used, 5pg/0. 1 
ml <Huang, Peyman and McGetrick, 1979). Intravitreal 
amphotericin B methyl ester was not toxic at 10 pg and 
reversed the course of exogenous candidal endophthalmitis.
Amphotericin B was found to be toxic at concentrations 
greater than 15 pg per eye, it produced vitreous opacities 
which were dose dependant <MCGetrick, Peyman and Nyberg, 
1979). Raichand et al. <1980) concluded that amphotericin
B methyl ester at 10 pg/ml in vitrectomy infusion fluid is 
a safe effective agent in the treatment of experimental 
endophthalmitis. These two sets of results are 
contradictory, as the volume of the vitreous is 4 ml and 
at a dose of 10 pg/ml the dose per eye would be 40 pg 
above the toxicity limit described by McGetrick et al. 
<1979). One study which compared miconazole, ketoconazole, 
amphotericin B and flucytosine found oral ketoconazole and
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intravenous amphotericin B in combination to be an 
effective treatment for the disease (Jones et al. t 1981), 
The eye is immunologically unique as it is devoid of a 
lymphatic system and has no directly associated lymph 
nodes. Some work indicates that uveal and limbal tissues 
play a role similar to that of secondary lymphoid tissue 
elsewhere in the body. Some studies have shown that blood 
borne lymphocytes and splenic lymphoid tissue play a role 
in the recognition of intra-ocular antigens. This is 
termed the splenocameral axis (Kaplan and Streilein, 1978; 
Kaplan, 1983).
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2. QPTRgRAir OF HAWBTDA CTDnPHTHAT.lCTTTS 
Iff GLASWEGIAN HEROIN ADDICTS
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2. 1. Candida Kndnphthalmltis In Glaswegian Heroin Addicts
Glasgow, like many large cities lias an increasing problem 
with heroin addiction (Ditton and Spiers, 1982). Heroin is 
readily available in the city and a conservative estimate is 
that there are a 100 new addicts each year.
In this study we were concerned with one area of the city
called Castlemilk. This estate is situated to the south of 
the city and was built in the 1950's (Figure 1).
2.1.1 Street Heroin
There are two types of street heroin; white from Asia, 
mainly Pakistan and brown which may originate in Pakistan, 
Iran or Mexico.
The most common type used in Glasgow is brown heroin. It 
contains many diluents such as sugar, quinine and talcum, 
which tend not to be soluble. The heroin is a dirty brown
colour when the main dealer sells it to the "pushers" who
adulterate it further with impurities such as, scouring 
powder and cement before selling it to the addicts (Figure 
2) .
The addicts in Glasgow are therefore at present buying 
approximately 15% pure heroin. A 5mg bag costs £5 and some 
addicts eventually spend as much as £150—£200 per day on 
heroin. They finance their habit by theft and by becoming 
"pushers".
Figure 1 Position of Castlemilk
Figure 2 Heroin confiscated from a "pusher
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2.1.2. Injection Technique
The injection technique is to dissolve their drug in 
lemon juice, vinegar or water on a spoon. Sometimes they 
heat this mixture, not in order to reduce any microbial 
contamination but to help to dissolve the powder. They stir 
the mixture with the plunger from the syringe, break the 
fiTter from the end of a cigarette which they place on the 
spoon and draw the fluid through it into the syringe. After 
injection, the addicts often rinse out the syringe with 
their own blood, sometimes using saliva to lubricate the 
needle and sometimes licking their finger and holding it 
over the needle mark. Addicts use the same syringe 
repeatedly and it is suspected, share them with their 
friends.
2.1.3. Clinical Picture
In November 1982 the eye departments of a number of 
Glasgow hospitals saw several cases of what appeared to be 
fungal endophthalmitis. The patients presented with quite a 
wide range in the severity of their symptoms. Some had a red 
painful eye with deteriorating vision; some could just 
detect hand movements or count fingers at a distance of two 
metres (Figure 3). In other patients the eye was painless 
but they had blurred vision and annoying floaters in the 
visual field. The floaters were caused by yeasts and white 
blood cells in the normally clear vitreous.
Figure 3 Addict's eye showing circumlimbal injection 
and episcreral vessel dilation
Figure 4 Photograph of a healthy retina taken through 
a normal vitreous.
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A photograph of a retina taken through a normal vitreous 
shows a clear picture of blood vessels (Figure 4). In a 
patient with Candida endophthalmitis the hazy vitreous 
results in the retinal vasculature being out of focus. White 
fluffy snowballs of fungus cause refractive disturbances 
resulting in opacity (Figures 5 and 6).
2.1.4. Treatment of Candida Endophthalmitis
Treatment of the Glasgow patients varied with each case 
and has been detailed by the clinicians involved (Servant et 
al., 1985). Some of the cases resolved spontaneously.
Ketoconazole was used but problems of hepatotoxicity made 
the clinicians wary about using it with patients who already 
had a history of jaundice. With flucytosine, although the 
levels of the drug in the vitreous are therapeutic, there is 
a possibility of wild type and drug induced resistance.
IntraVitreal amphotericin B was the treatment of choice 
if the condition persisted. The addicts were usually treated 
as out-patients. If further deterioration occurred then 
intravenous amphotericin B was used; sometimes in 
conjunction with a vitrectomy to remove some of the fungal 
load. There have been inconsistant reports about ocular 
penetration of amphotericin B after intravenous 
administration. Using a bioassay method on vitreous samples 
amphotericin B was not detected in any of the Glasgow 
patients. However, the samples of neat vitreous were 
extremely small and if the amount of drug present was low it
Figure 5 Characteristic "snowball" appearance of 
Candida endophthalmitis lesion.
Figure 6 Lesion caused by Candida endophthalmitis.
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was not too surprising that it was not detected as the 
bioassay system used was not sufficiently sensitive (Figure 
7) .
Even after successful treatment the patient may be left 
with damaged sight. In some treated eyes there is macular 
scarring and fibrosis which leads to retinai folding and 
distorted vision (Figure 8). The scarring damages the most 
important region of the eye which leaves the patient with 
only peripheral vision.
2. 1.5. Patients
Twenty four Glasgow heroin addicts have now been 
diagnosed as having had Candida endophthalmitis.
Table 1: Castlemilk heroin addicts.
Male 20
Female 4
Age Range 1 6 - 3 3  years
Heroin Abuse 6 weeks - 5 years
Left Eye 15
Right Eye 2
The patients were asked to complete a questionnaire to * 
help to discover the source of the outbreak (see page 111). 
The majority of the infected addicts had a connection with 
Castlemilk (Figure 9). Eighteen of the addicts lived in
Figure 8 Photograph of a retina from a treated case of 
endophthalmitis, showing retinal folding and macular 
scarring.
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Castlemilk, two admitted buying their heroin from 
Castlemilk, three others stayed in the south of the city.
The green dot on the map shows the location of a female 
"pusher” who supplied several of the addicts. With the 
exception of a married couple and one friend, the heroin 
addicts claimed not to know each other.
All the addicts with Candida endophthalmitis seemed to 
dissolve their drug in "Jif” squeezy lemons and did not use 
water or vinegar. A number of the addicts suspected that the 
"pusher” may have been using shop-bought yeast to cut the 
drug before selling it.
The possible sources of infection appeared to be : - the 
drug itself, the lemon juice used as a solvent, the 
injection paraphernalia or they were infected from their own 
gut.
Figure 9 Map of Castlemilk showing the homes of heroin 
addicts and the suspected location of a "pusher".
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CANDIDA ENDOPHTHALMITIS IN HEROIN ADDICTS 
PATIENT DATA SHEET
Names 
Address:
Age: Sex
Which eye is involved?
Visual acuity:- Left eye
Right eye
Are there any lesions on the scalp or costochondral region? 
Are they experiencing any hair loss?
How long have they used heroin?
What type of heroin? e.g., brown/white
What diluent do they use? e.g., lemon juice/vinegar/water.
Is the injection paraphernalia available for culture? 
e.g., syringes, diluent, spoon, drug wrapper.
Do they, or have they ever shared syringes or drug diluent 
with their friends?
Have any of their addict friends suffered deteriorating 
vision recently?
Have they any connection with the Castlemilk area of Glasgow
0 0 0 O0 0 0
The following samples would be extremely useful to help with 
our understanding of the aetiology of this disease.
Mouthwash
Mouth swab
Faecal sample
Vitreous
Hair with roots/skin scrapings for lesions on scalp
Venous blood for Candida serology. (Please indicate 
Hep B and HIV test results)
Please return this form with any available samples to 
Gillian S. Shankland, Department of Medical Mycology, 
Anderson College, 56 Dumbarton Road, Glasgow.
(Tel. 339-8855 Ext. 4010/4011).
MTgTAig AID METHODS
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3. 1 Preparation of Antigone;
The antigens used, in this study to raise antisera to 
Rhizopus oryzae, Candida albicans and Aspergillus 
fumigatus, or for use in tests for serological 
specificity, were prepared in accordance with a method 
described by M"1'1 kenzie, Philpot and Proctor <1980). The 
isolates were stored as silica gel preserved cultures 
(Gentles and Scott, 1979). Several of the isolates had 
been stored in this way for many years. The antigens used 
are detailed in the following table.
Table 2: Antigens of Aspergillus, Rhizopus, and Candida 
species with their corresponding antigen number, details 
of the isolates involved with their sources and silica gel 
number, if stared in the Glasgow culture collection.
Antigen Hame/Humber Silica gel Source
A. fumigatus Bencard <1)
Humber
Commercial
A. fumigatus Bencard <2) Commercial
A.
A.
fumigatus
fumigatus
Indian 
GAF 5 AF5
Commercial
CLV
A. fumigatus GAF 83 AF5
Veybridge
CLV
A. fumigatus GAF 84 AF60
Veybridge 
Air Derm. 
Dept.
Air Derm.A. fumigatus GAF 85 AF59
A. fumigatus GAF 86 AF60
Dept.
Air Derm.
A . flavus GAF1 2 AFL6
Dept. 
Sputum
A. clavatus GAC 2 ACL1 Barley grain
A. nidulans GAHid 1 AHil IMI 75006
A. nlger GAN 2 AHig4 Sputum
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Table 2 continued
Antigen Name/Number Silica gel Source
Number
A. terreus GAT 2 ATe8 CLV,
Veybridge 
Soft palate 
Commercial
R. oryzae 
C. albicans
C. albicans 
C. albicans
C. albicans
GRhl 
Hereia 
(somatic)
MRL 3153 
(cytoplasmic) 
GCA003 
GCA406
Rhsp.1
CA9
CA6
Throat swab 
Skin biopsy
C. parapsilosis MRL 304
(cytoplasmic)
3.1.1. Antigens of Filamentous Fungi
Glucose peptone broth (300 ml) was inoculated with the 
fungus. Magnetic stirrers were used to ensure adequate 
aeration and the cultures were kept at 37°C for three days 
by which time the growth was dense.
The cultures were decanted into sterile 5 litre flasks 
containing 3 litres of glucose peptone broth and these 
were incubated on magnetic stirrers for a further three 
days.
Glucose Peptone Broth
D - glucose 20 g
Bacteriological peptone 5 g
Distilled water 1,000 ml
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The fungus was harvested by filtering through nylon and 
the hyphal mat was stored frozen at -20°C. The fungus was 
pulverised using mortar, pestle and sand that had been 
autoclaved for 30 minutes at 15 lbs p.s.i. pressure then 
dried in a sterilizing oven for 1 hour.
The fungus, sterile sand and volatile buffer were 
mixed, frozen in the mortar, pounded by the pestle until 
liquid, refrozen and ground again.
Volatile Buf£.er.
Ammonium hydrogen carbonate 8 g
Water 1,000 ml
The pH was adusted to 7.2 by dropwise addition of 
glacial acetic acid.
The slurry was centrifuged at 2, OOOg to remove the sand 
and debris, the supernatant was frozen overnight and 
recentrifuged.
The second supernatant was dialysed against daily 
changes of 10% polyethylene glycol 600 in volatile buffer 
at 4°C for 2 days. It was then frozen overnight at -20°C, 
centrifuged at 2,OOOg for 1 hour, the supernatant was 
decanted and spun for a further 30 minutes. The 
supernatant from this was freeze-dried to give a powdered 
antigen preparation.
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3.1.2. Antigens of Candida Species
The C. albicans antigen used to raise antiserum to C. 
albicans was supplied, as lyophilised powder, by Prof.
D.W. R. M*,ckenzie of the Mycological Reference Laboratory, 
Central Public Health Laboratory, 61, Colindale Avenue, 
London <MRL> . The C. parapsilosis antigen was also 
received from this source.
Other C. albicans antigens were prepared from glucose 
peptone agar cultures grown in roux bottles. The yeasts 
were incubated for 24 hours at 37°C, they were then 
harvested by washing in saline before centrifugation to 
recover the organisms. The yeasts were frozen, thawed then 
disrupted in a Braun MSK homogeniser. A suspension of 
yeast and an equal volume of number 12 (0.124-0.176 mm 
diameter) ballotini glass beads were placed in a 
homogeniser bottle. Homogenisation of the cells was 
conducted under continuous carbon dioxide cooling. At 
minute intervals the bottle was removed to check for 
freezing or overheating. After four minutes the homogenate 
was examined microscopically to ensure that disruption had 
occurred. The homogenate was centrifuged at 2,000 g. The 
supernatant was then dialysed against distilled water for 
24 hours before being freeze dried.
3.1.3. Commercial Antigens
The following commercial antigens were used in this 
study: Bencard numbers 1 and 2 A. fumiga'bus Bencard Ltd. ,
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Brentford, Middlessex; A. fumigatus Indian culture filtrate 
V.P. Chest Institute, University of Delhi.; C. albicans 
somatic Mercia Diagnostics Ltd., Guildford U.K.; C. 
albicans and C. parapsilosis cytoplasmic Mycological 
Reference Laboratory, London.
3. 2. Production of Antisera
3.2.1. Laboratory Raised Antisera
The antisera were raised in Mew Zealand white rabbits 
housed in Forth—Tech rabbit cages 10x18x24 inches. They 
were maintained on a diet of Labsure R14 plus a supply of 
hay and water ad libertum from drop bottles.
A 10 ml test bleed was collected from the marginal ear 
vein of each rabbit to test for fungal antibodies prior to 
the start of immunisation. A. fumigatus and R. oryzae 
freeze dried antigens were reconstituted in phosphate 
buffered saline <P.B.S.) to a concentration of 30 mg/ml.
Phosphate Buffered Saline (PBS) fpr.Reconstitution o£
Antigens
Sodium chloride 8 8
Potassium chloride 0,2 g
Disodium hydrogen phosphate (anhydrous) 1.15 g
Potassium dihydrogen phosphate 0.2 g
Magnesium chloride (hydrated) 0.1 g
Calcium chloride (add last) 0.1 g
Distilled water 1,000 ml
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The reconstituted antigens were mixed with equal 
volumes of Freund's incomplete adjuvant CDifco 
Laboratories) and 0.2 ml was injected subcutaneously into 
New Zealand white rabbits. This was done five times at 
intervals of three weeks over a four month period, freshly 
prepared antigens were used each time.
A 10 ml sample of blood was taken from each rabbit's 
ear to determine if precipitating antibodies were present 
for each antigen. The rabbits were exsanguinated 3 weeks 
after the final injection, provided the serum had a titre 
of at least 1 in 8 by counterimmunoelectrophoresis. The 
blood was allowed to clot and the separated serum was 
stored frozen in 4 ml amounts in bijoux bottles.
In raising antiserum to C. albicans a shorter course of 
injections was used. A 5 mg/ml solution of antigen in 
P.B.S. was emulsified with an equal volume of Freund's 
incomplete adjuvant and 0.5 ml was injected subcutaneously 
into the thigh of New Zealand white rabbits. This was 
performed at four day intervals for 16 days, the rabbits 
were rested for three weeks then a booster dose was 
administered. Blood was taken for precipitin tests after a 
further two weeks and when the sera had a titre of 1 in 8 
the rabbits were exsanguinated.
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3.2.2. Commercial Antisera
Antisera raised in rabbits, against Aspergillus 
species, were purchased from the Institut Pasteur, Paris, 
for use in specificity determinations.
Details of the antisera employed in this study are 
given in Table 3.
Table 3: Origins of antisera indicating the species and 
antigen type to which they were raised.
Source Antiserum Antigen
Rabbit 1 A. fumigatus GAF 5
Rabbit 2 R. oryzae Rh. sp.1
Rabbit 3 C. albi cans MRL
Rabbit 4 C. al bi cans MRL
Rabbit 6 A. fumigatus GAF 5
Past. Inst. A. fumigatus Commercial
Past. Inst. A. flavus Commercial
Past. Inst. A. nidulans Commercial
Past. Inst. A. niger Commercial
Past. Inst. A. terre us Commercial
In the subsequent tables, rabbits 1 — 6 are designated 
as R1 - R6 and the sera from the Institut Pasteur are 
designated as PI.
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3.3. Strength .and Specificity of Antisfira
The strength and specificity of laboratory raised or 
commercial antisera were determined by countei—  
Immunoelectrophoresis, agar gel double diffusion and 
enzyme linked immunosorbent assay.
3.3.1. Counterimmunoe 1 ectrophoresis <CIB> .
Endosmosis in a electrophoretic gel ensures that water 
molecules migrate from anode to cathode, this slows the 
movement of negatively charged particles and may reverse 
the direction of flow of the slower moving ones.
In an agarose gel with a high pH of 7.2 - 9,
immunoglobulins move to the cathode while most soluble 
antigens travel towards the anode. Where they converge a 
precipitin band is formed. This rapid and sensitive method 
was used to determine the titres of the antisera and to 
reveal any cross—reactivity with antigens other than those 
the sera was raised against.
<i> Preparation and Electrophoresis of Gels
Sigma type 111 high electroendosmosis <E.E.O.) agarose 
was prepared as 1% in barbitone/sodium barbitone buffer, 
then measured into 4 ml amounts which were melted when 
required.
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Barbitone/Sodium Barbitone Buffer
Barbitone 3. 55 g
Sodium barbitone 7.55 g
Sodium azide 0.5 g
Distilled water 1000 ml
Adj ust to pH 8. 2
The 1% agarose was poured on to 5 cm square glass 
slides sitting on coins, this helps to avoid spillage and 
facilitates handling the slides when the gels have set. 
Wells were cut in the gels in rows using a 4 mm gel cutter 
<Figure 10>.
Opposing wells were filled with serum and antigen 
solutions and the slides placed in an electrophoresis tank 
containing barbitone/sodium barbitone buffer. The serum 
wells were connected to the anode and the antigen wells to 
the cathode with lint wicks.
A direct current power supply with a constant voltage of 
6 volts per cm width of gel was passed through the gels 
for 90 minutes.
<ii) Washing of Gels
The slides were removed from the tank and washed in 
citrate buffer at 37°C for two days before being dried and 
stained.
o o o o
o o o o
o o o o
o o o o
o o o o
o o o o
Figure 10 Template used for cutting the wells for 
counterimmunoelectrophoresis. Antisera were placed in 
the left hand and antigens in the right hand wells of 
the two columns.
1 2 2
Citrate.-Buffer
Sodium chloride 40 g
Trisodium citrate 100 g
Sodium azide 1 S
Distilled water 2, 000 ml
Dissolve by stirring
<iii> Drying and Staining Gels
The gels were removed from the washing solution 
(citrate buffer), rinsed in tapwater and dried beneath 
filter paper squares using a hair dryer; this binds the 
gels to their slides. The filter paper was moistened 
before it was removed and the gels dried further. The gels 
and slides were stained in Coomassie brilliant blue for 
five minutes before being removed and destained in 
methanolic acetic acid. The destaining time varied, the 
ideal being enough time for the background to clear while 
allowing any weak precipitin lines to show clearly. 
Background stain usually cleared within 30 minutes.
Coomassie Brilliant Blue
B.D.H. Page Blue 83 0.5 g
Methanolic acetic acid 100 ml
1 2 3
Methanolic Acetic Acid
Methylated spirits 5 parts
Glacial acetic acid 1 part
Distilled water 5 parts
The antisera and antigens run in CIE to indicate their 
selectivity and specificity are given in Table 4
Table 4: CIE to demonstrate interactions of different 
Aspergillus, Candida and Rhizopus antigens with homologous 
antisera and to indicate possible cross-reactions with 
heterologous antisera.
Antiserum Antigen Antigen Number
A. fumigatus A. fumigatus Indian
A . fumigatus A. fumigatus GAF 5
A. fumigatus A . fumigatus GAF 70
A . fumigatus A. fumigatus GAF 83
A. fumigatus A. fumigatus GAF 84
A. fumigatus A. fumigatus GAF 85
A. fumigatus A. fumigatus GAF 86
A. fumigatus A. fumigatus GAF 86B
A. fumigatus A. flavus GAF1 2
A. fumigatus A. clavatus GAC 2
A. fumigatus A. nidulans ANi 1
A. fumigatus A. niger ANig 4
A. fumigatus A. terreus ATe 8
A . fumigatus C. albicans Mercia
A. fumigatus C. albicans MRL
A . fumigatus C. parapsilosis MRL
A. fumigatus R. oryzae Rh 1
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Table 4 continued
Antiserum Antigen Antigen Number
C. albi cans C . albicans Mercia
C. al bi cans C, albicans MRL
C. albi cans C. albicans GCA003
C. albicans C. albicans GCA406
C. albicans C. parapsi1osis MRL
C. albi cans A. fumigatus Indian
C. albicans R. oryzae Rh 1
R. oryzae R. oryzae Rh 1
R. oryzae A. fumigatus Indian
R. oryzae C. albicans MRL
A. flavus A. fumigatus Indian
A . flavus A. flavus GAF1 1
A. flavus A. clavatus GAC 2
A . fl a vus A. nidulans GANi 1
A. fl a vus A. niger GANig 4
A. fl a vus A. terreus GATe 8
A . nidulans A. fumigatus Indian
A . nidulans A . fl a vus GAF1 1
4. nidulans A. clavatus GAC 2
A. nidulans A. nidulans GANi 1
A. nidulans A. niger GANig 4
A. nidulans A. terreus GATe 8
A. niger A. fumigatus Indian
A. niger A. flavus GAF1 1
A. niger A. clavatus GAC 2
A. niger A. nidulans GANi 1
A. niger At niger GANig 4
A . niger A. terreus GATe 8
A . terre us A. fumigatus Indian
A . terreus A. flavus GAF 1
A. terreus A. clavatus GAC 2
A. terreus A. nidulans GANi 1
A . terreus A. niger GANig 4
A. terreus A. terreus GATe 8
3.3.2. Agar Gel Double Diffusion
Gels for double diffusion tests were poured as 
described for the CIE method. Wells were cut in the gels 
using cork borers and gel cutters of the appropriate
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sizes. The template used in these tests is illustrated in 
Figure 11. The gels were incubated in humid chambers for 
48 hours to allow diffusion of the antigens and antibodies 
through the agar. The double diffusion gels were washed 
and stained as described previously.
The template was used to find any lines of identity 
common to the antiserum tested against particular antigens 
the details of which are given in Table 5.
= Table 5: Double diffusion experiments to determine cross­
reactions between antisera and their homologous and 
heterologous antigens.
Antiserum Antigen Antigen
A. fumigatus A. fumigatus MRL
C. al bicans A. fumigatus MRL
F. oryzae A. fumigatus MRL
A . fumigatus A. fumigatus GAF 83
C. albicans A. fumigatus GAF 83
F. oryzae A. fumigatus GAF83
A. fumigatus A. fumigatus GAF 84
C. albicans A. fumigatus GAF 84
F. oryzae A. fumigatus GAF 84
A. fumigatus C. albi cans MRL
C. al bicans C. albicans MRL
F. oryzae C. albi cans MRL
A. fumigatus C. albi cans GCA003
C. albi cans C. al bicans GCA003
F . oryzae C. albi cans GCA003
A. fumigatus C. albi cans C406
C. albicans C. al bicans C406
F . oryzae C. albi cans C406
A. fumigatus F. oryzae Rh. 1
C. albicans F. oryzae Rh. 1
F. oryzae F. oryzae Rh. 1
o
o
o
12mm
O
o
Figure 11 Showing the pattern of wells used in 
double diffusion experiments. The test serum was 
placed in the centre well with the antigens in the 
surrounding smaller wells.
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3.3.3. Enzyme— 1 inked Immunosorbent Assay For Antibody 
Detection <ELISA>
In order to detect the presence of antibodies to 
antigens of either the same or a different species as 
those against which the antisera were raised, an ELISA 
technique was employed. This method had the advantage of 
being able to quantify the strength of the reaction of the 
antisera against the antibodies in the assay. A schematic 
representation of the procedure is shown in Figure 12.
<i> Coating of Solid Phase
The antigen solutions were prepared to provide a range 
of antigen concentrations from 1.5 mg/ml to 30 mg/ml in 
sodium carbonate coating buffer, pH 9.6.
Sodium Carbonate Coating Buffer
Sodium carbonate 1.56 g
Sodium hydrogen carbonate 2.93 g
Sodium azide 0.2 g
Make up to 1,000 ml with distilled water and adjust to pH 
9. 6 wi th Na OH .
Volumes of 150 pi of antigen solutions were dispensed 
into wells of 96 well polyvinyl micro titre plates 
<Sterlin Ltd., Middlesex, England). These were then 
incubated at 37°C in a shaking incubator cabinet for 1
Substrate
Enzyme Labelled Conjugate
Antibody
Antigen
Solid Phase
Figure 12 Diagramatic representation of the ELISA 
technique used to detect antibodies in serum.
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hour. This enhances antigen binding to the plastic 
surface.
<ii) Washing Technique
The contents of the wells were discarded and the plates 
were washed with phosphate buffered saline Tween 20 
<F.B.S.T20) three times for three minutes. This ensures 
that no unbound antigen remains in the wells.
B .-S, Tween 20
Sodium chloride 8 g
Potassium dihydrogen phosphate 0.34 g
Dipotassium hydrogen phosphate 1.21 g
Tween 20 0.5 ml
Make up to 1,000 ml with distilled water.
IT. B. It is advantageous to heat a little of the water to 
rinse out the pipette after measuring the Tween 20 as it 
adheres to the pipette and is difficult to remove 
completely.
<iii> Addition of Primary Antibody
Dilution series were made of the antisera to be tested 
and 150 pi of each concentration were dispensed into the 
wells. The plates were then incubated at 37°C for one 
hour.
The plates were washed as described previously.
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<iv> Application of Conjugate
150 pi of anti-rabbit heavy and light chain IgG- 
alkallne phosphatase conjugate,(Miles Laboratories, Stoke 
Pages Slough), diluted 1:2000 in P.B.S.T20, were pipetted 
into each well and the plates were incubated for a further 
hour at 37°C.
After incubation the wells were again washed with 
P. B. S. T20.
= <v> Addition of Substrate and Reading of Plates
A substrate solution was prepared using one 5 mg. 
tablet of p-nitrophenyl phosphate (Sigma 104) dissolved in 
5 ml substrate buffer and agitated until it dissolved and 
150 pi of this solution was dispensed into the wells. The 
plates were incubated at 37°C with constant agitation and 
were checked after 10 minutes, after which time if the 
positive control had turned visibly yellow the plates were 
read at a wavelength of 405 nm on a Dynatech MR 950 
microBLISA plate reader (Dynatech Laboratories, 
Billingshurst, U.K.). The plates were incubated and the 
absorbance read after a further 20 minutes.
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Substrate Buffer
Sodium azide 0.1 g
Diethanol amine* 48.5 ml
Distilled water 400 ml
Add 1M hydrochloric acid to adjust pH to 9.8 
Make up to 500 ml. with distilled water.
Store in a dark bottle as it is light sensitive.
* Store at 37°C as it freezes at 26°C.
The antigens and antibodies which were tested against 
each other using this method are listed in Table 6. C. 
parapsi 1 osls has been abreviated to C. parap.
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Table 6: Details of reagents assayed by ELISA to detect 
reactions of various antigens at different concentrations 
with, homologous and heterologous antisera from laboratory 
and commercial sources.
Antigen Antigen Number Antiserum Source
C. al bi cans KRL 3153 <5 mg/ml> C. albicans R3
C. al bi cans KRL 3153 <5 mg/ml) C. albicans R4
C. al bi cans KRL 3153 <5 mg/ml) A. fumigatus R1
C. al bicans KRL 3153 <5 mg/ml) A. flavus IP
C. al bicans KRL 3153 <5 mg/ml) A. nidulans IP
C. albi cans KRL 3153 <5 mg/ml) A. nlger IP
C. al bicans KRL 3153 <5 mg/ml) A. terre us IP
C. al bicans KRL 3153 <5 mg/ml> R. oryzae R2
C. al bicans KRL 3153 <30 mg/ml) C. albicans R3
C. albicans KRL 3153 <30 mg/ml> C. albicans R4
C. albicans KRL 3153 <30 mg/ml) A. fumigatus R1
C. al bicans KRL 3153 <30 mg/ml) A. flavus IP
C. albicans KRL 3153 <30 mg/ml) A. nidulans IP
C. al bicans KRL 3153 <30 mg/ml) A. niger IP
C. albi cans KRL 3153 <30 mg/ml) A. terreus IP
C. alblcans KRL 3152 <30 mg/ml) R. oryzae R2
C. al bicans mannan <30 mg/ml) C. albicans R3
C. al bicans mannan <30 mg/ml) C. al bicans R4
C. al bicans mannan <30 mg/ml) A. fumigatus R1
C. al bicans mannan <30 mg/ml) A. fumigatus R6
C. al bicans mannan <30 mg/ml) A. flavus IP
C. al bicans mannan <30 mg/ml) A. nidulans IP
C. alblcans mannan <30 mg/ml) A. niger IP
C. albicans mannan <30 mg/ml) A. terreus IP
C. al bicans mannan <30 mg/ml) R. oryzae R2
C. parap. KRL <5 mg/ml) C. albicans R3
C. parap. KRL <5 mg/ml) C. albicans R4
c. parap. KRL <5 mg/ml) A. fumigatus R1
c. parap. KRL <5 mg/ml) R. oryzae R2
A. fumigatus Indian C. al bicans R3
A. fumigatus Indian C. albi cans R4
A. fumigatus Indian A. fumigatus R1
A. fumigatus Indian R. oryzae R2
A. fumigatus AF 5 <5 mg/ml) C. albi cans R3
A. fumigatus AF 5 <5 mg/ml) C. al bicans R4
A. fumigatus AF 5 <5 mg/ml) A. fumigatus R1
A. fumigatus AF 5 <5 mg/ml) A. fumigatus R6
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Table 6 continued
Antigen Antigen Number Antieerum Source
A. fumigatus AF 5 <5 mg/ml) A. flavus PI
A, fumigatus AF 5 <5 mg/ml) A. nidulans PI
A. fumigatus AF 5 <5 mg/ml > A. niger PI
A. fumigatus AF 5 <5 mg/ml) A. niger PI
A. fumigatus AF 5 <5 mg/ml > A. terreus PI
A. fumigatus AF 5 <5 mg/ml > R. oryzae R2
A. fumigatus AF 5 <30 mg/ml) C. albi cans R3
A. fumigatus AF 5 <30 mg/ml) C. al bicans R4
A. fumigatus AF 5 <30 mg/ml > A. fumigatus R1
A. fumigatus AF 5 <30 mg/ml) A. flavus PI
A. fumigatus AF 5 <30 mg/ml) A. nidulans PI
A. fumigatus AF 5 <30 mg/ml) A. niger PI
A. fumigatus AF 5 <30 mg/ml > A. terreus PI
A. fumigatus AF 5 <30 mg/ml > R. oryzae R2
A. fumigatus KRL <1.5 mg/ml > C. al bicans R3
A. fumigatus KRL <1.5 mg/ml > C. albi cans R4
A. fumigatus KRL <1.5 mg/ml > A. fumigatus R1
A . fumigatus KRL <1.5 mg/ml > A. flavus PI
A. fumigatus KRL <1.5 mg/ml > A. nidulans PI
A. fumigatus KRL <1.5 mg/ml > A. niger PI
A. fumigatus KRL <1.5 mg/ml > A. terreus PI
A. fumigatus KRL <1.5 mg/ml) R. oryzae R2
A . fumigatus KRL <30 mg/ml) A. fumigatus R1
A. fumigatus KRL <30 mg/ml > A. fumigatus R6
A. fumigatus KRL <30 mg/ml) A. flavus PI
A. fumigatus KRL <30 mg/ml) A. nidulans PI
A. fumigatus KRL <30 mg/ml) A. niger PI
A. fumigatus KRL <30 mg/ml > A. terreus PI
A. flavus GA FL 1 <3 mg/ml) C. al bicans R3
A. flavus GA FL 1 <3 mg/ml) C. albi cans R4
A. fl a vus GA FL 1 <3 mg/ml> A. fumigatus R1
A. flavus GA FL 1 <3 mg/ml) A. fumigatus R6
A. fl a vus GA FL 1 <3 mg/ml) A. flavus PI
A. flavus GA FL 1 <3 mg/ml) A. nidulans PI
A. flavus GA FL 1 <3 mg/ml) A. niger PI
A. fl a vus GA FL 1 <3 mg/ml) R. oryzae R2
A. fl a vus GA FL 1 <30 mg/ml) C. albicans R3
A . flavus GA FL 1 <30 mg/ml) C. albi cans R4
A. flavus GA FL 1 <30 mg/ml > A. fumigatus R1
A. flavus GA FL 1 <30 mg/ml> A. fumigatus R6
A. flavus GA FL 1 <30 mg/ml> A. flavus PI
A. flavus GA FL 1 <30 mg/ml) A. nidulans PI
4. flavus GA FL 1 <30 mg/ml) A. niger PI
i4. flavus GA FL 1 <30 mg/ml) R. oryzae R2
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Table 6 continued
Antigen Antigen Number Antieerum Source
A. nidulans GA Nid 1 <30 mg/ml) C. albi cans R3
A. nidulans GA Nid 1 <30 mg/ml) C. albicans R4
A. nidulans GA Nid 1 <30 mg/ml) A. fumigatus R1
A. nidulans GA Nid 1 <30 mg/ml> A. flavus PI
A. nidulans GA Nid 1 <30 mg/ml) A. nidulans PI
A. nidulans GA Nid 1 <30 mg/ml) A. niger PI
A. nidulans GA Nid 1 <30 mg/ml) A. terreus PI
A. nidulans GA Nid 1 <30 mg/ml> R. oryzae R2
A. niger GA N 2 <3 mg/ml) C. albi cans R3
A. niger GA N 2 <3 mg/ml) C. al bicans R4
A. niger GA N 2 <3 mg/ml) A. fumigatus R1
A. niger GA N 2 <3 mg/ml) A. flavus PI
A . niger GA N 2 <3 mg/ml) A. nidulans PI
niger GA N 2 <3 mg/ml) A. niger PI
A. niger GA N 2 <3 mg/ml) A. terreus PI
A. niger GA N 2 <3 mg/ml) R. oryzae R2
A. niger GA N 2 <30 mg/ml > C. albicans R3
A. niger GA N 2 <30 mg/ml) C. albicans R4
A. niger GA N 2 <30 mg/ml) A. fumigatus R1
A. niger GA N 2 <30 mg/ml) A. flavus PI
A. niger GA N 2 <30 mg/ml) A. nidulans PI
A. niger GA N 2 <30 mg/ml) A. niger PI
A. niger GA N 2 <30 mg/ml) A. terreus PI
A. niger GA N 2 <30 mg/ml) R. oryzae R2
A. terreus GA T 2 <30 mg/ml) C. al bicans R3
A. terreus GA T 2 <30 mg/ml) C. albicans R4
A. terreus GA T 2 <30 mg/ml) A. fumigatus R1
A. terreus GA T 2 <30 mg/ml) A. fumigatus R6
A. terreus GA T 2 <30 mg/ml) A. flavus PI
A. terreus GA T 2 <30 mg/ml) A. nidulans PI
A. terreus GA T 2 <30 mg/ml) A. niger PI
A. terreus GA T 2 <30 mg/ml) A. terreus PI
A. terreus GA T 2 <30 mg/ml) R. oryzae R2
2?. oryzae G Rhl <30 mg/ml) C. albicans R3
2?. oryzae G Rhl <30 mg/ml) C. al bicans R4
2?. oryzae G Rhl <30 mg/ml) A. fumigatus R1
2?. oryzae G Rhl <30 mg/ml) A. flavus PI
R. oryzae G Rhl <30 mg/ml) A. nidulans PI
R. oryzae G Rhl <30 mg/ml) A. niger PI
2?. oryzae G Rhl <30 mg/ml) A. terreus PI
2?. oryzae G Rhl <30 mg/ml) R. oryzae R2
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3.3.4. Streptavidln—Blot In Enzyme Linked Immunosorbent 
Antigen Assay for the Testing of Antiserum Specificity
<i> Principal of Assay
A new generation of immunoassays with high sensitivity 
has evolved from the attraction between proteins and water 
soluble proteins. Streptavidin from Streptomyces avidinil 
is a tetrameric protein with four affinity binding sites 
for biotin. Exploitation of this high affinity results in 
the sensitivity of immunoassays being enhanced.
<ii) Assay Method
To test for cross-reactions among the Aspergillus 
antigens a streptavidin-biotin capture antibody system was 
used. Aspergillus antigens from A. fumigatus, A. clavatus, 
A. flavus, A. niger, A. nidulans and A . terreus were 
diluted in normal human serum at levels of 100 pg to 100 
ng/ml before being tested in the system.
The capture antibody was human anti-A. fumigatus from 
an aspergilloma patient (indirect ELISA titre 1:10,000) 
used at 1/500 dilution in sodium carbonate coating buffer. 
The detection antiserum was a rabbit anti-A. fumigatus 
antisera (Institut Pasteur) diluted to 1/500 in P.B.S. 
incorporating bovine serum albumen (B.S.A.)
Other reagents were biotinylated donkey anti-rabbit Ig 
G <R.P.N. 1004; Lot 19; Amersham Int. p.I.e.; Amersham)
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used at 1/1000 dilution in P.B.S.—B.S.A. and streptavidin— 
biotin-horseradish peroxidase <S-B-HPR0) <1/1000 dilution: 
R.P.N. 1051, Lot 23: Amersham Int.p.I.e.; Amersham). The 
reaction was made visible by the addition of 1,2— 
phenylene-diamine dihydrochloride <Dakopatts; Dako Ltd., 
High Wycombe)
Assay Schedule
1. Solid phase coated with 200 pi human anti-A. fumigatus 
capture antibody for 1 hour
Wash, the same technique was used as described 
previously.
2. Antigen dilutions added 200 pi for 1 hour.
Wash
3. Detection antibody, rabbit anti-A. fumigatus 200 pi for 
1 hour
Wash
4. Biotinylated donkey anti-rabbit Ig G 200 pi added for 1 
hour
Wash
5. Biotin-streptavidin horseradish peroxidase preformed 
complex 200 pi for 1 hour
Wash
6. Substrate <1,2 phenylene-diamine dihydrochloride) added 
for 30 minutes.
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The intensity of the reactions was measured on a 
Dynatech MR950 microELISA mini reader at light wavelength 
490 nm.
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3.4. Preparation of Material for Histopathalogy
3.4.1. Tissue Fixation
Unfixed material from biopsy, post mortem or animal 
sources was immersed in neutral buffered formalin until 
adequately fixed <at least 24 hours) before being 
processed.
Fixative
Formaldehyde<40%> 10 ml
Calcium chloride 1 g
Water 90 ml
3.4.2. Tissue Processing and Paraffin Embedding
The fixed tissue was impregnated in paraffin wax using 
an automatic tissue processor.
Paraffin Processing Schedule
Tissues were processed with an automatic tissue
processor (Histokinette) using the foilowing schedu1e :-
1. 50% methylated spirit 1 hour
2. 80% methylated spirit 1 hour
3. 8% phenol in methylated spirit 2 hours
4. 8% phenol in methylated spirit 2 hours
5. 8% phenol in methylated spirit 3 hours
6. Absolute alcohol 2 hours
7. Absolute alcohol 2 hours
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8. Absolute alcohol:xylene <50:50) 1 hour
9. Xylene 1 hour
10. Xylene 1 hour
11. Paraffin wax Difco polywax M. P.,57°C 3 hours
12. Paraffin wax Difco polywax M. P.,57°C 3 hours
The tissues were aligned and embedded in fresh paraffin 
wax in embedding pans. These blocks were trimmed and 
mounted on wooden chucks using melted wax as an adhesive.
=" Mol if ex" was used to soften the tissue face before 
cutting. Serial 5p sections of the embedded organs were 
sliced using a flat cutting Leitz rotary microtome. The 
wax of the block face was cooled with ice between ribbons, 
this facilitated cutting.
3.4.3 Special Processing For Mouse Eyes
When mouse eyes were processed the same schedule as 
above was followed but the xylene in steps 8,9 and 10 was 
substituted by chloroform as this is a softer reagent and 
prevents hardening of the sclera which, if friable, makes 
the eye difficult to section.
3.4.4. Techniques for Preparing Mounted Tissue Sections 
<i) Mounting Tissue Sections
Ribbons of sections were floated on warm water in a 
thermostatically controlled mounting bowl set at 56°C and 
the individual sections were picked-up upon cleaned,
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grease-free glass slides that had been coated with gelatin 
or in the case of the eye sections coated with poly-L- 
lysine. To encourage the sections to adhere to the slides 
they were baked in a 60°C oven for 30 minutes.
Cleaning Solution for Glass Slides 
Potassium dichromate 
Water
Nitric acid
<ii> Gelatinised Slides
Sheet gelatine <5 g) was dissolved in 1 litre warmed 
distilled water then 0.5 g Chromate potassium sulphate was 
added. Cleaned slides were immersed in the solution for 
one minute before being dried in racks in a 37°C 
incubator.
<iii> Poly-L-lysine Slides
A 1 mg/ml solution of poly-L-lysine <MW>15,0000;Sigma) 
was prepared and vials stored frozen until required. A 10 
pi drop of the solution was placed on the cleaned slides 
and spread over them with the end of another slide. The 
solution dried almost at once.
120 g
200 ml 
120 ml
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3.4.5. ExamLnatian of Tissues for Fungi by the Peroxidase 
Anti—Peroxidase IxnmunohistochemLcal Staining Method
The peroxidase anti-peroxidase <PAP> method of staining 
is an immunohistochemical technique used to locate and 
identify fungi present in tissues. Many tissue types were 
examined for the presence of fungi using the PAP staining 
method. Several fungal diseases were represented in the 
tissues examined and these were stained with homologous 
and heterologous antisera. Table 7 details the types of 
tissue examined, the diagnosis of the infection and the 
basis for that diagnosis. Table 8 lists the sections and 
the antisera used.
In the following tables abbreviations have been used :— 
A/loma denotes aspergilloma, P/nasal denotes paranasal and 
L/geal denotes laryngeal.
** and *■** in Table 7 are patients whose identities are 
not known.
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Table 7: Details of tissues examined by PAP 
immunoperoxidase staining, the disease suspected, which 
fungus, if any, was isolated, the tissue involved and 
basis on which the diagnosis was made.
Patient Fungus Basis for Diagnosis Tissue
Mucormycosis
M F Tissue morphology Kidney
M F Tissue morphology Spleen
M S R. oryzae Culture and morphology Soft
palate
A G Tissue morphology Brain
A G Tissue morphology Palate
A H Tissue morphology Brain
A H Tissue morphology Kidney
Candidosis
I C C. parap. Culture and morphology Lung
I C C. parap. Culture and morphology Adrenal
I C C. parap. Culture and morphology Kidney
** Tissue morphology Larynx
*** Tissue morphology Liver
I McK Tissue morphology Brain
J H C. albicans Culture and morphology Liver
Aspergillosis
V C Tissue morphology Brain
H F Tissue morphology Brain
A P A. fumigatus Culture and morphology Brain
A P A. fumigatus Culture and morphology Lung
J D A . fumigatus Culture and morphology Lung
V B A. fumigatus Culture and morphology A/loma
F DeS A. fumigatus Culture and morphology A/loma
B L Tissue morphology Lung
Brum Tissue morphology Lung
A Hed Tissue morphology P/nasal
sinuses
A Hug Tissue morphology Kidney
A Hug Tissue morphology Heart
A Hug Tissue morphology Lung
A S A. flavus Culture and morphology Lung
V P Tissue morphology Lung
J k A. fumigatus Culture and morphology Trachia
W R Tissue morphology Lung
P B A. fumigatus Culture and morphology Lung
141
Table 8: Histology sections for the validation of the PAP
staining method. Details of disease and tissue type and 
the antiserum employed are listed.
Antiserum Disease Organ
A. fumigatus Aspergillosis (.A. fumigatus) Lung
A. fumigatus Aspergillosis <A. fumigatus) A/loma
A. fumigatus Aspergillosis (A. fumigatus) Brain
A. fumigatus Aspergillosis (A . fumigatus) Trachia
A. fumigatus Aspergi11osi s P/nasal 
sinuses
A. fumigatus Aspergillosis Kidney
A. fumigatus Aspergi11osis Heart
A. fumigatus Aspergillosis <A. flavus) Lung
A . fumigatus Candidosis (C. al bl cans) Liver
A. fumigatus Candidosis (C. al bicans) Kidney
(mouse)
A. fumigatus Candidosis Liver
A. fumigatus Candidosis Brain
A. fumigatus Candidosis L/geal
biopsy
A. fumigatus Candidosis (C. parap. ) Lung
A. fumigatus Candidosis <C. parap. ) Kidney
A. fumigatus Candidosis <C. parap. ) Adrenal
A. fumigatus Mucormycosis (R . oryzae') Soft
palate
A. fumigatus Mucormycosis Brain
A. fumigatus Mucormycosis Kidney
A . fumigatus Mucormycosis Spleen
A. flavus Aspergillosis (A. fumigatus) Lung
A. flavus Aspergillosis <A. flavus) Lung
C. albicans Candidosis <C. albi cans) Liver
C. albicans Candidosis (C. al bicans) Kidney
(mouse)
C. albicans Candidosis Liver
C. albicans Candidosis Brain
C. al bicans Candidosis L/geal
biopsy
C. al bicans Candidosis (C. parap. ) Lung
C. al bicans Candidosis <C. parap. ) Kidney
C. al bicans Candidosis (C. parap. ) Adrenal
C. albicans Aspergillosis (.A. fumigatus) Lung
C. al bicans Aspergillosis <A. fumigatus) A/loma
C. al bicans Aspergillosis Lung
C. albicans Aspergillosis Trachia
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Table 8 continued
Antiserum Disease Organ
C. alblcans Aspergillosis P/nasal 
sinuses
C. al bicans Aspergillosis Kidney
C. alblcans Aspergillosis Heart
C. al bicans Aspergi11osi s <A. flavus') Lung
C. al bicans Mucormycosis (R. oryzae> Soft
palate
C. al bicans Mucormycosis Brain
C. al bicans Mucormycosis Kidney
C. al bicans Mucormycosis Spleen
R. oryzae Mucormycosis <J?. oryzae> Soft
palate
S. oryzae Mucormycosis Brain
R. oryzae Mucormycosis Kidney
R. oryzae Mucormycosis Spleen
R. oryzae Aspergillosis <A. fumigatus) Lung
R. oryzae Aspe rgi11osi s <A. fumigatus) A/loma
R. oryzae Aspergillosis Lung
R. oryzae Aspergillosis Trachia
J?. oryzae Aspergillosis P/nasal 
sinuses
R. oryzae Aspergillosis Kidney
R . oryzae Aspergillosis Heart
R. oryzae Aspergillosis < A . fla vus) Lung
R. oryzae Candidosis <C. al bicans) Liver
R. oryzae Candidosis <C. al bicans> Kidney
<mouse)r
R . oryzae Candidosis Liver
R. oryzae Candidosis Brain
R. oryzae Candidosis L/geal 
bi opsy
R. oryzae Candidosis <C. parap. ) Lung
R. oryzae Candidosis <C. parap. ) Kidney
R. oryzae Candidosis <C. parap. ) Adrenal
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3.4.6. Development of Agar Block Technique for 
Histopathological Staining and Evaluation of PAP 
Immunoperoxidase Method.
<i> Inoculation of the Agar
As control sections of fungal infections were not 
always available and to demonstrate any possible cross­
reactivity amongst the antisera used for staining, an agar 
block technique was developed. This method simulates three 
dimensional fungal hyphae growth through tissue. The 
technique is easy to perform and unlike animal models the 
amount of fungus present in the blacks could be 
controlled.
Suspensions of filamentous fungi comprising of spores 
and hyphal fragments were prepared from freshly grown 
cultures of the organisms in sterile distilled water with 
1% Tween 80. The yeast suspensions were prepared in 
sterile distilled water from overnight cultures.
Molten glucose peptone agar or Czapek Dox Tween 80 agar 
in 30 ml amounts were inoculated with 3 X 107” suspensions 
of the fungi and poured into 9 cm diameter petri dishes.
At least a 30 ml volume of agar was required, as the depth 
of agar constituted the depth of the block to be cut and 
thin blocks are more difficult to handle. The plates were 
allowed to set and were incubated for 24 hours at 28°C. 
Czapek Dox agar was chosen for the yeasts to encourage the 
formation of mycelium and pseudomycelium.
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Glucose Peptone Agar
D-glucose 20 g
Bacteriological peptone 5 g
Agar 10 g
Sterilise by autoclaving at 15 p.s.i. for 20 minutes.
Czapek Dox Agar
Dissolve by boiling add 5 ml Tween 80. Sterilise for 20 
minutes at 15 p.s.i.
<ii> Preparation and Sectioning of the Blocks
Squares of one cm dimensions were cut from the agar 
plates and attached to metal cryostat chucks by freezing. 
The chucks were put in a container with acetone and dry 
ice, a drop of water was spotted onto the cold chuck and a 
square of the agar culture was placed on top. A few more 
drops of water around the agar block ensured it remained 
frozen in position. The chucks and attached blocks were 
stored at -20°C until they were cut.
The blocks were sectioned on a cryostat and the blanks 
were picked-up on gelatinised slides This prevented the 
sections floating away during the long washing stages of 
the immunoperoxidase staining procedure. The slides with 
the agar sections were stored in sealed Coplin jars at
Czapek Dox agar <Oxoid) 22.7 g
Distilled water 500 ml
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-20°C until they were stained. The staining methods 
employed for the sections were identical to those for the 
paraffin sections but the agar sections did not require to 
be hydrated prior to staining.
Table 9: Details of sections from inoculated agar blocks 
st-ained by PAP immu noperoxidase method with information on 
the source of the primary antibody.
Agar Block Primary Antibody Source
Inoculated With
C. albicans C, al bicans R3 & R4
C. albicans A. fumigatus R1
C. al bicans A. flavus P I
C. albicans A. nidulans P I
C. albicans A. niger P I
C. al bi cans A. terreus P I
C. albicans J?. oryzae R2
C. al bicans Negative Serum Rabbit
C. parap. C, alblcans R3 & R4
A. fumigatus C. al bicans R3 & R4
A, fumigatus A. fumigatus R1
A. fumigatus A. flavus P I
A. fumigatus A, nidulans P I
A. fumigatus A. niger P I
A. fumigatus A. terreus P I
A. fumigatus F. oryzae R2
A , fumigatus Negative Serum Rabbit
A. flavus C, al bicans R3 & R4
A, flavus A. fumigatus R 1
A, flavus A, flavus P I
A. flavus A. nidulans P I
A. flavus A, niger P I
A, flavus A. terreus P I
A, flavus F. oryzae R2
A, flavus Negative Serum Rabbit
A. nidulans C, al bicans R3 & R4
A, nidulans A. fumigatus R1
A, nidulans A. flavus P I
A, nidulans A. nidulans P I
A. nidulans A. niger P I
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Table 9 continued
Agar Block 
Inoculated With
Primary Antibody Source
A. nidulans A . terreus P I
A. nidulans R. oryzae R2
A. nidulans Negative Serum Rabbit
A . niger C. albicans R3 & R4
A. niger A. fumigatus Ri
A. niger A . flavus P I
A', niger A. nidulans P I
A . niger A . niger P I
A. niger A. terreus P I
A. niger R. oryzae R2
A. niger Negative Serum Rabbit
A . terreus C. albicans R3 & R4
A. terreus A. fumigatus Rl
A. terreus A. flavus P I
A. terreus A. nidulans P I
A. terreus A. niger P I
A. terreus A. terreus P I
A. terreus R. oryzae R2
A . terreus Negative Serum Rabbit
R. oryzae C. albicans R3 & R4
R. oryzae A. fumigatus Rl
R. oryzae A. flavus P I
R. oryzae A. nidulans P I
R. oryzae A. niger P I
R. oryzae A . terreus P I
R. oryzae R. oryzae R2
R. oryzae Negative Serum Rabbit
Mucor hi emails C. albicans R3 & R4
Mucor hi emails A. fumigatus Rl
Mucor hiemalls A. flavus P I
Mucor hiemalis A. nidulans P I
Mucor hiemalis A. niger P I
Mucor hiemalis A. terreus P I
Mucor hiemalis R. oryzae R2
Mucor hiemalis Negative Serum Rabbit
A. glauca C. albicans R3 & R4
A. glauca A. fumigatus Rl
A. glauca A . flavus P I
A. glauca A. nidulans P I
A. glauca A. niger P I
A. glauca A . terreus P I
A. glauca R. oryzae R2
A, glauca Negative Serum Rabbit
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3.5. fitalTilTig 1fetTir»ri« fnr the HiairiTifltjnn n:f SftcrM nnfi frnm 
Tissues and. Agar Blnclre
3.5.1. Periodic Acid—Schiffs
1. Paraffin sections to water 5 minutes
2r 70% Methylated spirits 10 minutes
3. Alcoholic periodic acid 5 minutes
4. 70% Methylated spirits 5 minutes
5. Acid reducing rinse 5 minutes
6. 70% Methylated spirits 5 minutes
7. Rinse briefly in tap water
8. Schiff's reagent (in dark staining jar) 25 minutes
9. Rinse in tap water
10. Haematoxylin (Mayers) 1 minute
11. Rinse in water
12. Blue quickly in Scott's tapwater substitute
13. Rinse in tap water
14. Dehydrate, clear and mount
Using this method fungi stain red/purple.
3.5.2. Gomori* s JCethenandLne Silver Nitrate (Armed Forces 
Institute of Pathology U.S.A.)
1. Paraffin sections to water
2. 5% chromic acid 1 hour
3. Vash for a few seconds
1 4 8
4. Rinse in 1% sodium bisulphate 1 minute
5. Wash 5 minutes
6. Wash with 4 changes of distilled water
7. Methenamine silver nitrate in oven at 58°C for 30
minutes until section turns yellowish brown. Use 
paraffin coated forceps to remove slide from this 
solution. Dip slide in distilled water and check for 
adequate silver impregnation with microscope.
Fungi should be dark brown at this stage.
£. Rinse in 6 changes of distilled water
9. Tone in 1% gold chloride solution for 2-5 minutes
10. Rinse in distilled water
11. Remove unreduced silver with 2% sodium thiosulphate 
<hypo> solution for 2-5 minutes.
12. Wash thoroughly
13. Counterstain with working light green 30-45 seconds.
14. Dehydrate, clear and mount.
This technique sharply delineates fungi in black.
Solutions
5% Chromic Acid
Chromic acid 5 g
Distilled water 100 ml
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3% Methenamine
Hexamethylenetetramine 3 g
Distilled water 100 ml
Stock Methenamine—Silver Nitrate
Silver Nitrate 5% solution 5 ml
Methenamine 3% solution 100 ml
A white precipitate forms but disperses immediately on 
shaking. Clear solutions remain usable for months if kept 
in a refrigerator.
1% Sodium Bisulphate
Sodium bisulphate 1 g
Distilled water 100 ml
2% Sodium Thiosulphate CHypo)
Sodium Thiosulphate 2 g
Distilled Water 100 ml
Working Light Green
Light green stock solution 5 g
Distilled water 100 ml
5% Silver Nitrate
Silver Nitrate 5 g
Distilled water 100 ml
5% Borax
Borax (photographic or USP) 
Distilled water
5 g 
100 ml
Working Methenamine - Silver Nitrate
Borax 5% solution 2 ml
Distilled water 25 ml
Mix and add:
Methenamine-Silver Nitrate stock solution 25 ml
0. 1% Gold Chloride
Gold chloride, 1% solution 10 ml
Distilled Water 90 ml
(May be used repeatedly)
Stock Light Green
Light Green S.F.(Yellow) 0.2 g
Distilled water 100 ml
Glacial Acetic Acid 0.2 ml
The stained sections were mounted in harleco synthetic 
resin (H.S.R.) and covered with coverslips of the 
appropriate size.
The remaining unstained sections were stored as blanks 
until they were stained using the PAP immunocytochemical 
staining method.
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3.5.3. Peroxidase Anti—Peroxidase Staining Technique for 
the Examination of Tissue and Agar Bloch Sections.
<i> Principal of the Method
Although the PAP method is more complex and time 
consuming than the direct or indirect methods of 
immunoperoxidase staining it is far more sensitive.
The primary antibody is followed by a second layer of 
serum raised in another animal species. The third and 
final antiserum comprises of IgG from the same species as 
the first layer but which has been raised against and 
conjugated to, horseradish peroxidase. Peroxidase is 
therefore bound to the Fab portion of the IgG and the Fc 
portion should bind with the Fab sites on the second 
layer. The reaction is made visible by the substrate 
diaminobenzidine (D.A.B.). (Figure 13>
<ii> Titration of Antisera
The dilution of each antiserum which gave optimal 
staining was used. This was determined by checkerboard 
titrations and was different for each antibody.
<iii> Peroxidase Anti-Peroxidase Staining Procedure
AS DAB staining was conducted in the aqueous phase the 
sections were first brought to water. The labelled slides 
were dewaxed in xylol then alcohols. The endogenous
AA
PAP M ethod .
AA Tissue A ntigen
A
 P r im ary  A ntibody  
3 S e c o n d a ry  An tibody
P e ro x id a s e  E n z y m e
PA P C o m p lex
Figure 13 Diagramatic representation of the peroxidase 
anti-peroxidase staining method.
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peroxidase activity was inhibited to prevent background 
staining by D.A.B. .
As the primary antisera used in this study were 
polyclonal they might have exhibited binding to unrelated 
antigens, collagen and connective tissue. To prevent this 
phenomenon, sections were incubated with normal swine 
serum <N.S.S.>, which was the same animal species as that 
which provided the antiserum for the second layer 
antibody.
To carry out the primary and subsequent incubations 
with antisera the slides were placed horizontally with 
sections uppermost upon a rack within a humid container. 
The appropriate serum or antiserum dilutions was then 
dispensed onto the tissue sections <approx 50 pl/slide). 
Surface tension retains the liquid on the slide. The 
sections were incubated at room temperature. The 
containers were either petri dishes or custom made shallow 
perspex boxes with glass rod racks.
Vhen the sections were washed in Tris Buffered Saline 
<T.B.S.) they were placed in a slide rack in a needle box 
containing TBS, a magnetic stirrer ensured that excess 
antibody was removed during each wash. A Coplin staining 
jar housed the slides when the endogenous peroxidase was 
inhibited and also while they were submerged in the D. A.B. 
solution.
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After a brownish colour had developed in the control
tissue, the sections were rinsed in tap water, dehydrated,
cleared and mounted in a synthetic resin H.S,R.
<iv) Peroxidase Anti-Peroxidase <P.A.P.) Schedule
1. Dewax slides in xylol, alcohol, methylated spirits and 
running tap water.
2. Remove endogenous peroxidase.
Slides were immersed in 100 ml methanol containing 0.2 
ml HC1 and 0.5 ml H2 O2  for 20 minutes.
3. Wash in tris buffered saline <TBS>
4. Lay slides out in a humid chamber and incubate with 
normal swine serum <NSS> diluted 1/20 with Tris 
buffer.
5. Tilt slides to remove NSS then cover with diluted 
primary antiserum and incubate for 30 minutes.
6. Wash in TBS for 15 minutes.
7. Coat slides in 25 pg/ml swine anti rabbit <S.A. R. > in
T.B.S. and leave for 20-30 minutes.
8. Wash slides in T.B.S. for 15 minutes.
9. Incubate slides with rabbit peroxidase anti-peroxidase 
<P.A.P.) diluted to 1/100 with T.B.S. leave for 20 
minutes
10. Wash for 15 minutes in T.B.S.
11. Slides are stained with 30 mg D.A.B in 100 ml of Tris
buffer with one drop of H2 O2 . The positive control
slide was used to assess the degree of staining. It
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should develop a brown colour in approximately 10 
minutes.
D.A.B. should be handled with gloved hands in a fume 
cupboard. Such care must be excercised as D.A.B. is a 
suspected carcinogen.
12. Wash slides in running tap water.
13. Dehydrate and clear sections: -
Methylated spirits 1 minute
Absolute alcohol 3 minutes
Xylol 5 minutes
14. Mount in H.S.R. and use coverslip of appropriate size,
Buffers
Tris Saline
Saline 450 ml
Tris buffer 50 ml
Tris Buffer
Trizma 12.12 g
Trizma base 2.78 g
Distilled water 2,000 ml
Saline
Sodium chloride 
Distilled water
17 g 
2, 000 ml
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<v> Controls for Specificity of Immunoperoxidase Staining 
Controls are required to verify the specificity of the 
immunohistochemical staining procedures as it must be 
ascertained that the antibody is specific for the antigen 
being investigated. The following control sections were 
examined.
lr Non-immune serum as primary antiserum — No staining.
2. Unrelated antiserum as primary antiserum - No staining.
3. Omission of primary antiserum - No staining.
4. Omission of secondary antibody - No staining.
5. Incubation with D.A.B. only - No staining.
6. Incubation of unrelated/uninfected tissue from same 
species, with primary antiserum - No staining.
7. Incubation of specific antigen with specific antiserum
- Staining of specific antigen.
8. Pre—absorption of specific antiserum with specific 
antigen prior to incubation with known positive tissue
- Diminished or no staining of specific antigen,
9. Pre-absorption of specific antiserum with unrelated 
antigen before incubation with positive control - 
Staining of specific antigen.
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3.6. A Mouse Model n-f Tiring__Candida
Bndophthnl mi t1 f>
The possibility of establishing an animal model for 
haematogenous Candida endophthalmitis analogous to man was 
examined. Such a model would allow investigation of the 
pathological changes and pathogenesis associated with the 
infection.
3.6. 1. Fungus
C. albicans Glasgow heroin strain 11 <patient 22, 
vitrectomy isolate) which had been stored in silica gel 
was used. When fresh cultures were required, they were 
grown on glucose peptone agar for 24 hours at 37°C.
Inocula for animal challenge experiments were prepared as 
blastospores in distilled water and were standardised to 
the appropriate concentrations by counting in an improved 
Neubauer counting chamber.
3.6.2. Animals
Balb/c mice were used. They were housed in "shoe box" 
mouse cages and fed on a diet of "Labsure CRMX" and 
water ad libertum.
Balb/c mice do not exhibit retinal degeneration on 
exposure to light as is the case with some other mouse 
strains. However, the animals were kept (as far as
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possible) in a light regime of 12 hours light at low 
luminance and 12 hours dark. An excess of light could have 
damaged the retinae of the mice which would have made the 
pathology more difficult to interpret.
Mice were employed in preference to rabbits, which have 
been used in other studies (Hoffman, 1966; Edwards et al., 
1975), as they are easier to handle. Moreover they are 
cheaper to buy and to maintain. The most important factor 
governing the choice of a murine model was the similarity 
of the mouse retinal blood supply to that of man. However 
mice do not possess a macula. The retina of both man and 
mouse is holangiotic, that is the entire inner retina is 
supplied with blood vessels. This is in contrast to the 
rabbit which is a merangiotic animal, its retinal 
vasculature is confined to an elongated band across the 
centre of the retina (Duke-Elder, 1958).
Balb/c mice were selected in view of their lack of 
susceptibility or resistance to candidal infection. The 
mice used were randomly bred within a closed colony. This 
ensured a potential for heterogenicity in the expression 
of the experimental disease,
3.6.3. Infection Protocol
Infections were established by injecting 1x10® 
blastospores into the tail vein of each mouse; 0.2 ml of a 
5x10® suspension was injected with a 30 gauge stainless 
steel needle.
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3. 6. 4. Determination of Cumulative Mortality
The ability of the C. albicans strain Hll to cause 
systemic infection leading to death, in Balb/c mice, at 
the concentration used in the mouse model, was determined. 
Twenty-nine mice were inoculated and maintained under the 
same conditions as the animals used in the model. The 
number of deaths occurring on subsequent days was 
recorded.
3.6.5. Fundus Examination
Some of the experimental mice were examined with an 
indirect ophthalmoscope during the experimental period.
Not all the mice were examined as the intense light beam 
required for this technique damages the retina. The fundus 
examination was restricted to four mice.
In order to examine the eyes, the pupils were dilated 
with 0.5% tropicamide (Minims, Smith and Nephew, Hull) to 
achieve full dilation the mice were left for 2 minutes 
before being examined with a 33 diopter Nikon lens and 
a Keeler indirect ophthalmoscope.
The clinical appearances of the eyes were recorded.
This entailed looking for evidence of retinal detachment, 
segmentation of the blood column, tortuosity of the blood 
vessels and examining the colour of the choroid.
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3.6.6. Fundus Photography
Four days after infection the fundi of the murine eyes 
were photographed after the method described by Dutton et 
al. <1984). The risk of causing retinal damage precluded
mice other than those examined by indirect ophthalmoscopy 
being photographed.
The eyes were dilated by applying a drop of 0.5% 
tropicamide. The mice were left for 2 minutes to allow the 
pupils to dilate fully before the application of one drop 
of' 0.4% benoxinate (Minims) as a local anaesthetic. This 
ensured the eyes remained open. The mouse to be examined 
was encouraged to enter a plastic 50 ml syringe case from 
which the end had been removed. The animal's head 
protruded from the end but it was unable to turn round 
(Figure 14). A drop of 2 % methyl cellulose (Dispersa) 
followed by a circular 22 mm glass coverslip (Chance 
Propper) were placed on the eye. This allowed the retina 
to be seen without refractive interference due to the 
corneal surface.
The photographs were taken using a Zeiss operating 
microscope (Op-Mi-1) with a beam splitter, a slit lamp 
attachment, a flashlight, a Zeiss Ikon camera and a 125 mm 
objective lens. The photographs were taken on Ektachrome 
64 ASA film (Kodak) at fl8 and at X40 magnification.
Figure 14 Restraining device for mice, illustrating 
a mouse with a coverslip in place.
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3.6.7. Establislinent of Animal Model
Twenty nine mice were infected as described above. The 
mice were sacrificed at various times after challenge. If 
any of the mice appeared moribund they were sacrificed; 
six mice died during the course of the experiment.
After sacrifice by chloroform, the eyes were removed. 
One eye from each mouse was fixed for histology and the 
other was cultured. Which eye was taken for histology and 
which for culture was decided by random sequence.
<i> Histology
The eye chosen for histological examination was 
carefully removed. The upper and lower eye lids were 
peeled back and the socket exposed. The eye was held with 
fine forceps and was cut from the muscles and optic nerve. 
The eye was immersion-fixed in neutral buffered formalin 
immediately after it was removed. It was embedded in 
paraffin and cut as described previously. The sections 
were placed on poly-L-lysine coated slides in ribbons or 
individually. Alternate slides were stained by PAS and the 
others were left as unstained blanks for PAP 
immunoperoxidase staining.
Some of the mice were selected for a more detailed 
histopathological examination. These animals were killed, 
then the skull was split along the saggittal suture. The 
bone was broken at the nose and the skull cap was removed. 
The thorax and abdominal cavities were opened. The mice
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were iminers!on-fixed in neutral buffered formalin before 
being processed. Sections were prepared from brain, liver, 
skeletal muscle and the heart of these mice. The sections 
were stained by H & E and by PAS.
<ii> Culture
“The kidneys and one eye from each animal were taken for 
culture to detect the presence of yeast. Culture of the 
organs would show the presence of any micro-organisms 
other than the expected C. albicans. The eyes were 
cultured to show eye infections that may not have been 
detectable On histological examination, to confirm the 
identity of any yeast present and to establish that any 
yeast present was viable.
The eyes and kidneys were homogenised with sterile 
distilled water in a Griffiths tube and cultured on 
glucose peptone agar. The identity of the isolated yeast 
was confirmed by germ tube production and chlamydospore 
tests.
<iii> Latex Particle Agglutination Assay for Hannan 
Ant i ge nae mi a
Blood was taken from some of the mice for serological 
tests. This blood was removed by heart puncture 
immediately after death. A C. albicans latex agglutination 
test (Mercia Diagnostics Ltd. , Guildford, U.K.) was used 
to detect mannan antigenaemia in the sera.
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Table 10; Details of the number of mice sacrificed at 
different time intervals post challenge and which eye was 
examined by histology and which by culture. The table also 
indicates which mice were selected for detailed histology 
and which animals were tested for mannan antigenaemia.
Time Mouse Eye Eye Antigen Detailed
Histology Culture Assay Histology
0 1 R L
0 2 L R
5 min 3 L R
5 min 4 R L
5 min 5 L R
1 hour 6 L R
1 hour 7 R L
1 hour 8 L R
36 hour 9 L R Yes
36 hour 10 L R Yes
36 hour 11 R L Yes
3 days 12 L R Yes
3 days 13 R L Yes
3 days 14 L R Yes
5 days 15 R L Yes
5 days 16 L R
5 days 17 R L
5 days 18 L R Yes
6 days 19 L R
6 days 20 R L
6 days 21 L R Yes Yes
6 days 22 R L Yes
7 days 23 R L Yes Yes
7 days 24 L R Yes Yes
8 days 25 L R Yes Yes
8 days 26 R L Yes
8 days 27 L R
9 days 28 L R Yes Yes
9 days 29 R L Yes Yes
3.6.8. Differential Localisation of Yeasts Between House 
Eyes as Determined by Culture.
The Candida endophthalmitis infections in the 
Glaswegian heroin addicts appeared to have a predilection
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for the left eye in cases in which unilateral infection 
was present. Bilateral infection did occur in some 
patients and often developed if the infection persisted.
To ascertain if this phenomenon was reflected by the 
animal model, colony counts from cultures of whole eye 
homogenates were compared. The asymmetric nature of renal 
candidal infection in mice has been reported (Winblad, 
1975).
Three groups of mice were infected with the same C. 
albicans Glasgow Hll strain under the same conditions as 
described previously. The eyes were removed, homogenised 
in 2.5 ml sterile distilled water and diluted to 1/10, 
1/100, 1/1,000. Four 50 pi amounts of these dilutions were
cultured on glucose peptone agar. The number of counts per 
eye was then calculated.
The minimum and maximum counts, for each mouse, were 
compared. The differences in the two counts were analysed 
by a small sample t-test (Bailey, 1981) to discover if any 
of the differences were significant.
t = x - u 
S>Jn
The overall results for each group were compared as 
were the differences in counts per mouse for different 
times post challenge, in groups 2 and 3.
Group 1 - 8  mice; overall comparison
Group 2 - 1 0  mice; overall, day 3 and day 5 comparisons
1 6 4
Group 3 - 28 mice; overall, 5 min, 1 hour, 6 hour, 24
hour, 72 hour comparisons.
3.6.9. Determination of Candida Antigenaemia In the Mouse 
Model
<i> Sampling Frequency
Immediately after death blood was removed from 2 groups 
of mice, by puncturing the heart. The blood was allowed to 
clot then the serum was separated in a microcentrifuge. 
Candida mannan was assayed in these sera.
(ii) Antigen Detection Methods
Two latex agglutination methods were employed.
1. Immy La Candida (Immuno-Mycologics, Inc. , Norman, OK,
USA). This test detects mannan antigen. The sensitivity
and specificity of this test have not been determined.
The test incorporates a proteolytic enzyme step which is 
designed to dissociate immune complexes and to inactivate 
interfering factors such as rheumatoid factor.
2. Candida latex (Mercia Diagnostics Ltd. , Guildford,
U.K.). This test is designed to detect Candida mannan down 
to a level of 50 ng/ml. The test is specific for C. 
albicans serotypes A and B, and C. glabrata. The test has 
a control for rheumatoid factor, but has no dissociation 
step to release antigens from immune complexes.
In both tests the serum was used neat. Measured amounts 
of serum and sensitised latex particles were pipetted onto
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a dark glass slide in one spot. The slide was gently 
agitated. If agglutination occurred (clumping of the latex 
particles) then the result was recorded as positive.
Mice were sacrificed at five minutes, one hour, six 
hours, 24 hours, 48 hours and 72 hours. Five mice were 
sacrificed at each time interval apart from at 48 hours, 
when only four mice were killed.
(iii) Controls for False Positives Results 
* Eight unchallenged Balb/c mice were sacrificed and the 
blood was removed and tested for Candida antigenaemia with 
the two latex agglutination kits described above.
3.7. PrftftimiBd Candida Endophthalmitis la Heroin.Abusers; 
Aa Epidemiological Study
The aetiology of the C. albicans endophthalmitis in 
Glaswegian heroin addicts was examined from four aspects 
which appeared to be the most likely sources of the 
infection. Clinical specimens were taken from the addicts. 
The injection paraphernalia, a small sample of the street 
drug, and the diluent the addicts used for their heroin 
were cultured.
3.7.1. Patient Details
Twenty four heroin addicts who presented at the eye 
departments of several Glasgow hospitals were suspected of 
having Candida endophthalmitis. Details of these patients 
are given in Table 11. In an attempt to establish the 
source of the disease, several samples of injection 
paraphernalia and patients specimens were cultured on 
glucose peptone agar containing 50 pg/ml chloramphenicol. 
Table 12 lists the specimens and paraphrenalia that were 
obtained from the addicts for culture.
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Table 11: Details of patients involved in the Glasgow 
outbreak. Available information on their age, sex, 
address, history of heroin abuse and which eye was 
involved. signifies details not known.
Patient Age Sex Eye Address Heroin Abuse
1 G T 29 M B Castlemilk 18 months
2 L S 23 M L Castlemilk 5 years
3 T S 22 M R Castlemilk 2 1/2 years
4 R V 16 M L Castlemilk 1 year
5 R M*=L 22 M L Castlemilk 1 1/2 years
6 G C 22 M L Castlemilk 3 years
7 C C 21 F L Castlemilk 2 years
8 S K 20 M L Castlemilk 6 weeks
9 R R 22 F L Castlemilk -
10 J Mc C 27 M L Calton -
11 R J - M - Pollockshaws -
12 A T - M - Castlemilk -
13 P J 30 M L Castlemilk -
14 J K 19 M L Castlemilk -
15 R V 21 M L Easterhouse -
16 J K S - M - Castlemilk -
17 T A 25 M - Castlemilk -
18 G B 33 M L Castlemilk -
19 L B - F - Castlemilk -
20 A B — M — Castlemilk
Heroin
—
21 J C - M - Castlemilk -
22 G W 26 M L Castlemilk -
23 P M*=C 33 F L G5 -
24 I R 23 M L Barrow/ Furness -
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Table 12: Details of fungal isolates from patients or their
inj ection paraphernalia and the numbers assigned to
isolates.
Patient Source Isolate Isola
Number Numbe
3 T S Vitrectomy C. albicans —
5 R Mc L Heroin no fungi —
Syringe Trichosporon sp. —
7 crc Spoon No fungi —
Syringe C. albicans 1
Syringe A. fu mi gat us —
Lemon C. albicans 2
9 R R Scalp C. albicans 4
10 J M^C Vitreous No fungi -
Syringe washing No fungi -
Plunger Penicillium sp. —
Syringe A. fumigatus —
Needle No fungi —
Lemon No fungi —
11 R J Syringe C. parapsi 1 osi s —
Syringe F. rubra —
Lemon No fungi —
12 T A Lemon C. albicans 3
13 J P Vitreous No fungi -
14 J K Throat swab No fungi -
15 V R Throat swab C. albicans 5
18 G B Mouth wash C. albicans 6
Mouth swab C. albicans 7
19 L B Mouth swab C. albicans 8
Mouth wash C. albicans 9
20 A B Mouth swab No fungi -
Mouth wash No fungi -
21 J C Vitreous No fungi -
22 V G Vitreous C. albicans 10
23 P McC Mouth wash C. albicans 13
Faeces C. albicans 14
Lemon No fungi -
24 I R Faeces C. albicans 16
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3.7.2. Biotyping Technique for C. albicans Isolates From 
Heroin Addicts.
The isolates of C. albicans cultured from the addicts and 
their paraphernalia were biotyped by the method of Odds and 
Abbott <1980; 1983). The method was used to determine if
there was any relationship among the isolates by attempting 
to fingerprint each isolate by its growth pattern on 14 
different media. Five of the media differentiated the 
species and the other nine were used to determine the 
biotype.
This technique was performed on the heroin isolates using 
the facilities in Dr. F.C. Odds* laboratory in Leicester.
The materials and methods are not described here since the 
methods employed are given in detail in published papers 
<0dds and Abbott, 1980; 1983). Essentially, the procedure
reveals patterns of assimilation or resistance to chemicals.
The isolates were grown on bromocresol green glucose 
peptone agar. Three dissimilar colonies from purity plates 
of each isolate were subcultured for use in the tests. The 
inocula were prepared from overnight cultures on nitrogen 
base glucose agar (JTBGA) in accordance with the method 
described by Odds and Abbott <1980) to attain a 
concentration of yeast of 10G cells/ml.
Test petri dishes were poured from freshly prepared agar 
and employed yeast nitrogen base <YNB) or yeast carbon base
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(YCB) as the basal medium. The test media were made in 
accordance with the modified recipes described by Odds and 
Abbott (1983) and were dried for the allotted time at 37°C. 
The proteinase test plates were not dried. Inoculation was 
made with a Leicester designed multipoint inoculator and the 
plates were inoculated in the order recommended; the details 
are given in Table 13. The plates were read at different 
time intervals depending on the test media concerned and the 
triplicate results recorded.
Table 13: Biotyping media in the order in which the plates 
were inoculated and the time after inoculation at which they 
were read.
Order Agar Reading (Days)
Inoculated
1 Control 5-7
2 pH 1.55 3-4
3 Proteinase 5-7
4 pH 1.4 3-4
5 Urea 3-4
6 5-FC 5-7
7 Sorbose 5-7
8 Salt tolerance 3-4
9 Citrate 3-4
10 Boric acid 3-4
11 Safranine 2-3
12 Tetrazolium salts 5-7
13 MacConkeys 5-7
14 Ce trimide 3-4
15 Periodate 3-4
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The incubation of five control strains on each plate 
ensured that; the media preparation, drying times, 
concentration of inocula and incubation period gave 
consistent results. The biotype consists of a three digit 
sequence which is consistent for a particular combination 
of test results for C. albicans grown on nine of the 
precisely controlled agar media. The other media were used 
to confirm the identification of the yeast.
Table 14; Strain differentiation for designation of 
biotypes, showing the calculation of biotype number by 
group.
Group 1 Group 2 Group 3
Test Score if + Test Score if + Test Score
if +
pH 1.4 1
2
4
Urea
Sorbose
Salt
1
2
4
Citrate 1 
Boric acid 2 
Safranine 4
Proteinase
5FC
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3.7.3. Inhibition of Yeast Growth by Heroin
The effect of heroin on yeasts was studied in an 
attempt to elucidate the cause of the Glasgow outbreak.
The temporalspatial clustering of the Candida 
endophthalmitis suggested a common source of the 
infection. The obvious common denominator for all of these 
patients was heroin, especially as the patients themselves 
suspected their pusher of adulterating the drug with 
bakers yeast.
<i> Culture of Street Drug
Some samples of heroin confiscated from Castlemik were 
provided for culture by the Glasgow Drug Squad. The 
samples included one sample of dealers drug and six 
samples of pushers drug (Figure 2). The contents of the 
bags and the bags themselves were cultured on glucose 
peptone agar.
<ii> Antifungal Activity of Diamorphine Hydrochloride 
Sensitivity Plates - Powdered Drug
Agar plates of glucose peptone, yeast morphology and 
potato dextrose media were seeded with 0.5 ml of a 10e 
suspension of strains of C. albicans and Saccharomyces 
cerevisiae. Then 1 mg, 5 mg or 10 mg of diamorphine 
hydrochloride was placed in the centre. The plates were
173
prepared in duplicate and one was incubated at 28°C and 
the other at 37°C. In the instances when an inhibition 
zone was seen the zone was excised with a size 2 cork 
borer and further incubated on drug free media.
Yeast isolates Tested:- CA 6, CA 9, SAC 1, SAC 2 and 
Bakers Yeast (freeze dried shop bought yeast)
Heroin Isolates:- 2,3,4,5,6,7,8,9,10,11,12,13,14,15,16.
Sensitivity Plates - Liquid Drug
Plates seeded with C. albicans CA 6 and S . cerevisiae 
SAC 2 had wells removed using a size 2 cork borer. The 
wells were filled with diamorphine hydrochloride at 
different concentrations and distilled water to act as a 
control. The plates were incubated at 37°C and examined at 
24 and 48 hours.
Drug concentrations;- 10, 100, 1,000, 10,000 pg/ml
Yeast Isolates:- CA6, CA9, SAC 1, SAC 2.
Incorporation Plates
Glucose peptone agar plates incorporating diamorphine 
hydrochloride were prepared. The plates were spot 
inoculated with 20 pi of 1x10s suspension of yeast.
Yeast isolates:- CA 6, CA 9, SAC 1, SAC 2 and Bakers 
Yeast.
Drug concentrations;- 5, 10, 100 mg/ml.
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Broth Dilution Experiments for Minimum Inhibitory 
Concentrations <MIC)
Tubes of glucose peptone broth containing different 
concentrations of diamorphine hydrochloride were 
inoculated with strains of yeast to give a final 
concentration of 5x10^ yeasts/ml in culture. To test the 
viability of the yeast after different contact times with 
the drug, 100 pi of the culture medium was removed for 
further incubation in drug free glucose peptone broth.
Dj-ug concentrations:- 0, 2.5, 5, 10, 100, 250 or 500 mg/ml
Time intervals:- te, 1, 2, 3, 4, 24 hours
Isolates tested;- CA6, CA9, SAC1, SAC2, Bakers Yeast
Broth Dilution Experiments for ICso Determinations
The quantity of diamorphine hydrochloride required to 
perform MICs in broth tubes for a range of isolates, 
necessitated the reduction of the technique. A photometer—  
read broth microdilution method was used to assess the 
antifungal properties of the drug (Johnson, Richardson and 
Varnock, 1984). Test were performed in 96-well microtitre 
plates (Sterlin Ltd., Middlessex). The strains were tested 
against dilutions of diamorphine hydrochloride. The drug 
solutions and inoculum dilutions were prepared in glucose 
peptone broth and dispensed from an eight channel 
variable—volume pipette. The final volume in each well was
1 7 5
0.2 ml. Each row of 12 was used to assess one isolate at 
seven drug concentrations, the first well contained 
inoculum but no drug and the last well contained drug at 
the highest concentration but no yeast. The inoculum 
dilution was 1 x 10e cells/ml for every test and 
incubation was at 37°C. The plates were read at various 
times depending on the isolate tested.
The optical density <0D> of the microdilution plates 
were measured by a Dynatech MR 950 microELISA plate reader 
(Dynatech Laboratories, Billingshurst, U.K.) operating at 
a wavelength of 570 nm. the results were read and recorded 
manually.
The contact time with the heroin that leads to yeast 
death was determined in preliminary experiments. Aliquots 
of the culture were removed at intervals and cultured in 
drug free broth for 24 hours in an attempt to quantitate 
the survival of the yeasts.
Isolates tested:- CA6, CA9, SAC1, SAC2, Bakers Yeast 
Drug concentrations:- 10, 20, 30, 40, 50, 100, 200 mg/m1,
Time intervals:- te, 1, 2, 3, 4, 6, 7%, 24, 48 hours
The ICso was determined for patient isolates after 24 
hours incubation in diamorphine hydrochloride at various 
concentrations in glucose peptone broth. The IC®o was
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calculated as the lowest concentration at which the OD was 
<30% of that of the positive control.
Isolates from Heroin Addicts:- 1, 2, 3, 4, 5, 6, 7, 8, 9, 
10, 11, 12, 13, 14, 15.
Drug Concentrations:- 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50
mg/ml.
Time Interval:- 24 hours.
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3.7.4. Growth of Fungi in Lemon Juice
The drug addicts from Castlemilk diluted their heroin 
in the juice from "Jif plastic lemons. The possibility 
that Candida could survive or grow in this juice was 
investigated.
- Twenty seven "Jif” lemons were cultured for fungi.
Seven were from friends and colleagues who had kept them 
in their cupboards for several months, five were donated 
by addicts. The remaining 15 werfe purchased from shops in 
the Castlemilk area of Glasgow.
<i) Survival of C. albicans in "Jif" Lemon Juice
C. albicans strain H 11 was inoculated into "Jif" lemon 
juice:— new juice, steamed new juice and juice past its 
"best by" date. 100 pi of a 1.2 X 10^ yeast suspension in 
2.5 ml of juice.
100 pi amounts were removed and cultured on glucose 
peptone agar plates at one hour intervals up to six hours 
and at 12 and 14 hours. The numbers of yeasts were high so 
dilution plates were employed. A glucose peptone broth was 
used as a control.
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<ii> Determination of Sulphur Dioxide Content
Sulphites are permitted preservatives for certain foods 
including lemon juice. The amount of preservative is 
calculated in parts per million <ppm> of sulphur dioxide 
(S0®>.
Sulphurous acid inhibits the growth of moulds, yeast 
and bacteria. The browning of fruit and vegetables due to 
natural enzymatic activity is prevented by SO®. SO® also 
prevents the breakdown of ascorbic acid but it causes the 
destruction of vitamin Bi. Since SO® is a gas there is a 
tendency for it to be lost if the packaging is not 
completely airtight. Once a container is opened the level 
of SO® falls rapidly. Moreover, a proportion of the gas 
will have formed complexes with constituents of the food 
and will no longer have any antimicrobial properties. The 
legislation, however is based on the total level of SO® 
in the foodstuff. The permitted level for lemon juice is 
350 ppm (Preservative in Food Regulations, 1979).
Colemans, the manufacturers of "Jif " lemons, say they buy 
lemon juice from more than one country, dilute it by one 
third in tap water, incorporate SO® as a preservative and 
then flash sterilise it at 200c>C for 10 seconds before 
putting the juice into containers.
There are two principal methods for determining SO® 
content. The iodine titration method which is simpler and
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quicker but less accurate than the distillation method.
The more precise distillation method was the one employed 
in this study. The SO® in the sample is distilled slowly 
in the presence of an inert atmosphere. The gas is trapped 
in an oxidising agent which converts the sulphurous acid 
to sulphuric acid. The amount of sulphuric acid is 
determined by titration.
Distillation Method <Egan, 1981)
1. 15 ml of 3% H®0® was pipetted into a Q & Q conical 
flask.
2. 5 ml of H®0® was pipetted into a Q & Q U-tube.
3. 20 ml of H®0® was pipetted into a conical flask for 
the blank titration.
4. 350 ml of deionised water was measured into a round 
bottomed flask.
The unit was assembled as in Figure 15. The condenser 
was cooled by tap water and the flow rate of the nitrogen 
gas was set at nine bubbles a minute. The nitrogen tube 
was removed and the weighed sample of lemon juice was 
introduced into the apparatus and 20 ml of concentrated 
hydrochloric acid <HC1) were added. The nitrogen tube was 
replaced.
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The sample was distilled far 30 minutes. The conical 
flask and U-tube were disconnected and the liquid from the 
U-tube was washed into the conical flask.
Three drops of 0.4% bromophenol blue were added to the 
flask before the sample was titrated against 0.05 N sodium 
hydroxide <NaOH). The blank was titrated against NaOH to 
detect any free acid.
The concentration of SO® was determined as:-
1 ml 0.05 N Na OH = 1.6 mg SO® <mg/kg = ppm).
The following samples of lemon juice were tested for 
the presence of SO® by the method described above.
Table 15: Lemon juice samples tested. Details of the "best 
by" date, the source of the lemon if known, and if steamed 
how long it was steamed for.
Best By Date
Before Date 
Before Date 
New 
New 
New
Beyond Date <5 months) 
Beyond Date <7 Months)
^denotes lemons purchased
Condition
2 Weeks old 
2 Weeks old 
Steamed 5 minutes 
Steamed 15 minutes 
Steamed 30 minutes 
Lemon 17s*
Lemon 18*
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4.1. Strength and Specificity of Antisera
4.1. 1. CounterImmunoelectrophoresis
<i) Strength of Antisera
To determine the strength of the sera used in this 
study each antiserum was titred against a corresponding 
antigen type on an agarose gel in a CIE system as 
described in section 3.3.1. The results are shown in Table 
16.
Table 16: Titre of laboratory prepared and commercial 
antisera as determined by CIE.
Source Antiserum Antigen Titre
Rabbit 1 A. fumigatus GAF 5 1: 8
Rabbit 2 R. oryzae Rh.sp.1 1:8
Rabbit 3 C. albicans MRL 1:8
Rabbit 4 C. albicans URL 1: 16
Rabbit 6 A. fumigatus GAF 5 1: 8
Inst. Past. A. fumigatus Commercial 1:8
Inst. Past. A. flavus Commercial 1: 8
Inst. Past. A. nidulans Commercial 1: 8
Inst. Past. A. niger Commercial 1: 8
Inst. Past. A. terreus Commercial 1:8
<ii> Sensitivity and Specificity of Antisera
To demonstrate the ability of the antisera to react 
with a wide range of homologous antigens the antisera were 
electrophoresed in CIE with several antigens of the fungal 
species they were raised against. The presence <+) or 
absence <-> of cross-reactivity is shown in Table 17.
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Table 17: Results of CIE demonstrating interactions of 
different Aspergillus, Candida and Rhizopus antigens with 
homologous antisera and indicating possible cross­
reactions with heterologous antisera.
Antiserum Antigen Antigen Result
A. fumigatus A. fumigatus Indian +
A. fumigatus A. fumigatus GAF 5 +
A. fumigatus A . fumigatus GAF 83 +
A. fumigatus A. fumigatus GAF 84 +
A . fumi ga t us A. fumigatus GAF 85 +
A. fumigatus A. fumigatus GAF 86 +
A. fumigatus A. fumigatus GAF 86B +
A. fumigatus A. flavus GAF1 2 —
A . fumi ga t us A. clavatus GAC 2 —
A. fumigatus A. nidulans ANi 1 —
A. fumigatus A. niger ANig 4 —
A. fumigatus A. terreus ATe 8 +
A. fumigatus C. albicans Mercia —
A . fumigatus C. albicans MRL —
A. fumigatus C. parap. MRL —
A . fumi ga tus R. oryzae Rh 1 —
A. fl a vus A. fumigatus Indian +
A. flavus A. flavus GAF1 1 +
A. flavus A. clavatus GAC 2 +
A. fl a vus A. nidulans GANi 1 -
A. flavus A. niger GANig 4 -
A. flavus A. terreus GATe 8 —
A. nidulans A. fumigatus Indian —
A . nidulans A. flavus GAF1 1 —
A. nidulans A . clavatus GAC 2 -
A. nidulans A. nidulans GANi 1 +
A. nidulans A. niger GANig 4 -
A. nidulans A . terreus GATe 8 -
A. niger A. fumigatus Indian +
A. niger A . flavus GAF1 1 +
A . niger A. clavatus GAC 2 +
A. niger A. nidulans GANi 1 +
A. niger A. niger GANig 4 +
A. niger A. terreus GATe 8
A. terreus A. fumigatus Indian -
A. terreus A. flavus GAF 1 —
A . terreus A. clavatus GAC 2 -
A. terreus A. nidulans GANi 1 -
A. terreus A. niger GANig 4 —
A. terreus A. terreus GATe 8 +
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Tabla 17 continued
Antiserum Antigen Antigen Result
C. albicans C. al bicans Mercia +
C. albicans C. al bi cans MRL +
C. albicans C. albi cans GCA003 +
C. al bi cans C. albicans GCA406 +
C. albicans C. parap. MRL +
C. albicans A. fumigatus Indian —
C. albicans R. oryzae Rh 1 —
R.-- oryzae R. oryzae Rh 1 +
R. oryzae A. fumigatus Indian —
R. oryzae C. albi cans MRL —
The A. fumigatus antisera reacted well against all the 
homologous antigen strains tested. There was no evidence of 
cross—reactions with C. albicans, C. parapsilosis or R. 
oryzae antigens. The other aspergilli varied in the 
response. No cross-reaction was evident with A . clavatus, A. 
flavus, A. nidulans and A. niger but precipitin lines were 
seen on gels electrophoresed with A. terreus antigen.
The A. flavus antiserum reacted not only with the A. 
flavus antigen but with the A. fumigatus and A. clavatus 
antigens. The A. nidulans antiserum showed no cross­
reactions when tested with antigens from the other 
aspergilli. A . niger antiserum cross-reacted with antigens 
of all the aspergilli tested with the exception of A. 
terreus. The A. terreus antiserum only showed a response to 
the antigen from that species. The summarised results of the 
CIE experiments are given in Table 18.
s0TpoqTq.uv
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4.1.2. Double Diffusion Experiments to Demonstrate Cross- 
reactions and Lines of Identify With Antigens and 
Heterologous Antisera.
Cross-reactions between antigens with homologous and 
heterologous antisera were determined by double diffusion. 
The results are presented in Tables 19 and 20.
Table 19: Results of double diffusion experiments to 
determine cross-reactions between antisera and their 
homologous and heterologous antigens.
Antiserum Antigen Antigen Result
A. fumigatus A. fumigatus MRL +
C. al bicans A. fumigatus MRL —
R. oryzae A. fumigatus MRL —
A. fumigatus A. fumigatus GAF 83 +
C. al bicans A. fumigatus GAF 83 —
R . oryzae A. fumigatus GAF 83 —
A. fumigatus A. fumigatus GAF 84 +
C. albi cans A. fumigatus GAF 84 —
R. oryzae A . fumigatus GAF 84 —
A. fumigatus C. al bicans MRL -
C. albicans C. albi cans MRL +
R. oryzae C. albi cans MRL —
A. fumigatus C. albi cans GCA003 —
C. albi cans C. albicans GCA003 +
R. oryzae C. albicans GCA003 —
A. fumigatus C. albicans C406 —
C. al bicans C. albi cans C406 +
R. oryzae C. albicans C406 —
A . fumigatus R. oryzae Rh. 1 -
C. al bicans R. oryzae Rh. 1 —
R . oryzae R. oryzae Rh. 1 +
There were no lines of identity indicating cross­
reactions among antigens of A. fumigatus, C. albicans and
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R. oryzae and the heterologous antisera, although there 
were precipitin lines formed with the homologous antisera.
Table 20: Cross-reactivity results among A . fumigatus, C. 
albicans and R. oryzae as determined by double diffusion.
Antigens 10 mg/ml 
Antibody C. albicans A. fumigatus R. oryzae
C. abicans + - -
A . fumigatus - + -
R. oryzae - - +
4.1.3. Experiments to Determine Strength and Specificity 
of Antibody with ELISA.
ELISA experiments were performed to ascertain the 
strength of the antisera with relation to homologous 
antisera and the amount of cross-reactivity with 
heterologous antisera. Dose response curves of antisera 
activity were plotted for each antigen antiserum 
combination. The discriminatory point between positive and 
negative values was set by taking the minimum positive 
response value as being x .3 the mean absorbance of the 
negative control <de Savigny and Voller, 1980>. Any value 
greater than X*- 3 that of the negative controls at serum 
dilution 10_1 was regarded as being positive.
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Tables 21 and 22 list the detailed results of the ELISA 
experiments comparing cross-reactions of antisera with 
various antisera. These results are summarised in Table 
23. Examples of the dose response graphs drawn for A . 
fumigatus, C. albicans and R. oryzae are shown in Figures 
16, 17 and 18.
Table 21: Details of ELISA experiments to detect reactions 
of various antigens at different concentrations with 
homologous and heterologous antiserum from laboratory and 
commercial sources.
Antigen Antigen Humber Antiserum Results
C. a bicans MRL 3153 <5 mg/ml) C. albi cans < R3 ) +
C. a bicans MRL 3153 <5 mg/ml) C. albicans <R4) +
C. a bicans MRL 3153 <5 mg/ml) A. fumigatus <R1) -
C. a bicans MRL 3153 <5 mg/ml) A. fumigatus <R6) —
C. a bicans MRL 3153 <5 mg/ml) A. flavus <PI) -
C. a bicans MRL 3153 <5 mg/ml) A . nidulans <PI) -
C. a bicans MRL 3153 <5 mg/ml) A. niger <PI) -
C. a bicans MRL 3153 <5 mg/ml) A . terreus <PI) -
C. a bi cans MRL 3153 <5 mg/ml) R. oryzae <R2) —
C. a bi cans MRL 3153 <30 mg/ml) C. albicans <R3) +
C. a bicans MRL 3153 <30 mg/ml) C. albicans <R4) +
C. a bicans MRL 3153 <30 mg/ml) A . fumigatus <R1) -
C. a bi cans MRL 3153 <30 mg/ml) A. flavus <PI) +
C. a bicans MRL 3153 <30 mg/ml) A. nidulans <PI) +
C. a bicans MRL 3153 <30 mg/ml) A. niger <PI) +
C. a bicans MRL 3153 <30 mg/ml) A. terreus <PI) —
C. a bicans MRL 3153 <30 mg/ml) R. oryzae <R2) —
C. a bicans mannan <30 mg/ml> C. albicans <R3) +
C. a bicans mannan <30 mg/ml> C. albicans <R4) +
C. a bicans mannan <30 mg/ml> A, fumigatus <R1) -
c. a bicans mannan <30 mg/ml) A. fumi ga tus < R6 ) —
c. a bicans mannan <30 mg/ml) A . flavus <PI) +
c. a bicans mannan <30 mg/ml) A. nidulans <PI) +
c. a bicans mannan <30 mg/ml) A. niger <PI) +
c. a bicans mannan <30 mg/ml) A. terreus <PI) —
c. a bi cans mannan <30 mg/ml) R. oryzae CBS') —
c. parap. MRL <5 mg/ml) C. albicans <R3) +
c. parap. MRL <5 mg/ml) C. albicans <R4) +
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Table 21 continued
Antigen Antigen Number Antiserum Results
c. parap. MRL (5 mg/ml > A. fumigatus (Rl) -
c. parap. MRL (5 mg/ml) JR. oryzae (R2) —
A. clavatus GAC 2 (30 mg/ml) A. fumigatus (Rl) +
A. clavatus GAC 2 (30 mg/ml) A. flavus (PI) +
A. clavatus GAC 2 (30 mg/ml) A. nidulans (PI) +
A. clavatus GAC 2 (30 mg/ml) A. niger (PI) +
A. clavatus GAC 2 (30 mg/ml) A. terreus (PI) +
A, fumigatus Indian C. albicans (R3) —
A. fumigatus Indian C. albicans <F4) -
A. fumigatus Indian A. fumigatus (Rl) +
A. fumigatus Indian F. oryzae (R2) -
A. fumigatus AF 5 (5 mg/ml) C. albicans (R3) -
A. fumigatus AF 5 (5 mg/ml) C. albicans (R4) -
A. fumigatus AF 5 (5 mg/ml) A. fumigatus (Rl) +
A. fumigatus AF 5 (5 mg/ml) A. fumigatus (R6) +
A. fumigatus AF 5 (5 mg/ml) A. flavus (PI) +
A. fumigatus AF 5 (5 mg/ml) A. nidulans (PI) -
A. fumigatus AF 5 (5 mg/ml) A. niger (PI) +
A. fumigatus AF 5 (5 mg/m 1) A. terreus (PI) -
A. fumigatus AF 5 <5 mg/ml) F. oryzae <F2> —
A. fumigatus AF 5 (30 mg/ml) C. albicans (R3) -
A. fumigatus AF 5 <30 mg/ml) C. albicans (R4) -
A. fumigatus AF 5 (30 mg/ml) A. fumigatus (Rl) +
A. fumigatus AF 5 (30 mg/ml) A. flavus (PI) +
A. fumigatus AF 5 (30 mg/ml) A. nidulans (PI) -
A. fumigatus AF 5 (30 mg/ml) A. niger (PI) +
A. fumigatus AF 5 (30 mg/ml) A. terreus (PI) —
A. fumigatus AF 5 (30 mg/ml) F. oryzae (R2) —
A. fumigatus MRL (1.5 mg/ml) C. albicans (R3) -
A. fumigatus MRL (1.5 mg/ml) C. albicans (R4) -
A. fumigatus MRL (1.5 mg/ml) A. fumigatus (Rl) +
A. fumigatus MRL (1.5 mg/ml) A. flavus (PI) +
A. fumigatus MRL (1.5 mg/ml) A. nidulans (PI) -
A. fumigatus MRL (1.5 mg/ml) A. niger (PI) +
A. fumigatus MRL (1.5 mg/ml) A. terreus (PI) —
A. fumigatus MRL (1.5 mg/ml) F. oryzae(R2) —
A. fumigatus 
A. fumigatus 
A. fumigatus 
A . fumiga tus 
A . fumigatus
A. flavus 
A. flavus
MRL <30 mg/ml) A.
MRL <30 mg/ml) A.
MRL (30 mg/ml) A.
MRL (30 mg/ml) A.
MRL (30 mg/ml> A.
GA FL 1 (3 mg/ml) C.
GA FL 1 (3 mg/ml > C.
fumigatus (Rl) + 
flavus <PI> + 
nidulans <PI> - 
niger <PI> 
terreus <PI>
al bicans 
albi cans
<R3> -
<R4> -
+ 
+
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Table 21 continued
Antigen Antigen Number Antiserum Results
A. flavus GA FL 1 <3 mg/ml) A. fumigatus <R1> -
A. flavus GA FL 1 <3 mg/ml) A. fumigatus <R6> -
A. flavus GA FL 1 <3 mg/ml) A. flavus <PI> +
A . flavus GA FL 1 <3 mg/ml) A. nidulans <PI> -
A. flavus GA FL 1 <3 mg/ml> A. niger <PI> +
A . flavus GA FL 1 <3 mg/ml) A. terreus <PI> +
A. fla vus GA FL 1 <3 mg/ml> R. oryzae <R2> —
A . flavus GA FL 1 <30 mg/ml) C. albicans <R3> +
A. flavus GA FL 1 <30 mg/ml) C. albicans <R4> +
A. flavus GA FL 1 <30 mg/ml) A. fumigatus <R1> +
A . flavus GA FL 1 <30 mg/ml) A. fumigatus <R6) -
A. flavus GA FL 1 <30 mg/ml) A. flavus <PI> +
A. flavus GA FL 1 <30 mg/ml) A. nidulans <PI> +
A. flavus GA FL 1 <30 mg/ml) A. niger <PI> +
A. flavus GA FL 1 <30 mg/ml> A. terreus <PI> +
A. fla vus GA FL 1 <30 mg/ml) R. oryzae <R2) -
A. nidulans GA
A. nidulans GA
A. nidulans GA
A. nidulans GA
A. nidulans GA
A. nidulans GA
A. nidulans GA
A. nidulans GA
A . niger GA
A, niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A. niger GA
A . niger GA
A. niger GA
A. niger GA
A . niger GA
A. terreus GA
A . terreus GA
A. terreus GA
A. terreus GA
A. terreus GA
Nid 1 <30 mg/ml) 
Nid 1 <30 mg/ml> 
Nid 1 <30 mg/ml) 
Nid 1 <30 mg/ml) 
Nid 1 <30 mg/ml) 
Nid 1 <30 mg/ml) 
Nid 1 <30 mg/ml> 
Nid 1 <30 mg/ml)
N 2 <3 mg/ml)
N 2 <3 mg/ml)
N 2 <3 mg/ml >
N 2 <3 mg/ml)
N 2 <3 mg/ml >
N 2 <3 mg/ml)
N 2 <3 mg/ml)
N 2 <3 mg/ml)
N 2 <30 mg/ml)
N 2 <30 mg/ml>
N 2 <30 mg/ml)
N 2 <30 mg/ml >
N 2 <30 mg/ml)
N 2 <30 mg/ml)
N 2 <30 mg/ml)
N 2 <30 mg/ml>
T 2 <30 mg/ml)
T 2 <30 mg/ml)
T 2 <30 mg/ml)
T 2 <30 mg/ml)
T 2 <30 mg/ml>
C. albicans <R3> -
C. albicans <R4> -
A. fumigatus <R1) - 
A. flavus <PI) - 
A. nidulans <PI> + 
A. niger <PI) -
A. terreus <PI) - 
R. oryzae <R2> -
C. albicans <R3> -
C. albicans <R4) -
A. fumigatus <R1> - 
A. flavus <PI> + 
A . nidulans <PI> + 
A. niger <PI>
A. terreus <PI)
R. oryzae <R2>
C. albicans <R3) +
C. albicans <R4> +
A. fumigatus <R1> - 
A. flavus <PI> + 
A. nidulans <PI> + 
A. niger <PI> +
A. terreus <PI> + 
R. oryzae <R2> -
C. albicans <R3> +
C. albicans <R4> -
A. fumigatus <R1> + 
A. fumigatus <R6> - 
A. flavus <PI> +
+ 
+
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Table 21 continued
Antigen Antigen Number Antiserum Results
A. terreus GA T 2 <30i mg/ml) A. nidulans <PI) +
A. terreus GA T 2 <30i mg/ml) A. niger <PI) +
A. terreus GA T 2 <30i mg/ml) A. terreus <PI) +
A. terreus GA T 2 <30i mg/ml) R. oryzae <R2) —
R . oryzae G Rhl <30 mg/ml) C. albicans <R3) -
R. oryzae G Rhl <30 mg/ml) C. albicans <R4) -
R. oryzae G Rhl <30 mg/ml) A. fumigatus <R1) —
RT oryzae G Rhl <30 mg/ml) A. flavus <PI) —
R. oryzae G Rhl <30 mg/ml) A. nidulans <PI) —
R. oryzae G Rhl <30 mg/ml) A. niger <PI) —
R. oryzae G Rhl <30 mg/ml) A. terreus <PI) —
R. oryzae G Rhl <30 mg/ml) R. oryzae <R2) +
The ELISA cross-reactivity results are summarised in Table 
22.
The C. albicans antisera had a high affinity for both 
C. albicans antigens tested at both concentrations. They 
also reacted against the C. parapsilosis antigen. The 
antisera did not cross-react with any of the Aspergillus 
antigens at the lower concentration. However, if the 
concentration of the coating antigen was increased then 
the sera bound to A . flavus and A. niger. There was no 
reaction against the R. oryzae antigen.
The antisera raised against R. oryzae demonstrated no 
cross—reactions with any of the Candida or Aspergillus 
antigens even at the highest concentrations tested. The 
serum only reacted with the antigen it was raised against.
The A. fumigatus antiserum did not bind to either the 
Candida or the R. oryzae antigens. However, it did react 
against all the A. fumigatus antigens it was tested
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Figure 16 Reactivity of A.fumigatus (X \ ), C.albicans (O) # 
R.oryzae ( ■ ) antisera and normal rabbit serum ( • ) 
against A.fumigatus CF antigen in ELISA. The positive/ 
negative discrimination was set at three times the optical 
density (OD) of the normal rabbit serum at 10-1 and is 
indicated by the dotted line.
Dilutions of Antisera
Figure 17 Reactivity of A.fumigatus (A ), C.albicans (O )/ 
R.oryzae ( ■ ) antisera and normal rabbit serum ( • ) against 
C .albicans MRL 5mg/ml antigen in ELISA, The positive/ 
negative discrimination was set at three times the optical 
density (OD) of the normal rabbit serum at 10~1 and is 
indicated by the dotted line.
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Figure 18 Reactivity of A.fumigatus ( A ), C .albicans 
(O )• R.oryzae ( ■ ) antisera and normal rabbit serum 
( • ) against R.oryzae antigen in ELISA. The positive/ 
negative discrimination was set at three times the 
optical density (OD) of the normal rabbit serum at 10-  ^
and is indicated by the dotted line.
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against. It also reacted against A. clavatus and A. 
terreus at the 30 mg/ml concentration of antigen. The 
antiserum did not cross-react with A . niger or A. nidulans 
at the same concentration, nor did it react with the A. 
flavus antigen at 3 mg/ml.
The commercial Aspergillus antisera showed a greater 
amount of cross-reactivity than the laboratory raised 
antisera. A. flavus cross-reacted with all the antigens it 
was tested against with the exception of A. nidulans and a 
C. albicans antigen at 5 mg/ml. The A. nidulans antiserum 
did not show any reaction with R. oryzae, A . fumigatus or 
the lower concentration of the A. flavus antigen but bound 
to C. albicans, A. clavatus, A. niger, A. terreus and 
thehigher concentration of the A. flavus antigen.
Table 23 shows a summary of the ELISA cross-reactivity 
results
4.1.4. Streptavidin—Biotin Enzyme Linked Immunosorbent 
Antigen Assay for Testing Antiserum Specificity.
A streptavidin-biotin ELISA system employing an anti A. 
fumigatus human capture antibody and a rabbit secondary 
antibody was used to detect cross-reactions of A. 
fumigatus antisera with antigens of other aspergilli.
Ho cross-reactions were seen with antigens of A. 
clavatus, A. flavus, A. nidulans, A. niger or A. terreus 
when the antigens were diluted in human sera at levels of 
100 pg to 10 ng/ml (Figure 19).
0- 5 r -
oo
^ 0- 3<
0 1
-A
l O O u g
M
lug 10ng
Figure 19 Dose-response curves for cytoplasmic antigens 
of A .fumiga tus ( O  )» A .flavus ( □ ) , A .niger ( A ),
A .terreus ( • ) and A .nidulans ( ■ ) diluted in normal
human serum detected by a human anti-A.fumigatus capture 
antibody - rabbit anti-A.fumigatus second antibody assay 
forma t.
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4. 2. Agar Block Technique for -the Evaluation of the 
Pfirnyjdnse Anti-PercnH riara Staining Technique.
In order to determine the specificity of the peroxidase 
anti—peroxidase <PAP> technique, frozen sections from agar 
blocks inoculated with different species of fungi were 
stained using homologous and heterologous antiserum. The 
agar block method was successful in simulating fungi 
penetrating tissue in three dimensions. The results of 
staining sections from the blocks, employing the PAP 
technique are given in Table 24 and are summarised in 
Table 25. Positive staining and no staining are signified 
by "+" and .
Table 24: Results of staining of agar blocks with the PAP 
technique. C. parap. is an abbreviation for C. 
para psi 1 osl s.
Agar Block Primary Antibody Source Result
Inoculated With
C. albicans C. albicans R3 & R4 +
C. al bl cans A. fumigatus R1 —
C. albicans A. flavus P I —
C. albicans A. nldulans P I —
C. albicans A. nlger P I —
C. albicans A. terreus P I —
C. albicans R. oryzae R2
C. albicans Negative Serum Rabbit
C. parap. C. albicans R3 & R4 -
C. parap. A. fumigatus R1 —
C. parap. A. flaws P I —
C. parap. A. nldulans P I —
C. parap. A. nlger P I _
C. parap. A. terreus P I
C. parap. R. oryzae R2
C. parap. Negative serum Rabbit
1 96
Table 24 continued.
Agar Block Primary Antibody
Inoculated with
Source Result
A. fumigatus C. albi cans
A. fumigatus A. fumigatus
A. fumigatus A. fl a vus
A. fumigatus A. nldulans
A. fumigatus A. niger
A. fumigatus A. terreus
A. fumigatus R. oryzae
A. fumigatus Negative Serum
A. fl a vus C. al blcans
A. flavus A. fumigatus
A. flavus A. flavus
A. fl a vus A. nidulans
A. flavus A. nlger
A. flavus A. terreus
A. flavus R. oryzae
A. flavus Negative Serum
A. nldulans C. al bicans
A. nldulans A. fumigatus
A. nidulans A. flavus
A. nidulans A. nidulans
A. nidulans A. niger
A. nldulans A. terreus
A. nidulans R. oryzae
A. nidulans Negative Serum
A . niger C. al bicans
A. nlger A. fumigatus
A. niger A. flavus
A. niger A. nidulans
A. niger A. nlger
A. niger A. terreus
A. niger R. oryzae
A. niger Negative Serum
A. terreus C. albi cans
A. terreus A. fumigatus
A. terreus A. flavus
A. terreus A. nidulans
A. terreus A. niger
A. terreus A. terreus
A. terreus R. oryzae
A. terreus Negative Serum
JR. oryzae C. albi cans
R. oryzae A. fumigatus
2?. oryzae A. flavus
2?. oryzae A. nidulans
R3 & R4 
R1 
P I 
P I 
P I 
P I  
R2
Rabbit 
R3 & R4
R 
P 
P 
P 
P 
R2
Rabbit
R3 & R4 
R1 
P I 
P I 
P I 
P I 
R2
Rabbit
R3 & R4 
R1 
P I 
P I 
P I 
P I 
R2
Rabbit
R3 & R4 
R1 
P I 
P I 
P I 
P I 
R2
Rabbit
R3 & R4 
R1 
P I 
P I
+
+
+
+
+
+
+
+
+ 
+ 
I 
I 
I 
I 
+ 
+
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Table 24 continued.
Agar Block Primary Antibody Source Result
Inoculated With
R. oryzae A. nlger P I +
R. oryzae A . terreus P I —
R. oryzae R. oryzae R2 +
R. oryzae Negative Serum Rabbit —
M. hiemalis C. albicans R3 & R4 —
M. hiemalis A. fumigatus R1 -
M. hiemalis A. flavus P I +
M. hiemalis A. nidulans P I +
M. hiemalis A. niger P I +
M. hiemalis A. terreus P I -
M. hiemalis R. oryzae R2 +
= M. hiemalis Negative Serum Rabbit —
A. glauca C. albicans R3 & R4 —
A. glauca A. fumigatus R1 -
A. glauca A. flavus P I —
A. glauca A. nidulans P I -
A. glauca A . niger P I -
A. glauca A. terreus P I —
A. glauca R. oryzae R2 -
A. glauca Negative Serum Rabbit —
The cross-reactivity results are summarised in Table 25. 
The C. albicans antisera stained the sections from the C. 
albicans block (Figure 20>. However, it did not appear to 
stain the sections from the C. parapsilosis block. Rone of 
the sections from heterologous blocks stained when the C. 
albicans antisera was employed as the first antibody.
The R. oryzae antiserum did not react with any of the 
sections from the Aspergillus blocks nor the C. albicans 
sections it was tested against. The R. oryzae antiserum 
stained only when used as the first antibody for the R.
1 9 8
oryzae (Figure 21) and Mucor hiemalis sections. It did not 
stain sections containing Absidia glauca.
The A. fumigatus antiserum when employed as the primary 
antibody only stained the sections from the agar inoculated 
with A. fumigatus (Figure 22). This antiserum did;not stain 
any of the other Aspergillus sections nor did it stain any 
of the mucoraceous fungi or Candida.
Candida sections were not stained when the A. flavus 
antisera was used as the first antibody in the PAP 
= technique. However, the antiserum showed positive staining 
in sections from blocks inoculated with all the other 
Aspergillus species tested and with R. oryzae and M. 
hiemalis. The A. flavus antiserum did not react with the A. 
glauca sections,
A. nidulans antiserum did not stain any Candida or A. 
glauca sections. The antiserum did not stain A. fumigatus or 
A. terreus. but did stain sections from A. flavus and A. 
niger blocks in addition to the sections from the A. 
nidulans block.
Cross-reactions were evident when the antiserum raised 
against A. niger was used as the primary antibody in PAP 
staining. The antiserum did not stain the Candida or the A. 
glauca sections. However, the R. oryzae, M. hiemalis and all 
the Aspergillus sections which the serum was tested against 
showed positive staining (Figure 23) .
The A. terreus antiserum did not stain sections from 
blacks inoculated with fungi from genera other than
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Aspergillus. However, the A. terreus antiserum did cross- 
react with every Aspergillus species it was tested against 
in the PAP immunoperoxidase staining procedure.
Examples of the PAP staining of sections from agar blocks 
inoculated with fungi are illustrated in Figures 20, 21, 22 
and 23.
Figure 2 0 Section from an agar block inoculated with 
C .albicans stained by the PAP method using C .albicans 
antiserum as the primary antibody.
Figure 21 Section from an agar block inoculated with 
R.oryzae stained by the PAP method using R.oryzae 
antiserum as the primary antibody.
Figure 2 2 Section from an agar block inoculated with 
A.fumigatus stained by the PAP method using A.fumigatus 
antiserum as the primary antibody.
Figure 2 3 Section from an agar block inoculated with 
A.niger stained by the PAP method using A.niger 
antiserum as the primary antibody.
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4.3. Pernxl dasfi An-t1-PfiT-nxldam Staining of Tissues
Tissue samples from several cases of opportunistic fungal 
infections were stained by the PAP immunoperoxidase method. 
Homologous and heterologous antisera were employed to 
determine the degree of cross-reactivity that occurred.
Details of diseases, organs, which antiserum was used as 
the primary antibody in the staining method and the results 
of the staining are given in Table 26.
Table 26: Sections from clinical material stained by the PAP 
immunoperoxidase method with details of the organ involved, 
the suspected aetiologic agent and the antiserum used as the 
primary antibody. A/lorna denotes aspergilloma, A. fum. 
denotes A. fumigatus and C. parap. denotes C. parapsilosis.
Antiserum Disease Organ P€
A. fumigatus Aspergi11osi s (A. fum. ) Lung +
A. fumigatus Aspergillosis (A. fum. ) A/loma +
A. fumigatus Aspergillosis (A. fum. ) Brain +
A. fumigatus Aspergillosis <A . fum. ) Trachea +
A. fumigatus Aspergillosis Paranasal
sinuses
+
A. fumigatus Aspergi11osi s Kidney +
A. fumigatus Aspergi1losis Heart +
A. fumigatus Aspergillosis (.A. flavus) Lung —
A. fumigatus Candidosis < C. al bicans') Liver -
A . fumigatus Candidosis <C. albi cans) Kidney
<mouse)
A. fumigatus Candidosis Liver -
A. fumigatus Candidosis Brain —
A. fumigatus Candidosis Laryngeal
biopsy
A. fumigatus Candidosis <C. parap. ) Lung —
A. fumigatus Candidosis <C. parap. ) Kidney —
A. fumigatus Candidosis <C. parap. > Adrenal —
2 0 2
Table 26 continued
Antiserum Disease Organ Res
A. fumigatus Mucormycosis (.R. oryzae) Soft palate -
A. fumigatus Mucormycosis Brain —
A . fumigatus Mucormycosis Kidney —
A . fumigatus Mucormycosis Spleen —
A. flavus Aspergillosis <A. fum. ) Lung +
A. flavus Aspergillosis (.A. flavus) Lung +
C. alhi cans Candidosis <C. albi cans) Liver +
C. al bi cans Candidosis (C. al bleans) Kidney
(mouse)
+
C. alhi cans Candidosis Liver +
C. al bi cans Candidosis Brain +
C. al bi cans Candidosis Laryngeal
biopsy
+
C. al bicans Candidosis <C. parap. ) Lung —
C. albi cans Candidosis (C. parap. ) Kidney —
C. albi cans Candidosis <C. parap. ) Adrenal
C. al bi cans Aspergi11osi s (A. fum. ) Lung -
C. albicans Aspergillosis (.A. fum. ) A/loma +
C. albi cans Aspergillosis Lung -
C. al bi cans Aspergillosis Trachea —
C. al bi cans Aspergillosis Paranasal
sinuses
C. albicans Aspergillosis Kidney -
C. al bi cans Aspergillosis Heart —
C. albicans Aspergillosis (.A. flavus) Lung —
C. al bi cans Mucormycosis <i?. oryzae> Soft palate -
C. al bi cans Mucormycosis Brain —
c. albi cans Mucormycosis Kidney —
c. al bi cans Mucormycosis Spleen
R. oryzae Mucormycosis (.R. oryzae') Soft palate +
R. oryzae Mucormycosis Brain +
R. oryzae Mucormycosis Kidney +
R. oryzae Mucormycosis Spleen +
R. oryzae Aspergillosis (A. fum. ) Lung -
R. oryzae Aspergillosis <A. fum. ) A/loma —
R. oryzae Aspergillosis Lung —
R. oryzae Aspergillosis Trachea —
R. oryzae Aspergi11osi s Paranasal
sinuses
R. oryzae Aspergillosis Kidney —
R. oryzae Aspergillosis Heart —
R. oryzae Aspergillosis <A. fla vus) Lung —
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Table 26 continued
Antiserum Disease Organ Result
R. oryzae Candidosis (C. al bi cans') Liver —
R. oryzae Candidosis (C. albi cans) Kidney -
(mouse)
R. oryzae Candidosis Liver -
R . oryzae Candidosis Brain -
R. oryzae Candidosis Laryngeal —
biopsy
R. oryzae Candidosis (C. parap. ) Lung —
R. oryzae Candidosis (C. parap. ) Kidney —
R. oryzae Candidosis (C. parap. ) Adrenal —
As indicated in Table 26 the laboratory raised A. 
fumigatus antisera, when used as primary antibody, stained 
A. fumigatus in sections from all the infected organs 
tested (Figures 24 and 25). In addition to staining A. 
fumigatus from culture proven cases, the method confirmed 
the infection in cases where the aetiologic fungus was not 
isolated in culture. The A. fumigatus antisera did not 
stain sections from cases of A. flavus aspergillosis. No 
unstained sections from cases of aspergillosis caused by 
other Aspergillus species were available. The A. fumigatus 
antisera did not stain sections from cases of candidosis 
caused by either C. albicans or C. parapsllosls, nor any 
of the sections from patients with mucormycosis.
However, the commercial A . flavus antiserum not only 
stained the sections from A. flavus cases of aspergillosis 
but also sections of lung from non-A. flavus cases. •
The laboratory raised C. albicans antisera strongly 
stained cases of infections attributable to C. albicans 
(Figure 26) but it was less successful in staining cases
* . *-',c
Figure 24 A.fumigatus infection of lung stained 
by the PAP method using A.fumigatus as the 
primary antibody.
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Figure 25 A.fumigatus infection of trachea 
stained by the PAP method using A.fumigatus 
as the primary antibody.
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infected by C. parapsllosis. The C. albicans antisera did 
not stain tissue sections from patients with aspergillosis 
or mucormycosis.
The R. oryzae antiserum only stained fungus in tissue 
from patients with mucormycosis (Figure 27). It stained 
the fungi in all the sections, although in two of the 
cases the mucoraceous fungus implicated had not been 
isolated. The amount of cross-reaction with this antiserum 
appeared to be minimal as it did not stain the fungi in 
sections from patients with aspergillosis or candidosis.
An example of the lack of staining by this antibody when 
employed in staining heterologous fungi is shown in Figure 
28.
Figure 26 C .albicans infection of mouse kidney 
stained by the PAP method using C .albicans as 
the primary antibody. The section was weakly 
counterstained with haematoxylin.
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Figure 27 Muceraceous fungi in brain stained 
by the PAP method using R .oryzae antiserum as 
the primary antibody. The section was weakly 
counterstained with haematoxylin.
Figure 28 A .flavus infection of lung that did 
not stain by the PAP method using R .orzyae 
as the primary antibody. The section was 
weakly counterstained with haematoxylin which 
demonstrates the presence of the fungal elements.
4.4. A Mouse Model n-f Ha^ra-hnggmnng HanfHrin
Bndophthalmf ti n
4.4.1. Cumulative Mortality
The H 11 strain of C. albicans was injected into 29 
mice at the concentration to be used in the mouse model 
and the cumulative mortality was recorded. The results are 
given in Table 27. Figure 29 shows the graph of cumulative 
mortality.
Table 27: Results of the cumulative mortality of 29 mice 
inoculated with C. albicans strain H 11 at a concentration 
of lxlO6, per animal.
Days Post Number of Cumulative
challenge mice died mortality
1 0 0
2 2 2
3 3 5
4 6 11
5 9 20
6 6 26
7 1 27
8 2 29
The mouse survival time was eight days, with
mice dying on the fifth day.
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Figure 29 Cumulative mortality curve for 29 mice 
inoculated with 1 x 106 blastospores of C .albicans 
stain Hll.
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4.4.2. Fundus Examination and Photography
The mice that were examined by indirect ophthalmoscopy 
had a clinical record taken of the appearance of their 
retinae during the experimental period.
<i> 36 hours post infection
All the retinae were normal.
<ii> 3 days post infection
Mouse 1. Both eyes showed evidence of detachment of the 
retina. There was diffuse elevation of the retina as 
evidenced by an increase in parallax between the retinal 
and choroidal vessels and by blurring of the choroidal 
vessels. Segmentation <Figure 30) and tortuosity of the 
retinal vessels were seen. Segmentation is narrowing of 
the vessels, probably due to perivascular inflammatory 
cell infiltration, this could be an indication of a focus 
of infection. Tortuosity is caused by elevation and 
distortion of the vessels as a result of an underlying 
inflammation and retinal detachment.
Mouse 2. There was parallax between the retinal and 
choroidal vessels with some evidence of vein dilation. 
Dilated capillary loops were visible and there was 
tortuosity of some vessels (Figure 31).
Mouse 3. The right eye of this animal was normal but 
the left eye had a deep intra-retinal focal lesion 
superonasal to the disc.
Mouse 4. There was evidence of elevation of the retina 
in both eyes and dilated veins were visible.
Figure 30 Fundus photograph of a mouse eye 
showing segmentation of a blood vessel.
Figure 31 Fundus photograph of a mouse eye 
showing tortuosity of the blood vessels.
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<iii> 6 days post infection
Mouse 1. Mouse died during the night and was therefore 
not available for examination.
Mouse 2. There was marked segmentation of the blood 
column within the arterioles, the retina remained elevated 
above the choroid as evidenced by parallax.
Mouse 3. Both eyes in this mouse showed attenuated 
arterioles, there was no segmentation but the retinae 
appeared elevated as evidenced by parallax.
Mouse 4. There was segmentation of the vessels of both 
eyes and the right eye showed some choroidal pallor.
(iv) 8 days post infection 
Mice 1, 2 and 3 were dead.
Mouse 4. The left eye appeared normal. The right eye 
showed segmentation of the vessels.
4.4.3. Establishment of Mouse Model for Candida 
Endophthalmltie
(i) Histological Examination of Eye
Start of Experiment:- Two control mice were sacrificed 
before the mice were infected to show the appearance of 
the normal retina of a Balb/c mouse that has been stained 
by the PAS method (Figure 32).
5 minutes post challenge:- The mice that were 
sacrificed after 5 minutes demonstrated the presence of C. 
albicans in the choroid. The choriocapi1laris is the part
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of the inner choroid which contains the capillaries. 
(Figures 33 A and B).
1 hour post challenge:- There were yeast cells visible 
in the choroid and occasionally in the nuclear layers 
(Figure 34>.
36 hours post infection:- Clumps of yeast cells could 
be seen throughout the retina, in the nuclear layers and 
in the ganglion cell layer. There was some evidence of 
pseudomycelial formation and in some cases local 
disturbances of the nucleated cells (Figures 35 A and B) .
3-6 days post infection:- There was development of foci 
of C. albicans infection in the retinae of animals that 
were sacrificed during this time interval (Figure 36).
The yeast could be seen in the nerve fibre layer, 
ganglion cell layer and inner plexiform layer. There was 
protrusion of cells into the vitreous giving the retina an 
elevated appearance. The fungus became surrounded by 
inflammatory cells and resulted in the disruption of the 
cellular configuration of the retina behind and adjacent 
to the focus of infection (Figure 37).
The inflammatory nodule projected into the vitreous and 
the yeast cells and pseudomycelium were visible (Figure 
38). The nodule appeared to be an outgrowth of a 
combination of yeasts and inflammatory cells extending 
into the vitreous cavity. The mononuclear cells were 
probably derived from the adjacent vasculature and were
Figure 33 Mouse retina 5 minutes post challenge, 
stained by A) PAS and B) PAP, yeast cells are 
present in the choriocapillaris.
Figure 34 Mouse retina 1 hour post challenge, 
yeast can be seen in the inner nuclear layer.
Figure 35 Mouse retina 36 hour post challenge 
stained by A) PAS and B) PAP. Yeast is throughout 
the retina in the nuclear layers and ganglion 
cell layer. There is evidence of pseudomycelium 
formation and disturbance of the nuclear cell 
layers.
Figure 36 Mouse retina showing the development 
of a focus of infection.
Figure 37 Mouse retina demonstrating the 
disruption of the retinal layers adjacent to the 
focus of C.albicans infection.
Figure 38 Mouse retina showing a focus of 
C .albicans infection. The outgrowth contains 
yeasts, pseudomycelium and inflammatory cells.
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seen in close proximity to blood vessels. Inflammatory 
cells were also seen in the inner plexiform layer.
Overall there was localisation of the inflammatory
response to the Candida infection. It was a feature of the 
disease that there were no inflammatory cells in the 
subretinal space or underlying choroid.
There were differences in the number of sections cut 
from each eye block. In an attempt to quantify the number
of foci of infection in the mice at different time
intervals of the experiment an index of the number of 
lesions per section was calculated for each time of 
sacrifice. The results of this quantitative procedure are 
given in Table 28.
Table 28: Quantitative analysis of fungal lesions in the 
eyes of mice inoculated with C. albicans and sacrificed at 
time intervals during the experiment.
Time Number Foci Foci/ Sections Foci
of mice mouse sect
0 1 0 0 20 0
5 min 4 34 8.5 49 0. 69
1 hour 2 8 4 24 0. 33
36 hours 3 28 9. 3 36 0. 78
3 days 2 18 9 19 0. 95
5 days 5 0 0 44 0
6 days 3 12 4 18 0.67
7 days 2 0 0 18 0
8 days 3 0 0 27 0
9 days 2 0 0 18 0
210
There were no yeasts present in the mouse eyes taken at 
the start of the experiment before the mice were infected. 
There was a high number of Candida cells visible in the 
retina only five minutes after infection. The number of 
yeasts visible decreased after one hour then increased 
again at 36 hours. The numbers peaked at three days, had 
decreased by six days and on days seven, eight and nine; 
no yeasts were visible on the sections.
<ii> Histological Examination of Brain, Heart, Liver and 
Skeletal Muscle.
The pathology of the infection in these mice is 
detailed in Table 29. The mice used far detailed histology 
showed particular involvement of the brain (Figure 39), 
liver, heart (Figure 40) and skeletal muscle (Figure 41) 
ranked in that order. Other organs were examined but all 
were found to be normal insofar as there was no evidence 
of abscess formation or of fungi. However, the lungs of 
many animals were haemorrhagic.
The cerebral lesions appeared to be haematogenous 
microabcesses and consisted of focal encephalitis; in some 
animals there was associated meningitis and/or 
ventriculitis. Initially the lesions appear as necrotic 
foci surrounded by polymorphs and sometimes also 
eosinophils. As the lesions developed
monocytes/macrophages were apparent and by nine days there 
was early indication of granuloma formation.
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Figure 39 Section of mouse brain showing 
C .albicans stained by PAP. The section has been 
weakly counterstained with haematoxylin.
-i.
Figure 40 Section of mouse heart showing 
C .albicans stained by PAP. The section has 
been weakly counterstained with haematoxylin.
Figure 41 Section of skeletal muscle of mouse 
showing C .albicans stained by PAP. The section 
has been weakly counterstained with haematoxylin.
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There were many more lesions in the animals killed 
within six days than thereafter although fungi could be
demonstrated in the brain sections up to eight days. There
was a discrepancy between the number of lesions in the 
brain compared with other organs. It was usually possible 
to detect fungi in the brain lesions but this was not
always the case in other organs.
<iii> Culture of Eye and Kidney
The eyes that were taken from the mice for culture all 
yielded C. albicans apart from the control animal 
sacrificed before injection and the right eye from one 
mouse (number 6) sacrificed one hour post challenge. These 
eyes were culture negative.
The fungus was present in the eyes and was demonstrated 
by culture within five minutes after injection and 
remained present and viable in the eyes of mice for the 
duration of the experiment.
Vhen the kidneys of the mice were cultured a similar 
picture emerged. The kidneys from the control mouse and a 
mouse sacrificed one hour post challenge (number 6) did 
not grow C. albicans when cultured. All the other kidneys 
yielded C. albicans.
JTo attempt was made at this stage to quantify the 
amount of viable yeast present in the eyes or the kidneys.
2 1 3
Civ) Latex Particle Agglutination for Mannan Antigenaemia 
Blood was taken from some of the mice for Candida 
serology, the results are given in Table 30.
Table 30: Results of tests for Candida mannan 
antigenaemia, using Mercia Diagnostic latex agglutination 
kit, on mice infected with C. albicans Hll.
Time Post Mouse Ref Number Result
Infection
36 hours 9 -
36 hours 10 -
36 hours 11 -
6 days 21 +
7 days 23 +
7 days 24 +
8 days 25 +
9 days 28 +
9 days 29 —
The mice showed no evidence of having Candida mannan in 
their blood at 36 hours post infection but at 6 days all 
the mice tested were positive. The mice remained positive 
until nine days post challenge when one of the mice gave a 
negative result.
4.4.4. Differential Localisation of Yeast Between Mouse 
Eyes as Determined by Culture.
To determine if the Candida endophthalmitis was 
bilateral in the animal model, quantitative counts were 
made of the viable yeasts present in the eyes. The results 
were analysed to determine if there was an asymmetric
distribution of the organism between the eyes. The results 
are given in Tables 31, 32, and 33.
Table 31: Differential localisation of viable C. albicans 
between the eyes of mice infected with C. albicans. Group 
1.
Time Mouse L eye R eye Difference
Interval Number
6 days 6 1000 1400 400
6 days 19 350 350 0
7 days 7 562 137 425
7 days 9 350 140 210
7 days 10 - 110 110
15 days 5 50 13 37
22 days 3 — — 0
25 days 11 110 110
The values for the overall experiment were analysed as
there were insufficient numbers of mice to test the
significance of the difference in culture numbers at each 
time interval.
t = 2.69, there was a significant difference between the 
distribution of the yeast between the two eyes of each 
mouse at a 5 % level.
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Table 32: Differential localisation of viable C. albicans 
between the eyes of mice infected with C. albicans Group 
2.
Time Mouse L eye R eye Diffe]
Interval Number
2 days 23 2358 11034 8676
3 days 21 8100 14175 6075
3 days 22 7791 12150 4359
3 days 25 1788 1880 92
5 days 6 1404 1125 279
5 days 8 1062 1188 126
5 days 12 8280 180 8280
5 days 17 2106 2907 801
5 days 19 19350 6100 13250
6 days 14 882 1062 240
Overall t =2.84 with 9 degrees of freedom, therefore
there was a significant difference between the eyes a-
significance level.
Day three t = 1.97 with 2 degrees of freedom and there was 
no significance between the two eyes of the mice 
sacrificed on this day.
Day five t = 1.7 with 4 degrees of freedom therefore there 
was no significant difference between the distribution 
between the eyes.
21 6
Table 33: The differential location of viable C. albicans 
between the eyes of mice in group 3 at different time 
intervals after inoculation with C. albicans.
Time Mouse L eye R eye Diffe
Interval Number
5 min 26 1062 900 162
5 min 27 918 504 414
5 min 28 756 954 198
5 min 29 918 504 414
5 min 30 756 954 198
1 hour 1 684 932 248
1 hour 2 1170 206 964
1 hour 3 782 504 278
1 hour 4 612 234 378
1 hour 5 1080 792 288
6 hours 16 1062 1360 298
6 hours 17 1484 990 494
6 hours 18 1050 486 564
6 hours 19 288 756 468
6 hours 20 2016 1350 666
24 hours 6 0 0 0
24 hours 7 90 82 8
24 hours 8 218 414 196
24 hours 9 108 162 54
24 hours 10 144 198 54
48 hours 11 1360 750 610
48 hours 12 1160 970 190
48 hours 13 0 0 0
48 hours 14 380 380 0
48 hours 15 1140 40 1100
72 hours 21 1570 460 1110
72 hours 22 630 650 20
72 hours 23 140 940 800
72 hours 24 100 200 100
72 hours 25 570 720 150
Overall t=6.18 with 27 degrees of freedom, therefore there 
is a significant difference in the numbers of yeasts 
between the two eyes at a 5% significance level.
At 5 minutes post infection t=4.9 with 4 degrees of 
freedom which is significant at the 5% level.
217
One hour post infection t=3.19 for 4 degrees of freedom, 
therefore there was a significant difference between the 
eyes at a 5% level.
Six hours post infection t=8.2 with four degrees of 
freedom which is significant at the 5% level.
At 24 hours t=1.77 with 5 degrees of freedom and shows no 
significant difference.
At 48 hours t=1.79 with 4 degrees of freedom and shows no 
significant difference at the 5% level.
72 hours post infection t=2.23 with 4 degrees of freedom 
which is not significant at the 5 % level.
The results from the three groups of mice were examined 
collectively. The results are given in Tables 34 and 35.
Table 34: The significance of the difference between the 
localisation of yeast in mice eyes at different time 
intervals after challenge with C. albicans.
Time Group t value Signif i<
5 min. 3 4. 9 Yes
1 hour 3 3. 19 Yes
6 hours 3 8.2 Yes
24 hours 3 1. 77 Vo
48 hours 3 1. 79 Vo
3 days 3 2.23 Vo
3 days 2 1.97 Vo
5 days 2 1.7 Vo
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Table 35: Means of quantitative counts of C. albicans 
cultured from both eyes of mice sacrificed at different 
times post challenge.
Time post 
Challenge
5 minutes 
1 hour
6 hours
24 hours 
48 hours 
3 days
5 days
6 days
7 days 
15 days 
22 days
25 days
Mean Number of 
Colonies per Eye
1645
1399-
3050
345
3754
6483
8740
1681
433
63
0
0
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4.4.5. Determination of Candida Antigenaemia in the Mouse 
Model
Blood was taken from 29 mice sacrificed at different 
times after inoculation with. C. albicans H 11. The sera 
from the mice were tested for Candida antigenaemia using 
two latex agglutination kits. The results obtained using 
the two kits were compared and the results are given in 
Table 36.
Table 36: Results of latex tests for Candida antigenaemia 
for the sera from mice in a model for C. albicans 
endophthalmitis. HD denotes not done.
Time Post Number of Mercia Immy
Challenge Mice Tested + — +
5 min 5 0 5 2 3
1 hour 5 0 5 4 1
6 hours 5 0 5 5 0
24 hours 5 1 4 5 0
48 hours 4 3 1 3 0
72 hours 5 4 1 5 0
The Mercia kit did not indicate the presence of mannan 
in the mouse sera until 24 hours post challenge nor did it 
show all the mice to be positive at any time. The Immy 
test gave a positive result for 2 out of 5 mice after only 
five minutes post inoculation and showed all mice to be 
positive after six hours.
2 2 0
In tests for false positive results with latex 
agglutination kits.
The reagents were tested against sera from uninoculated 
control mice to discover if any false positive results
occurred. The results are detailed in Table 3'
Table 37: Results of test for false positive :
agglutination.
Mouse Weight Mercia Immy
Humber <S> Latex Latex
1 17. 9 — +
2 22. 0 - +
3 17. 1 - +
4 20. 4 - -
5 18. 4 - -
6 19. 9 - +
7 21. 2 - +
8 18.6 - -
Vith the control animals the Mercia kit gave 100 % 
negative results. However, the Immy kit gave 62.5% false 
positive results.
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4.5. Wplrfemlo! off leal Study rrf PraRimiRd Candida 
Bndopht-balrnl-hlf; Tn Harnln Abufifira
Various aspects of the aetiology of an outbreak of 
Candida endophthalmitis in Glasgow heroin addicts were 
examined. The most likely sources of the yeast appeared to 
be; the addicts' commensal flora, the injection 
paraphernalia, the street drug or the diluent employed in 
prepar ing the drug for injection.
4.5.1. Culture of Specimens and Paraphernalia from 
Glaswegian Heroin Abusers.
Several pieces of injection paraphernalia and clinical 
specimens from Glaswegian heroin addicts with presumed 
Candida endophthalmitis were cultured in an attempt to 
discover the possible source of infection. The details of 
the items and samples cultured are given in Table 12.
There were 33 samples cultured from 17 patients. Five 
were vitrectomy specimens from five different patients, 
one was a scalp biopsy, there were nine throat swabs and 
mouth washes from six addicts and two faecal samples from 
different patients. Four of the addicts donated their 
syringes, plungers and needles for culture. Five plastic 
lemons, the juice of which was used as a diluent, were 
provided by different addicts; one spoon and one sample of 
heroin were also obtained.
CULTURE FROM ADDICTS SYRINGE
Figure 42 C .parapsilosis cultured from 
addict's syringe.
CULTURE FROM ADDICTS SYRINGE
Figure 43 Culture of addict's syringe which 
yielded C .albicans.
.Figure 44 C .albicans culture from a "Jif" lemon 
provided by an addict.
Figure 4 5 Culture of C .albicans from an addict's 
"Jif" lemon.
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Thirteen of the samples did not grow yeasts or 
filamentous fungi when cultured. A Penlci11ium sp. was 
isolated from one syringe. Two sets of injection 
paraphernalia grew A. fumigatus. A Trichosporon sp. and a 
Rhodotorula rubra were isolated from two different 
syringes. C. parapsilosls was isolated twice, once from a 
syringe (Figure 42) of one addict and once from a faecal 
sample of another.
Thirteen of the samples yielded C. albicans on culture. 
These were from vitrectomy specimens <2>, the scalp biopsy 
(1), the throat swabs and mouth washes (6), and the faecal 
samples (1), a syringe (1) (Figure 43) and plastic "Jif" 
lemons (2) (Figures 44 and 45).
4.5.2. Biotyping of C. albicans Isolates From Heroin 
Addicts.
The isolates of C. albicans cultured from clinical 
specimens and injection paraphernalia were assigned a 
number and preserved in silica gel and sterile distilled 
water. The C. albicans isolates were fingerprinted by the 
Leicester biotyping method. The results of growth on the 
first five agars confirmed the indentity of the yeasts 
while the growth patterns on the other nine agars gave the 
biotype number as explained in Table 14. Table 38 gives 
the results of growth on the plates which were inoculated 
in duplicate with three colonies of each isolate. Table 39
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details a summary of the results and the biotype number 
for the isolates tested by this method.
Table 39: Biotypes of C. albicans isolated from heroin 
addicts and their injection paraphernalia.
Isolate Addict Source Biotype
Number Number Number
2 7 Lemon 1 5  3
4 9 Scalp 2 1/5 3
5 15 Throat Swab 1 5  3
6 18 Mouthwash 1 5  3
7 18 Mouth Swab 1 1/5 3
8 19 Mouth Swab 1 5 3/7
10 22 Vitreous 2 1 4
11 22 Vitreous (pellet) 1 5  5
12 22 Vitreous (pellet) 1 5  5
13 23 Mouthwash 4 5 5
14 23 Faeces 4 5 5
15 23 Mouthwash 4 5 5
The biotype results are internally consistent, apart 
from addict 22 who yielded isolates H10, Hll and H12. 
Biotype 153 was found to be the most common as it 
accounted for five of the isolates from five different 
addicts.
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4.5.3. Inhibition of Yeast by Diamorphine Hydrochloride
The role of street heroin in the outbreak of presumed 
Candida endophthalmitis was investigated. Samples of 
dealers and pushers heroin were cultured, and the growth 
of yeast in the presence of diamorphine hydrochloride was 
examined.
<i> Culture of Street Drug
Six samples of pushers drug and a sample of dealers 
drug, supplied by the Glasgow Drug Squad, were cultured on 
glucose peptone agar. The results are given in Table 40.
Table 40: Results of culture of samples of heroin supplied 
by the Glasgow Drug Squad.
Sample
Dealer 
Pusher 1 
Pusher 2 
Pusher 3 
Pusher 4 
Pusher 5 
Pusher 6
Organisms 
Recovered—Drug
A. fumigatus
Organisms 
Recovered-Bag
A. fumigatus
Bacteria 
A. fumigatus
C. albicans was not isolated from any of the samples or 
their containers. A. fumigatus was isolated from the drug 
on one occasion and was grown from the bags twice.
Bacteria were grown from one of the packets.
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(ii) Antifungal Activity of Diamorphine Hydrochloride 
Sensitivity Plates - Powdered Drug.
The results of powdered diamorphine hydrochloride on 
the growth of yeast are given in Table 41. The results 
were consistent regardless of which agar media was used.
Table 41: Results of sensitivity tests of yeast isolates 
to powdered diamorphine hydrochloride, including tests for 
fungicidal activity by incubation of core of agar from 
within the inhibition zone. "+" indicates the presence of 
a zone or growth of yeast from the zone.
Yeast Drug Incubation Zone Growth
Ve i ght Temperature of Zone
SAC 1 1 mg 28~C + +
SAC 1 1 mg 37-C + +
SAC 1 5 mg 28~C + —
SAC 1 5 mg 37~C + —
SAC 1 10 mg 28<=,C + —
SAC 1 10 mg 37<=‘C + —
SAC 2 1 mg 28°C + +
SAC 2 1 mg 37<=,C + +
SAC 2 5 mg 28°C + —
SAC 2 5 mg 37<=,C + —
SAC 2 10 mg 28°C + —
SAC 2 10 mg 37~C +
CA 6 1 mg 28~C + +
CA 6 1 mg 37<=,C + +
CA 6 5 mg 28~C + —
CA 6 5 mg 37<=’C + +
CA 6 10 mg 28~C + —
CA 6 10 mg 37<=,C +
“
CA 9 1 mg 28~C + +
CA 9 1 mg 37°C + +
CA 9 5 mg 2Q~C + +
CA 9 5 mg 37~C +
CA 9 10 mg 28-C + —
CA 9 10 mg 37c=,C +
B Y 1 mg 28~C + +
B Y 1 mg 37~C + +
B Y 5 mg 28c,C +
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Table 41 continued
Yeast Drug Incubation Zone Growth
Weight Temperature of Zone
B Y 5 mg 37~C + _
B Y 10 mg 28~C + —
B Y 10 mg 37~C + —
H 2 5 mg 37~C + —
H 2 10 mg 37~C + —
H 3 5 mg 37°C + —
H 3 10 mg 37°C + -
H 4 5 mg 37~C + +
H 4 10 mg 37~C + —
H 5 5 mg 37~C + —
H 5 10 mg 37-C + —
H 6 5 mg 37~C + —
H 6 10 mg 37~C + -
H 7 5 mg 37~C + -
H 7 10 mg 37~C + -
H 8 5 mg 37~C + -
H 8 10 mg 37~C + -
H 9 5 mg 37°C + -
H 9 10 mg 37~C + -
H 10 5 mg 37~C + -
H 10 10 mg 37~C + -
H 11 5 mg 37~C + -
H 11 10 mg 37°C + -
H 12 5 mg 37°C + -
H 13 10 mg 37~C + -
H 14 5 mg 37~C + -
H 14 10 mg 37~C + -
H 15 5 mg 37~C + +
H 15 10 mg 37°C + -
All the yeast isolates tested were sensitive to 
diamorphine hydrochloride regardless of the temperature of 
incubation or the media used (Figures 46 and 47>. The 
results were the same if actively growing or stationary 
phase yeasts were tested. There was some evidence of 
fungicidal activity. On the occasions when the excised 
zones showed evidence of yeast growth, the inhibition zone 
was smaller than the cork borer and carry over of viable 
yeast probably occurred.
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Sensitivity Plates - Liquid Drug
The results of plates seeded with yeast containing 
wells filled with various concentrations of diamorphine 
hydrochloride are given in Table 42.
Table 42: Growth of yeast around wells containing 
diamorphine hydrochloride.
Yeast Drug
Concentrat i on 
<pg/ml)
G
SAC 1 10 +
SAC 1 100 +
SAC 1 1000 +
SAC 1 10000 +
SAC 2 10 +
SAC 2 100 +
SAC 2 1000 - +
SAC 2 10000 +
CA 6 10 +
CA 6 100 +
CA 6 1000 +
CA 6 10000 +
CA 9 10 +
CA 9 100 +
CA 9 1000 +
CA 9 10000 +
None of the isolates tested, even the highest 
concentrations, showed sensitivity to the drug. There were 
no zones of inhibition surrounding the wells.
Incorporation Plates
Agar plates incorporating diamorphine hydrochloride 
were spot inoculated with yeasts. The results of growth of 
the yeasts on these plates are given in Table 43.
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Table 43: Growth of yeasts on agar incorporating 
different concentrations of diamorphine hydrochloride.
Yeast Drug Growth
Concentrat i on 
<mg/ml>
CA 6 5 +
CA 6 10 +
CA 6 100 —
CA 9 5 +
CA 9 10 +
CA 9 100
SAC 1 5 +
SAC 1 10 +
SAC 1 100 —
SAC 2 5 +
SAC 2 10 +
SAC 2 100 -
B Y 5 +
B Y 10 +
B Y 100 -
All the isolates grew on agar containing 5 mg/ml and 10 
mg/ml of diamorphine hydrochloride. However, none of the 
yeasts grew on the agar containing 100 mg/ml.
Broth Dilution Experiments - Minimum Inhibitory 
Concentrations (MIC) .
The contact time leading to the death of yeasts was 
determined for different concentrations of diamorphine 
hydrochloride. The results are detailed in Table 44. The 
killing times for the isolates when tested by this method 
were for both the C. albicans strains; more than 24 hours 
for up to 10 mg/ml, 3 - 4  hours up to 250 mg/ml decreasing 
to 2 - 3  hours for CA9 at 500 mg/ml. The killing times for 
the S. cerevisiae strains varied with the concentration of
2 3 0
Table 44 Presence of growth (+) of yeast isolates after 
various contact times with diamorphine hydrochloride.
Yeast Drug Cone. Time (hours)
Isolate mg/ml. 7 I I " '  ~
0 + + + + + +
2.5 + + + + + +
5 + + + + + +
10 + + + + + +
100 + + - + ' - -
250 + + + + - -
500 + + + . + - -
0 + + + + + +
2.5 + + + + + +
5 + + + + + +
10 + + + + + +
100 + + + + - -
250 + + + + - -
500 + + + - - -
0 + + + + + +
2.5 + + + + + +
5 + + + + + +
10 + + + + + +
100 + + + - - -
250 + + + - - -
500 - - - - - -
0 + + + + + +
2.5 + + + + + +
5 + + + + + +
10 + + + + - -
100 + - - - - -
250 + - - - - -
500 - - - - - -
0 + + + + + +
2.5 + + + + + +
10 + + + + + +
100 + + + + - -
250 + + + - - -
500 + + - - - -
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the diamorphine hydrochloride. SAC 1 was the least 
sensitive, with a killing time of more than 24 hours for 
10 mg/ml and less, for 100 and 250 mg/ml the killing time 
was 2 — 3 hours but 500 mg/ml killed the yeast within 30 
minutes. SAC 2 was killed after 1 hour in contact with 
diamorphine hydrochloride at 100 and 250 mg/ml, 500 mg/ml 
killed the yeast within 30 minutes. The shop bought bakers 
yeast was the most robust, it was killed only after 4 
hours exposure to the drug at 100 mg/ml, 250 mg/ml killed 
the strain after 3 hours and 500 mg/ml was fungicidal 
after 2 hours.
The HICS for the yeasts used in this study were 
determined by a broth dilution method. Table 45 lists the 
results.
Table 45: Growth of yeast strains after 24 hours in 
culture media containing diamorphine hydrochloride.
Yeast Isolates 
Drug CA6 CA9 SAC1 SAC2 BY
Cone, mg/ml
0 
10 
20 
25 
30 
40 
50
The range of MICs for the C. albicans strains is 40 - 
50 mg/ml which is higher than that of the S. cerevisiae 
strains which had XICs of the order of 20 — 25 mg/ml. The
+ + + + +
+ + + + +
+ + + + +
+ + - - +
+ +
+ +
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S. cerevisiae purchased from the supermarket as bakers 
yeast had a MIC in the range 25 -30 mg/ml.
Broth Dilution Experiments — ICs© Determinations.
The length of time that killed the yeast was determined 
for different concentrations of diamorphine hydrochloride.
The optical densities after 24 hours incubation were 
measured for the yeasts transferred to drug free media 
after various times in contact with the drug. Graphs of 
these optical densities <0Ds> after different contact 
times were platted for each drug concentration. Figure 48 
illustrates the ODs for the isolates tested with 100 mg/ml 
diamorphine hydrochloride.
Table 46 details the highest concentration at which 
yeasts were able to grow in drug free media, after being 
transferred, at various times, from media containing 
diamorphine hydrochloride. The MICs for the isolates 
tested this way were:-
CA 6 40 mg/ml CA 9 40 mg/ml
SAC 1 20 mg/ml SAC 2 20 mg/ml
Figure 49 shows graphs of some IC3 0  determinations for 
Isolates from heroin addicts.
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Table 46; Details of the highest concentration at which 
growth of yeast occurred after various contact times with 
diamorphine hydrochloride.
Yeast Isolates
Contact Time CA 6 CA 9 SAC 1 SAC 2
<Hours>
100 200 100 100
1 75 100 75 75
2 75 100 20 50
3 75 100 20 40
4 75 100 30 30
5 75 100 30 30
6 50 75 20 20
8 50 75 20 10
40
e
cor-
in
4->
(d
20Q
O
 Q
2 4 6 8
Contact Time (Hours)
Figure 48 Survival of C .albicans CA6 (^ ), CA9 ( ■ ) 
and S .cervisiae SAC1 ( □ ), SAC2 ( • ) in diamorphine 
hydrochloride at lOOmg/ml.
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Figure 49 IC^q determinations for addicts isolates of 
C.albicans.
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4.5.4. Growth, of Fungi in Lemon Juice.
The juice from twenty seven plastic HJif" lemons was 
cultured to detect the presence of fungi. Six of the seven 
lemons donated by friends and colleagues were culture 
negative. The seventh, which was mare than a year old, 
grew a yeast. The yeast was not one of the common 
pathogenic species and eluded attempts at identification 
by the API 20C system and conventional fermentation and 
assimilation methods.
Fine of the lemons purchased in shops in the Castlemilk 
locality were within their "best by" dates, two were at 
their "best by "dates and one was beyond its "best by " 
date, the juices from these lemons were all negative on 
culture. Three of the lemons had no date tags and appeared 
to be rather old, moreover the lemons showed signs of 
leakage. These three lemons were purchased at the Centra 
food store in the middle of the Castlemilk housing estate. 
When cultured, the juice from two were negative but the 
the juice from the third grew A. niger.
Five plastic lemons from addicts were cultured. Three 
were culture negative but the other two yielded C. 
albicans. One of these C. albicans isolates was 
investigated further by the Leicester biotyping method.
<i> Survival of C. albicans in Lemon Juice,
The length of time C. albicans remains viable in 
contact with juice from plastic lemons was investigated.
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New Juice, old juice and new juice which had been steamed 
were inoculated with C. albicans and the survival was 
studied. The results are given in Tables 47 and 48.
Table 47: Survival <+) of C. albicans in old <0> , new <N> 
and steamed lemon juice after different contact times. 
Glucose peptone broth was employed as a control <C).
Juice
Contact
Time Time Steamed
<Hours) C 0 N % 1 2 3 4 5 6 7 8
1 + + + + + + + + + + + + +
2 + + + + + + + + + + + + +
3 + + + + + + + + + + + + +
4 + + + + + + + + + + + + +
5 + + + + + + + + + + + + +
6 + + - + + + + + + + + + +
12 + + - + + + + + + + + + +
24 + + — + + + + + + + + + +
C. albicans could be grown in old and steamed lemon 
juice but was killed after five hours in new juice. Even a 
short steaming <15 minutes) appeared to allow the yeast to 
grow in the lemon juice.
Figure 50 shows the petri dish cultures of the 
dilutions of the surviving yeasts. The survival curve of 
the C. albicans in the three types of lemon juice is 
illustrated in Figure 51. The graph shows the number of 
viable C. albicans present in the juice, after 12 hours 
incubation. The number of viable yeasts present in the old 
and steamed lemon juice were comparable but after 12 hours 
incubation the yeast appeared to grow slightly better in
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Figure 51 Survival curves of C.albicans in new ( ■ ), 
old (□ ) and steamed (O) lemon juice.
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the old. lemon juice than the lemon Juice which had been 
steamed for one hour. C. albicans could not survive in the 
new lemon juice for longer than five hours.
The length of time the new lemon juice was steamed had 
some effect on the number of viable yeast present. The 
longer the juice was steamed the less able it became to 
support the growth of C. albicans (Figure 52).
<ii> Content of Sulphur Dioxide In Lemon Juice
The SOa content of seven samples of lemon juice was 
determined by a distillation method and the results, 
expressed as parts per million (ppm), are given in Table 
49.
Table 49: Levels of SOa in samples of lemon juice.
Best By Date Condition SOa Content
Before Date 2 weeks old 92. 1
Before Date 2 weeks old 83.4
New Steamed 5 minutes 53.1
New Steamed 15 minutes 26.9
New Steamed 30 minutes 0
Beyond Date 5 Months Past Date 0
Beyond Date 7 Months Past Date 0
The permitted level of preservative for lemon juice is 
350 ppm. However, the actual level in all of the lemons 
tested was far below this. The level of SOa in heated 
juice was considerably less than the new juice and after 
30 minutes steaming SOa could not be detected. The level
2 3 8
of the SOa was too low for detection in the two lemons 
which were beyond their "best by date".
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Figure 52 Number of viable C .albicans present after 
12 hours culture in juice which had been steamed for an 
increasing amount of time before inoculation.
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The advent of immunosuppressive therapy for the 
treatment of cancers and/'prevention of rejection in 
transplant patients, in conjunction with longterm 
antibiotic therapy has resulted in an increase in 
opportunistic fungal diseases in man. Diagnosis of these 
infections by serological or antigenic detection methods 
is not always satisfactory. In many cases the definitive 
diagnosis is only made at autopsy when there may be no 
unfixed material available for culture and the 
identification of the aetiologic agent can only be made by 
histological examination of tissue sections.
The conventional staining techniques of Periodic acid 
Schiff's and methenamine silver are adequate for detecting 
the presence of fungi in tissue. However, these methods 
seldom distinguish one fungus from another. The various 
fungi may closely resemble each other in tissue and the 
ideal staining technique would be one which was able to 
stain the infecting fungus in such away that it allowed 
the fungus to be identified accurately.
This study examined a peroxidase anti-peroxidase <PAP> 
immunological staining method as a means of identifying 
fungi in tissue sections. The PAP technique was chosen as 
it is one of the more sensitive of the immunoperoxidase 
methods. DAB was employed as the substrate because it 
allows the staining to be viewed using a light microscope 
and since the reaction product is permanent the slides may 
be kept indefinitely.
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The selectivity and the sensitivity of the antisera 
employed in the technique had to be ascertained by 
screening for cross-reactions using several different 
methods. These included a novel agar block technique 
developed to test the reagents in the staining method 
without interference from tissue binding or endogenous 
peroxidase activity. The agar block staining method 
successfully simulated three dimensional fungal growth 
through tissue and enabled cross-reactivity testing with 
fungi for which positive control material was not 
available.
The PAP staining method was also applied in the 
investigation of an animal model of endogenous C. albicans 
endophthalmitis. The model was evolved to investigate the 
pathology of the disease after an outbreak of the 
infection in heroin addicts in Glasgow.
Development of an Immunohistochemical Staining Method for 
the Recognition of Fungal Elements In Tissues
The accuracy of any detection system involving the use 
of antibodies, is only as reliable as the specificity and 
sensitivity of the antibodies employed.
The successful application of the immunohistochemical 
staining method described in this work was dependent on 
the strength and specificity of laboratory produced and 
commercial rabbit antisera raised against fungal antigens.
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The strength and specificity of both the commercial and 
the laboratory produced antisera were determined by 
several methods. These included: counter— 
Immunoelectrophoresis, agar gel double diffusion, ELISA 
for the detection of antibody, ELISA for the detection of 
antigen and a PAP immunostaining method on sections from 
agar blocks.
When tested by CIE all antigens of the Aspergillus 
species reacted with their homologous antisera and also 
with some of the heterologous sera. The A. niger antigen 
was the least cross-reactive, and demonstrated a reaction 
only against the homologous serum.
By agar gel double diffusion none of the A . fumigatus 
antigens cross-reacted with antisera raised to C. albicans 
or R. oryzae.
In an ELISA system for the detection of antibody, the 
ability of the antigens to cross-react with the antisera 
from other species or genera was dependent on the 
concentration of the solid phase antigen. For A. flavus 
and A. niger, if the concentration of the solid phase 
coating antigen was increased from 3 mg/ml to 30 mg/ml 
then there was increased cross-reactivity. This may have 
been due to an increase in the number of sites to which 
the heterologous antiserum could bind resulting in a 
detectable colourmetric reaction. The antigens of 
aspergilli, other than the A . fumigatus antigen, could not
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be detected by A. fumigatus antisera using an ELISA for 
antigen detection.
The staining results from the Aspergillus blocks 
presented a complex picture as cross—reactions within the 
genus were evident with the PAP staining method. All the 
sections from blocks inoculated with Aspergillus species 
were stained by their homologous antisera and, apart from 
two instances, by all the heterologous Aspergillus 
antisera. No staining was seen when either C. albicans or 
R. oryzae antisera were used as the primary antibody. This 
technique indicated a lack of cross-reactivity of the non- 
Aspergillus antisera with all of the aspergilli tested. 
Moreover, the method demonstrated that an antiserum raised 
against one Aspergillus species would cross-react with 
other aspergilli and lead to positive staining.
The A. fumigatus antigens consistently reacted against 
the A. fumigatus, A. flavus, and A. niger antisera 
regardless of which test method was employed. These same 
antisera also cross-reacted with A. fumigatus in the agar 
block staining method. A. fumigatus antigens cross­
reacting with A. flavus antisera has been recorded before 
<Kim and Chaparas, 1979).
The A. flavus antigen varied in its pattern of cross­
reactions depending on which method was employed although 
in all cases it reacted with its homologous antisera and 
with the A. niger antisera. A. nidulans antigen showed no 
reactions with the non aspergilli antisera and little
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cross-reaction with the other aspergilli by antibody-ELISA 
and CIE. However, the A. nldulans sections from the agar 
blocks were stained by all the Aspergillus antisera with 
the exception of A . fumigatus. The A. niger antigens only 
produced precipitins against the homologous sera when 
tested by the CIE system. The antigen however did show 
considerable cross—reactivity with heterologous 
Aspergillus antisera in the anti body-EL ISA system and when 
employed as the antigen in the agar block staining. This 
is in contrast to other investigators <Kim and Chaparas, 
1979) who found A. flavus and A. niger antigens to have a 
high degree of specificity. However these workers were 
using partially purified antigens and they attributed the 
majority of the cross-reactions to the polysaccharide 
portion of the mycelial extract.
A. terreus appeared to be the antigen which elicited 
most response from the heterologous antisera. Although it 
was not so reactive in the CIE system, giving precipitins 
only against A. terreus and A. fumigatus. In the antibody- 
ELISA and agar block staining method it cross-reacted with 
all the Aspergillus antisera and, in the antibody-ELISA 
system, even the C. albicans antisera.
That there was such a great deal of cross-reactivity is
not suprising since the extracts were all water soluble 
components prepared from whole mycelium. There is some
evidence to suggest that wall located antigens are more /
specific when tested against rabbit antisera. However,
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when these cell wall derived antigens were tested against 
patient sera, cross-reactivity was evident, indicating 
shared antigenic determinants (Hearn, Proctor and 
M*ckenzie, 1980).
When tested by CIE, the laboratory raised A . fumigatus 
antisera did not cross-react with antigens of other 
genera, although they gave precipitin bands when tested 
against some of the aspergilli. The commercial Aspergillus 
antisera demonstrated variable cross-reactivity. The A. 
terreus antisera only gave a precipitin line against its 
homologous antigen but the A. niger antibody showed cross­
reactivity against antigens of all the aspergilli apart 
from A. terreus. The A. fumigatus antisera did not cross- 
react with the antigens of the other genera when tested by 
double diffusion.
There was a great deal of cross-reactivity of the 
antisera demonstrated by the antibody-ELISA technique. All 
of the Aspergillus antisera showed some cross-reactivity 
with heterologous antigens within the genus. The 
commercial antisera even demonstrated some cross-reactions 
with C. albicans antigens. ELISA for antigen detection did 
not reveal any cross—reaction of the rabbit anti—A. 
fumigatus anti serum with any of the antigens from the 
other aspergilli. However, this may be attributable to the 
sensitivity of the test.
The laboratory raised antisera proved to be more 
specific than the commercial antisera in all of the tests.
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The laboratory produced A. fumigatus sera was specific and 
stained only the A. fumigatus containing sections. The 
commercial Aspergillus antisera showed a great deal of 
cross-reactivity. This cross-reactivity was also 
demonstrated by the other techniques employed in this 
study and is probably due, in part, to a vast amount of 
antigenic determinants ubiquitous to the genus 
Aspergillus. Based on the findings of this and other work 
this cross-reactivity may be unavoidable if the antigens 
used to raise the antisera are crude preparations. Only if 
antigens which are peculiar to each species can be found 
will there be any improvement in the antisera raised to 
the aspergilli. Moreover, the antigenic factors must be 
present in all the strains of that species if the anti sera 
is to be of any value in the diagnosis of clinical 
disease. If the antisera were only active against some 
strains of the Aspergillus species then lack of 
immunohistochemical staining of the fungi could result and 
an incorrect diagnosis could be made.
The commercial Aspergillus antisera showed more cross- 
reactivity than the laboratory raised antisera. This may 
be due to the hyperimmunity of the commercial rabbit 
antisera or the possibility that the sera were pooled from 
a number of rabbits, which would increase the possibility 
of introducing antibodies to the other aspergilli. The 
rabbits may have natural antibodies to the aspergilli the 
spores of which are frequently found in hay used as a
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supplement to rabbit diets. The cross-reactions with 
Candida antigens may be due to some intrinsic antigenic 
similarities between the genera Candida and Aspergillus as 
has been suggested by Magaldi and M*ckenzie <1984).
All the C. albicans antigens were detected by the C, 
albicans antisera by CIE. No cross-reactivity occurred 
with R. oryzae or A. fumigatus antisera. The C. 
parapsilosis antigen cross-reacted with the C. albicans 
antisera but not the A . fumigatus antisera. The C. 
albicans antigen only reacted with its homologous antisera 
when tested by agar gel double diffusion.
The C. albicans antibodies all reacted with the 
homologous antigens using ELISA for antibody detection but 
not with the R. orzyae or A. fumigatus antisera. However, 
there was evidence of cross-reactivity with three of the 
commercial antibodies. This phenomenon again may be due to 
hyperimmunity of the sera or common antigenic features 
between the aspergilli and Candida. It is significant that 
this occurred only with the commercially produced 
antisera.
Sections from agar blacks inoculated with C. albicans 
stained only with the homologous antisera. The sections 
from the C. parapsilosis inoculated block were not stained 
by any of the antisera tested, including the C. albicans 
antisera. This was in contrast to the results obtained by 
CIE and the antibody-ELISA which demonstrated that the C. 
albicans antisera could bind to some C. parapsilosis
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antigens. The antigenic sites expressed by the C. 
parapsi1osis in the block were somehow different from 
those expressed by the solutions of lyophilysed antigen 
prepared from this yeast. It is possible that the antigen 
solutions exposed a greater number of sites for binding 
antibody than did the relatively small amount of yeast 
present in the sections. The antigenic determinants of 
Candida appeared to be specific for that genus when PAP 
staining was employed. Little cross-reactivity was 
demonstrated with members of this genus and heterologous 
antibodies.
The C. albicans antigens demonstrated no cross­
reactivity by CIE or double diffusion. However, the 
antibody ELISA demonstrated cross-reactions with three of 
the four commercial Aspergillus antibodies. This cross­
reactivity may be due to the sensitivity of the ELISA 
technique but since the Candida antigens were not tested 
against the commercial antisera by CIE or double diffusion 
the results could not be compared. The C. parapsilosis 
antigen did form a precipitate with the C. albicans sera 
in CIE. These results suggest the presence of shared 
antigenic factors between C. albicans and C. parapsilosis. 
Although only one common antigenic factor is reported by 
Miyakawa et al., <1986) these workers could not
demonstrate agglutination of C. parapsilosis and C. krusei 
using monoclonal antibodies to C. albicans.
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The C. albicans antisera did not cross-react with 
either the R. orzyae or A. fumigatus antigens in the CIE 
test system. The C. albicans antisera showed no evidence 
of cross-reactivity with the heterologous sera but gave 
good precipitins with the C. albicans antigen by agar gel 
double diffusion.
The C. albicans anti sera reacted well with the C. 
albicans antigens in the ELISA antibody detection system. 
The antisera also reacted with the C. parapsilosis 
antigen. There was no cross-reactivity with the A. 
fumigatus or R . orzyae antigens. However, there were 
cross-reactions with the A. flavus and A. niger antigens 
at the higher concentrations tested.
The laboratory produced C. albicans antisera proved to 
be the most specific in the PAP staining method. The C. 
albicans antisera stained the C. albicans sections but 
they did not stain any of the sections with heterologous 
fungi.
The C. albicans antibody demonstrated strong reactions 
to its homologus antigens. Cross-reactivity with the C. 
parapsilosis antigen was seen in the CIE and antibody— 
ELISA systems. Monoclonal antibodies to exoantigens of C. 
albicans have been used for the serological analysis of 
yeast isolates by the western blot method. The work 
demonstrated cross—reactions of C. albicans monoclonal 
antibodies with C. parapsilosis antigens even though the
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C. parapsilosis antigen had a different molecular weight 
<Polonelli and Morace, 1986).
The C. albicans antisera cross-reacted with the higher 
concentrations of the A. niger and A. flavus antigens 
when tested in the antibody—ELISA system. These results 
may be another indication that Candida and Aspergillus may 
express antigens common to both genera.
The R. oryzae antigen only reacted with its homologous 
antserum in the CIE system. Double diffusion showed no 
evidence of cross-reactivity of the Rhizopus antigen when 
tested against heterologous antisera but it did form a 
precipitin line with the homologous antiserum.
The ELISA system for antibody detection showed that the 
R . oryzae antigen reacted well with its homologous 
antiserum. The only heterologous antiserum with which it 
demonstrated cross-reactivity was A. flavus.
The mucoraceous fungi varied in their staining 
response. Absidia glauca hyphae which stained well by PAS 
did not stain with any of the antisera tested in the PAP 
system therefore no cross-reactivity was demonstrated. The 
sections containing hyphae of K. hiemalis and R. oryzae 
stained with the R. oryzae antiserum and when some of the 
commercial Aspergillus antisera were employed.
There was only one Rhizopus antigen investigated and it 
appeared to be specific. The only evident cross-reaction 
was with a commercial antiserum and it may have been the 
result of a natural antibody present in the rabbits.
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CIB did not demonstrate any cross—reactivity of the R. 
oryzae antiserum with heterologous antigens. The antiserum 
only produced precipitin bands with the R. oryzae antigen 
when tested by double diffusion. The R. oryzae antiserum 
did not cross-react with any of the heterologous antigens 
it was tested against by this method but it did 
demonstrate strong reactivity with the homologous antigen, 
demonstrating the specificity of the antisera.
The R. oryzae antiserum appeared to be the most 
specific of all the antisera tested as it did not 
demonstrate any cross-reactions. However, the antibody was 
not tested against any of the mucoraceous fungi by CIE, 
double diffusion or ELISA but in the PAP staining of agar 
sections it did stain sections with M. hi email s.
The quality of the antisera used in immunoassays is 
dependent on several factors. The strain of fungus from 
which the antigen is produced will determine the antigenic 
properties of the extract used for antiserum production. 
Different strains of the same fungus may have different 
antigenic properties some of which may be similar to those 
produced by other genera. Whether the antigen was prepared 
from a culture filtrate, the entire mycelium or mycelium 
components will have a bearing on the final antiserum. The 
method of extraction and preparation of these components, 
eg. water soluble fractions or detergent extracted 
fractions will alter the nature of the antigen. The 
antigens used in this study were polyvalent preparations
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utilising all of the mycelium, thus they were composed of 
many different antigenic components.
Individual animals may recognise different components 
of the antigens and may exhibit slightly different 
immunological reactions to the same antigen. The 
commercial sera may have been the product oif several 
rabbits while the laboratory raised antisera were from 
single rabbits and were never pooled.
The different assay systems in this study, employed 
different reagents and this accounts for the lack of 
consistency of results obtained by the various tests. The 
number of steps required to perform the tests may also 
contribute to variation of the results. The double 
diffusion and CIE systems were the least sensitive at 
detecting cross-reactions, which is not surprising since 
there are no stages in the procedures which intensify the 
reaction.
The heterogenicity of fungal antigens and antibodies 
employed in different studies may be one explanation of 
the discrepancies in results found in this and other 
laboratories eg. Magaldi and M“*ckenzie <1984) did not find 
the A. flavus antigen reactive with the A. niger anti sera 
in the antibody-ELISA test.
The cross-reactivity found in various tests during this 
investigation indicate the passible complications that may 
be encountered when applying the PAP immunoperoxidase 
technique to the diagnosis of fungal disease.
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The laboratory produced sera all proved to be selective 
for their homologous genus. Unfortunately a great deal of 
intei— specific cross-reactions were demonstrated within 
genera. However, the commercial antisera were less 
specific and inter— genus cross-reactions were revealed. 
There was little evidence that false positive staining 
would occur when the laboratory produced antisera were 
employed. This indicates the suitability of these antisera 
for use in a diagnostic PAP staining system. The 
commercial Aspergillus antisera would be less suitable for 
use in such a system since an unacceptably high rate of 
false positive staining may occur.
Peroxidase Antiperoxidase Staining of Tissues
Having established the suitability of the various 
antisera for use in an immunohistochemical staining 
method, the peroxidase anti-peroxidase staining technique 
was evaluated for several clinical manifestations of 
opportunistic fungal diseases. The fungi were clearly 
stained and the technique performed well. There were 
several tissue types examined for each fungal infection 
and there were no apparent differences in background 
staining or the performance of the method with differing 
tissues. Regardless of which fungus or which organ was 
involved, staining was evident with the homologous primary 
antibody.
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C. albicans antisera was not absolutely specific since 
staining was evident when the antiserum was used as the 
primary antibody to stain the contents of an aspergilloma. 
This was in contrast to the findings with the agar block 
method, although the C. albicans antisera did show some 
cross-reactivity with A. flavus and A. niger in the 
antibody—ELISA test. The positive staining of the 
aspergilloma may have been due to the large amount of 
dense hyphae present which made a great number of common 
antigen sites available for binding. The A. fumigatus 
antisera did not stain tissues from diseases attributed to 
other fungi but clearly stained hyphal elements of 
Aspergillus in sections from patients with invasive 
aspergillosis, paranasal aspergillosis and aspergilloma. 
The R. oryzae antiserum was reasonably specific as it did 
not stain any of the sections from patients with 
aspergillosis or candidosis. However, all the sections 
from cases of suspected mucormycosis were stained although 
the aetiologic agent had not been determined in every case 
and possibly was not R . oryzae but some other mucoraceous 
fungus.
In summary, the PAP staining method appeared to be 
sensitive and able to demonstrate and identify fungi 
present in tissue even if present only in small amounts. 
There was a problem with background staining which was 
stronger than desirable on some occasions despite the 
blocking of endogenous peroxidase activity at the start of
2 5 5
the staining procedure. The dilution of the second stage 
antibody in human serum in addition to tris buffer helped 
to reduce this.
The technique is suitable for use as a diagnostic tool 
to aid the identification of the aetiologic agent of 
fungal infection. The method can distinguish to which 
family a fungus belongs and in many cases the particular 
genus. The PAP method produced consistant, reproduc i ble 
results. It is extremely sensitive, although this 
sensitivity increases the chances of demonstrating cross­
reactions with other fungi. The species of fungus can not 
be determined since there was evidence of cross-reactivity 
among species of the same genus.
Greater specificity may be achieved eventually by the 
use of monospecific or monoclonal antibodies but such 
antibodies would have to detect an antigen which is not 
only specific for the species but is ubiquitous to that 
species. The antisera would have to recognise a specific 
determinant common to every member of that species In 
vivo. Absorption of the antisera with antigens of other 
opportunistic fungi may help to eliminate some of the 
cross-reactivity but large quantities of antibody would be 
required.
The PAP method is a sensitive immunoperoxidase staining 
method and with the exception of the fungal antisera, the 
reagents employed are relatively inexpensive, readily
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obtainable, have a long shelf life and are interchangeable 
for detection of various antigens.
A drawback is perhaps the time required for processing 
the material because of the numerous antibody layers 
required. However, the need for more and better aids in 
the diagnosis of these serious and and ever more common 
Infections ensures immunoperoxidase staining a place in 
the mycological laboratory in the future.
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Epidemiology of Candida albicans Endophthalmitis in 
Glaswegian Heroin Addicts
An outbreak of endophthalmitis in heroin addicts in 
Glasgow was studied to determine the aetiologic agent, the 
source of the outbreak, the method of spread and, if 
possible, a method of containing the infection. Clinically 
the patients presented with optic symptoms suggestive of 
C. albicans endophthalmitis. This diagnosis was confirmed 
by culture of vitrectomy specimens and supported by 
Candida serology results. The possible sources of the 
infecting organism appeared to be the street drug, 
adulterants of the drug, the drug diluent, the injection 
paraphernalia or the addicts endogenous flora.
Some of the patients suspected a "pusher" may have been 
supplying them with heroin cut with bakers' yeast and 
initially S. cerevisiae was thought to be the aetiologic 
agent of this outbreak of endophthalmitis. Culture of 
dealers' and "pushers'" drug and their packets failed to 
yield any yeasts and indeed, whenever street heroin has 
been investigated by culture neither C. albicans nor S. 
cerevisiae have ever been grown (Mellinger et al., 1982; 
Moustoukas et al., 1983). This has been attributed to many
factors the most common being the small size and number of 
samples available but even when one hundred samples were 
cultured no evidence of yeast contamination was found 
(Tuazon et al., 1974).
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An explanation of the lack of cultural evidence for 
contamination of street heroin by yeasts, may be that 
diamorphine hydrochloride inhibits the growth of yeast.
The results of this investigation indicate that the neat 
drug in the powdered form is not only fungistatic but 
fungicidal for yeasts. However, when the drug was diluted 
in water and placed in wells in agar seeded with yeast no 
inhibition was detected. The passive diffusion of the drug 
through the agar may have been prevented by the drug 
binding to agar constituents. Some inhibition was evident 
when the diamorphine hydrochloride was incorporated in the 
agar. Broth dilution experiments showed that the 
concentration of the drug required to inhibit yeast growth 
was 20-50 mg/ml, which is substantially higher than the 
spectrum of activity of antifungal drugs.
The exposure time required to kill the strains of 
yeast, tested in a broth dilution system varied. The C. 
albicans isolates were more resistant than those of S. 
cerevisiae, taking a minimum of 4 hours to be killed at 
100 mg/ml.
ICso determinations were used to assess the effect of 
diamorphine hydrochloride. The measurement of MICs for 
drugs with an antifungal effect by agar incorporation and 
broth dilution methods can sometimes give misleading 
results. These methods can be dependant on inoculum size, 
temperature and duration of incubation. The end point of 
MIC assays can be subjective if there is partial
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inhibition over a range of concentrations (Johnson et 
al. , 1984). The IC3 0  method was beneficial as there was a
definite end point. Moreover, the amount of drug required
is small and a large number of isolates can be screened at
once. This made it an ideal system for testing all the 
isolates received from patients and injection apparatus. 
All of the yeast isolates cultured from the patients and 
their injection paraphernalia were killed by diamorphine 
hydrochloride in the range 20-78 mg/ml.
In an attempt to mimic the situation on the street,
diamorphine hydrochloride was mixed with freeze-dried 
cultures of C. albicans and S. cerevisiae. Even at 
proportions of eight parts diamorphine to one part yeast 
the yeasts remained viable and were recovered on glucose 
peptone agar medium. This is in contrast to the findings 
of Dupont and Drouhet (1985) who found that a paste of C. 
albicans and drug was able to inhibit the growth of the 
fungus after being stored at room temperature for one 
week. It may be significant that these workers chose to 
moisten the mixture and rehydration of the diamorphine 
hydrochloride may be required before its antifungal 
activity is expressed. However, in the present study, when 
a solution of diamorphine hydrochloride was stored for 24 
hours before it was tested no antifungal activity 
remained.
If there are any yeasts present in street heroin they 
may not be revealed by culture because they may be killed
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by the diamorphine hydrochloride, which, according to the 
results in this study has fungicidal activity. When the 
situation on the street was simulated despite employing 
pure diamorphine hydrochloride, a drug of greater quality 
and higher concentration than that purchased by addicts, 
the yeast was able to survive and remain viable in 
culture.
If the street drug was not the source of infection then 
the yeast may have originated from the addicts own flora 
of micro-organisms. Culture of body fluids and stool 
specimens from the addicts and culture of items of their 
injection utensils yielded several isolates of C. 
albicans. The biotyping system of Odds and Abbott <1980; 
1983) was employed to determine common features among the 
isolates. Biotyping fingerprints isolates of C. albicans 
by analysing their growth patterns on a range of different 
media. A biotype has no formal status and refers to a 
strain which has been differentiated experimentally beyond 
the level of species. The system was employed to try to 
discover if any common or similar strains of C. albicans 
had been isolated from the various samples cultured during 
the study.
Apart from addict number 22 who had two different 
biotypes the isolates from each of the individual addicts 
were similar and biotype number 153 was found from five 
different addicts. Addict number 23 harboured biotype 455, 
a different biotype from the other addicts. Unfortunately
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no one addict was available to donate a complete set of 
samples. The overall picture demonstrated a preponderance 
of biotype 153. This biotype has also been implicated in 
infections of heroin addicts in Madrid where it has been 
isolated from addicts skin lesions (F.C. Odds, personal 
communication). Every Isolate tested was positive for 
citric acid perhaps indicating their ability to survive 
and grow in lemon juice.
The practice of using "Jif" lemon juice to dissolve 
their heroin was peculiar to the addicts of the Castlemilk 
area of the city. Other addicts in different areas were 
not afflicted with endophthalmitis and used water or 
vinegar as a solvent. Fresh lemon juice has been 
implicated in this disease in heroin addicts before in 
Australia <Newton-John, 1984). The ability of C. albicans 
to survive in lemon juice from plastic "Jif" lemons, the 
preferred solvent of the Castlemilk heroin addicts, was 
examined. This investigation found that C. albicans could 
be grown in old or steamed lemon juice but after five 
hours in contact with new "Jif" lemon juice it was non- 
viable. Measurement of the levels of SOa present in 
samples of "Jif" lemon juice indicated that even a short 
period of steaming drove off significant amounts of the 
preservative. The samples of old juice tested had no 
detectable levels of preservative. The number of yeasts 
remaining viable in old lemon Juice and steamed lemon 
Juice with low levels of SOa increased dramatically over a
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24 hour period, whereas the number of viable yeasts in new 
juice dropped to zero after 24 hours illustrating the 
antifungal effect of the S02.
These results indicate the possibility of C. albicans 
surviving and multiplying in old "Jif" lemons near or past 
their "best by" date because the level of SOa preservative 
has been depleted to a level below which it could not be 
detected. "Jif" lemons past their "best by" date could be 
purchased in local shops in the area where the heroin 
abusers lived and indeed one of these lemons yielded a 
growth of A. niger. The addicts did not store their lemons 
under the ideal cool conditions but kept them with the 
rest of their paraphernalia at room temperature. This 
would enhance escape of the gaseous preservative through 
the plastic container and promote the growth of any micro­
organisms that were present. C. albicans was isolated as a 
confluent growth from Castlemilk addicts plastic lemons. 
Dupont and Drouhet <1985) believe that contamination from 
the diluent is unlikely to cause infection as the addicts 
heat the drug mixture before injection and they speculate 
that this will have a sterilising effect. This has yet to 
be substantiated by experiment.
If a heavy suspension of C. albicans, from a 
contaminated "Jif" lemon, was introduced into t^e blood 
stream of a heroin addict, it would be a larger inoculum 
than normally encountered in candidal infection. In 
addition the Immune status of heroin abusers might be
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impared. McDonough et al. , <1980) reported a significant
decrease in the total number of T lymphocytes In vivo and 
a concomitant increase in the number of null lymphocytes. 
Leukocytes may be a prime binding site for exogenous 
opiates in the peripheral circulating system since it has 
been determined thatphagocytic leukocytes have receptor 
sites for opiates. It has been demonstrated that the 
intracellular killing of C. albicans by polymorphonuclear 
leukocytes was reduced in one heroin abuser with pulmonary 
candidosis but in symptom-free addicts only minor 
abnormalities were noted <Lazzarin et al., 1985).
The culture results demonstrated that C. albicans was 
isolated from the needles, syringes and lemons of the 
addicts in addition to the addicts themselves whether as 
commensal colonisers in the mouth or gastrointestinal 
tract or as opportunistic pathogens isolated from vitreous 
or scalp lesions. The lemon juice may have become 
contaminated by C. albicans which possibly originated as 
part of the commensal flora of an addict. The yeast could 
grow in the lemon juice which was probably shared among 
several addicts, although the addicts involved in the 
outbreak claimed not to know each other and were adamant 
that they never shared syringes.
The similarity of the biotypes of the isloates is an 
indication that the yeasts may have had a common source or 
that a particularly viulent strain was involved. The 
Isolates from skin of a group of heroin abusers from
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Madrid have a preponderance of the same biotype. It is 
interesting to note that all the C. albicans tested were 
able to grow on the citric acid medium used as one of the 
tests in the biotyping procedure.
In conclusion, endophthalmitis in heroin abusers has 
been reported previously and in most reports it appears in 
clusters indicating a common source of infection. The most 
likely source is the drug itself but C. albicans has never 
been found. This work has indicated that the heroin 
diluent may be one reservoir of infection. A cocktail of 
lemon juice and C. albicans is perhaps being injected into 
the addict's blood stream along with other impurities 
present in the drug. The flakes of lemon present in the 
juice may cause obstructions that block the fine 
capillaries of the eye contributing to the start of the 
infection. The C. albicans may adhere to the endothelium 
of the capillaries more easily if the blood flow is slowed 
by a blockage. The yeast can reach and locate in the eye 
very quickly, as was demonstrated by the animal model and 
from there it may grow to form an infection focus.
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A Mouse Model For Haenatogenous Candida Endophthalmitis
This study has shown that the intravenous injection of 
mice with 1 X 10e cells of C. albicans into their tail 
veins was able to produce an experimental model of Candida 
endophthalmitis. This concentration of C. albicans 
consistently produced eye infection in Balb/c mice and, as 
illustrated by the mortality curve, allowed the mice to 
survive for two to eight days which is sufficient time for 
ocular lesions to develop or for the infection to clear.
In other experiments carried out under the same conditions 
the mice survived for up to 21 days. This may have been 
because some of the mice did not receive their full 
inoculum as the injection technique is difficult to 
perform. Alternatively, there may have been a greater 
range in the weights of the mice inoculated in these 
experiments with the larger mice receiving a 
proportionally smaller challenge for their body weight.
Fundus examination of selected animals revealed the 
start of ocular changes in the mice at three days post 
infection which is the same time interval after injection 
that Edwards et a 1. <1975) detected lesions appearing in
the eyes of infected rabbits. The mice showed detachment 
of the retina, which was visible as an increase in 
parallax between the retina and choroidal vessels. There 
was segmentation of the blood vessels. This may be a 
consequence of retinal vasculitis (an infiltration of
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inflammatory cells around the blood vessels) and may be an 
indication of a focus of infection. Vasculitis is also 
seen in cases of Candida endophthalmitis in man (Edwards, 
1974). Figure 37 illustrates inflammatory cells in the 
retina adjacent to a blood vessel. There was tortuosity of 
parts of the blood column which may have been caused by 
inflammation elevating and distorting the vessels. 
Examination by an indirect ophthalmoscope did not reveal 
the fluffy, snowball like lesions characteristic of human 
disease (Michelson et al. , 1971). This may have been due
to the small size of the lesions, perhaps insufficiently 
developed, or to the small sample of mice examined by this 
technique not accurately demonstrating the formation of 
lesions by the rest of the population.
The model demonstrated that the yeast reached the eye 
within a few minutes. This is not a surprising finding 
given that 0.2 ml of a blastospore suspension was injected 
into the mouse's blood system which has a total volume of 
about 3 ml.
The speed at which C. albicans is cleared from the 
blood of mice has been investigated by radiolabelling C. 
albicans with 1 and 1^^Ce (Trnovec et al., 1978). It
has been demonstrated that more than 85% of the 
radioactive cells were cleared from the blood within 30 
minutes and that by 24 hours less than 2% of the original 
radioactivity remained in the blood (Mardon and Robinette, 
1978). The earliest events in haematogenous Candida
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endophthalmitis must be adherence and penetration. In 
this particular study it was found that after one hour 
yeast was still present in the retina. This would be 
unusual if the fungus was being cleared from the blood 
stream unless some yeast adherence mechanism was taking 
place. Klotz et al. <1983) reported that C. albicans and
C. tropical Is which adhered to vascular endothelium in 
vitro were capable of transversing the endothelial surface 
before the production of germ tubes. These workers found 
adherence to be complete within 15 minutes and that as 
early as 15 minutes after attachment disruption of the 
endothelial cell surface was evident. Rotrosen et al.
<1985) studied the attachment of C. albicans to 
endothelial cells and found this was inhibited by rabbit 
antiserum to Candida which blocked the attachment by 
binding serum constituents to the organism. These workers 
implicated mannan associated cell wall constituents as the 
Candida adhesin in this system.
An alternative explanation is that the sheer size of 
the yeast relative to the small size of the blood vessels 
may have caused mechanical blockage. By 24 hours 
pseudomycelium and germ tubes developed in the retina and 
the number of visible yeasts increased, indicating some 
movement from the capillaries or perhaps as a result of 
bursting of these vessels.
C. albicans was able to divide and by 36 hours there 
were clumps of yeast cells seen throughout the retina. The
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yeast cells developed into focal lesions of infection 
which started to show disturbances of the nucleated cells 
of the retina. From these lesions the yeast could be seen 
spreading into the nerve fibre layer, the ganglion layer 
and the inner plexiform layers. This resulted in a bump 
being formed by the retina protruding into the vitreous. 
The protrusions started and grew at different rates in 
different mice. The raised lesion contained yeasts, 
pseudomycelium and inflammatory cells which were mainly 
mononuclear. Inflammatory cells were also seen in other 
layers of the retina. The results of this inflammatory 
process were the formation of discrete lesions surrounded 
by inflammatory cells which, in some cases, presumably 
resulted in the resolution of infection. The mice 
sacrificed later showed no evidence of infection. This may 
have been due to the mice overcoming the infection and 
clearing the Candida from their tissues. In the human 
manifestation of Candida endophthalmitis, spontaneous 
resolution is sometimes seen <Dellon et al., 1975).
The animal model showed a marked localisation of the 
lesions and there was no generalised inflammatory 
infiltration throughout the retina or choroid. The fungus 
appeared to be restricted to the areas associated with 
inflammatory cells. The damage of the adjacent retinal 
cells may have been caused by the Candida when it invaded 
the retina initially or been caused by the inflammatory 
cells releasing hydrolytic enzymes as has been suggested
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by Cohen et «al.<1977). Further evience thatC. albicans can 
cause tissue damage is provided by Danley and Polakoff, 
<1986). In their study C. albicans was described as 
having a cytotoxic effect. C. albicans was described as 
exhibiting a cytotoxic phenomenon 15 to 30 minutes after 
phagocytosis and this may represent an immediate reaction 
of blastospores when they are engulfed by phagocytes.
Quantitation of the fungal lesions by histological 
examination of the retinal sections indicated that the 
number of yeasts present in the eye immediately following 
inoculation was large. However, the number of yeasts 
visible decreased after one hour, illustrating the 
efficacy of the mouse system at clearing the fungus. The 
number of lesions increased at 36 hours as a consequence 
of multiplication of the viable yeasts which remained in 
the eye. The number of lesions reached a maximum at three 
days, after which time the number decreased. The decrease 
in the number of lesions may have been due to the mouse 
immune system arresting the development of the infection, 
resulting in survival of the mouse.
When the quantitative results of the lesions were 
compared with those of the average colony counts from 
eyes of mice sacrificed at the same times, a similar 
overall pattern emerged. There was an increase in the 
number of yeasts cultured, which reached a maximum at 
three days, decreasing at five days and dropping to zero 
at 22 days. However, the colony numbers in the first 24
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hours of the experiment did not reflect the number of 
lesions seen on histology. Demant and Easterbrook <1977) 
attempted to correlate culture results with clinical 
appearance in a rabbit model of the disease. They found 
the results could not be related consistently to the 
number and size of the lesions but the eye with the 
highest count was the only one with a vitreous haze. The 
authors attributed the lack of consistency to "inadequate 
homogenisation or poor dilution before plating". The 
discrepancy in the results of the present study may be due 
to the large range in the colony numbers for different 
mice sacrificed at the same time post challenge and the 
relatively small number of eyes investigated at each time.
The mice which were selected for early sacrifice were 
the ones not expected to survive the next 24 hours. 
Therefore mice which survived longest were either the ones 
most resistant to the infection or those mice which did 
not receive a full inoculum. Edwards et al. <1975) noted
flat chorioretinal scars in the eyes of rabbits caused by 
spontaneously healing lesions 52 days after infection.
In the present study the presence and severity of 
ocular lesions correlated with the presence of lesions in 
other organs. Histological examination of other organs 
showed development of lesions in the animals up to six 
days post challenge. The brain was heavily involved but 
the quantity of the brain lesions did not correlate with 
the other organs. This may have been a factor attributable
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to the small sample of mice subjected to detailed 
histological examination.
C. albicans endophthalmitis in the heroin addicts 
appeared to have an asymmetric distribution with the left 
eye being more frequently involved than the right. In the 
present mouse model there was no predominant involvement 
of one eye. However, some asymmetrical distribution of the 
fungus between the eyes was noted. Three groups of mice 
had their eyes removed after sacrifice, the eyes were 
cultured and the colony counts per eye were ascertained. 
Each of the three groups of animals analysed showed 
overall significant differences in the distribution of the 
yeast between the two eyes at the 5% level. In the third 
group, the mice sacrificed at five minutes, one hour and 
six hours showed a significant difference in the number of 
yeasts between the eyes of the mice. However, when group 
two was examined for asymmetrical distribution of fungus 
between the eyes at each time interval, there was no 
significant difference in the number of yeasts per eye in 
the mice sacrificed at three and five days post challenge.
When the results of the three groups were collated 
there was a significant difference for the first six hours 
post challenge. From 24 hours onwards there was no 
significant difference in the number of yeasts cultured 
from each eye of the mice. When the results were analysed 
overall there was a significant difference in the number 
of yeasts cultured from each of the two eyes of the mice,
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indicating an asymmetric distribution of the Candida. This 
peculiar phenomenon is difficult to interpret since there 
was a large range in the number of yeasts cultured from 
both eyes of different mice sacrificed at the same time 
post infection. The change in the significance of the 
yeast distribution, may be a reflection of the course of 
the disease. There may be an uneven distribution of the 
yeasts in the eyes or there may be an uneven clearing of 
the yeasts from the eyes. The original focus of infection 
may be unilateral and may act as a reservoir of the fungus 
which could then spread to the other eye.
The infection appears to take 24 hours to become 
established and for the yeasts to multiply. After it 
becomes established and forms a focus of infection the 
lesion may shed yeasts into the blood stream and these 
yeasts, if not destroyed by the mouse's phagocytes, may 
initiate a futher focus of infection elsewhere including 
the other eye. However, the infected lesions in the eyes 
appear to be discrete and contained by inflammatory cells. 
Moreover, if re-infection occurs, spontaneous resolution 
would be more difficult to explain, unless the yeast 
disseminates within the first 24 hours and before the host 
defences have succeeded in containing the infection. After 
24 hours the mice may be able to contain the fungus by 
surrounding the original focus with inflammatory cells 
thus preventing reinoculation of the blood stream. The 
immune system may then overcame the infection.
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The theory that yeasts are present in the blood and 
eyes of the animals is borne out by the culture results of 
the eyes, regardless of how long post challenge minimal 
growth of C. albicans was found. Blood cultures in 
animals with haematogenous C. albicans endophthalmitis 
have been consistently negative (Edwards, 1985).
The presence of Candida antigenaemia in the mouse model 
was investigated to study the kinetics of antigen release 
following systemic challenge with C. albicans. Two kits 
were compared in the tests but the Imrny kit produced 60% 
false positive results. The Mercia Diagnostics kit showed 
that no mannan was detectable until 24 hours post 
challenge. The fact that the kit did not detect the 
presence of mannan at 5 minutes post infection when there 
was a large number of yeasts in the mouse's body may be 
explained by the theory that the yeast cells may have to 
be phagocytosed before the mannan is released (Taschdj ian « 
et al., 1971) and that this method of detection is most
useful in diagnosing acute infection. If the patient has 
no immune function and the yeasts are not damaged 
sufficiently to release mannan then the kit will not 
detect the presence of the yeast. Detectable mannan 
persisted in the mice until the end of the experimental 
period of 72 hours. This indicated a pocket of infection 
releasing mannan into the blood stream. Mannan has been 
shown to be cleared from the blood rapidly, the plasma
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half life of Candida mannan is two hours <Kappe and 
Muller, personal communication) .
There requires to be a level of 25 pg /ml of mannan 
before it is detectable by the Mercia Diagnostics kit as 
used in this laboratory.
For future work it may be informative to look for the 
presence of mannan in the murine eyes and relate this to 
the presence of mannan in the sera. The volume of the 
vitreous of a mouse is too small to extract and test. 
However, the eye could be homogenised in a small volume of 
distilled water before testing. Preliminary results have 
demonstrated that after five minutes in water, viable C. 
albicans at a concentration of 1 x 103/ml, releases 
mannan, at levels which could be detected by the Mercia 
Diagnostics kit.
The protocol used in this study produced a reliable 
model for Candida endophthalmitis. Ocular changes were 
seen by fundus examination and study of the histological 
sections revealed the development of lesions containing 
yeasts and inflammatory cells within the retina. The 
number and severity of eye lesions correlated with lesions 
seen in other organs of the mice and reflected the 
progress of the infection as determined by culture of 
mouse eyes. This mouse model for Candida endophthalmitis 
has great potential for the study of the treatment of the 
disease by antifungal drugs and the assessment of their 
retinal toxicity.
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